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1. INTRODUCTION
One of the important functions of the immune system is the discrimination between “self” 
and “nonself”, or perhaps better between “danger” and “non-danger”. Currently, it is thought 
that such discrimination is made through a series of complicated and multi-step interactions 
between various cells and compounds of the immune system. Immune cells sometimes 
erroneously establish an immune reaction towards “self” during conditions of apparent “non-
danger”. If such immune reactions are violently self-directed, they may inflict pathological 
damage on tissues. So-called “autoimmune diseases” are the consequence.
Autoimmune diseases can be divided into two main categories: “organ-specific” and 
“systemic” autoimmune diseases. In the organ-specific autoimmune diseases, the immune 
attack is confined to one organ or organ system, while in the systemic autoimmune diseases 
the damage is widespread and often the consequence of immune complex destruction. 
In the majority of organ-specific autoimmune diseases, target tissues are of neuro-endocrine 
character; hence this category of autoimmune diseases is often referred to as “neuro-endocrine 
autoimmune diseases”. Important target tissues are the thyroid, the islets of Langerhans, 
the stomach, the adrenal and the ovary; important neurological target tissues are both the 
peripheral and central nerves. In this thesis emphasis is on the study of an animal model of 
endocrine autoimmunity, i.e. the Biobreeding (BB)-rat, an inbred animal in which thyroid and 
islet autoimmunity develop spontaneously in a large proportion of animals.
There are ethical and technical restrictions to studying the etiology and the pathogenesis 
of endocrine autoimmune diseases in man. Reliance on animal models is in part recognition 
of the primacy of patient safety - primum non nocere - first do no harm.1 In man the endocrine 
organ-specific autoimmune diseases often have sub- or non-clinical prodromal phases, which 
are difficult to study since signs and symptoms are virtually absent. In animal models these 
studies can be done. Unlike humans, animals with endocrine organ-specific autoimmune 
diseases can be bred to study and manipulate inheritance. Biopsies can be taken and the 
animals autopsied. Their genome can be altered. Therapies to prevent or reverse the disease 
can readily be tested. 
Over the past 50 years a number of animal models of various endocrine autoimmune 
diseases have been developed (Table I). These animal models have greatly contributed to the 
knowledge concerning the etiology and the pathogenesis of endocrine autoimmune diseases 
and their possible prevention and treatment. A word of caution is, however, necessary when 
trying to extrapolate data obtained in these animal models to the human situation. The animal 
models clearly show a caricature of the more complex and probably diverse human disorder. 
The animal disease is often studied in specifically inbred animals to generate homogenous 
and extreme forms of the diseases. In this way the disease will not only differ from the 
human disorder but also between various animal models. Hence, general conclusions drawn 
from studies in one of the animal models should always be verified in other animal models 
and in patients. This is exactly what we will do in the discussion section of this thesis; we 
will describe in detail what is presently known on the abnormalities in dendritic cell (DC) 
generation and function linked to the endocrine autoimmune reaction in the BB-DP rat, and 
we will compare these to the ones known in the NOD mouse (another model of spontaneously 
developing endocrine autoimmunity) and to the ones found in patients.
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Recent studies have culminated in the awareness that endocrine autoimmune diseases must 
be regarded as polygenic diseases, in which the penetrance of a combination of genes is strongly 
influenced by environmental factors. Firstly, multiple gene polymorphisms determine part of 
the aberrant immune response towards the endocrine self. The most important polymorphisms 
are those in the MHC region, pointing to differences in autoantigen presentation.2,3,4 
However other polymorphisms are also involved, including those with a general role in the 
regulation of the immune response, e.g. in the CTLA-4 and PTPN22 genes.5-9 There is also 
the involvement of polymorphisms and even mutations in genes controlling autoantigen 
presentation in the thymus, such as the VNT-INS gene10 and AIRE gene11 respectively, which 
force the thymocytes to develop into autoreactive T cells. However, genetic polymorphisms 
or mutations are clearly not explaining the etiology in total. Mono-zygotic twin studies, for 
example, have shown a concordance rate ranging from an 80% for thyroid autoantibody 
positivity,12 via a 30-40% for type-1 diabetes13 to a meager 20% for Graves’ disease.14 
This demonstrates the important role of environmental eliciting factors in the development of 
endocrine autoimmune diseases. Despite this important role of the environment, this thesis 
will primarily focus on the dendritic cell abnormalities in the BB rat in relation to the genes 
found important in this animal model. But I will here start the introduction with a section on 
tolerance.
2. TOLERANCE MECHANISMS 
An essential prerequisite for the pathogenesis of autoimmune diseases is the breakdown of 
immune tolerance. Immune tolerance is defined as a state of unresponsiveness of the immune 
system against a specific antigen (Ag) or group of Ags. In the following section we will 
discuss the two main mechanisms of tolerance: central and peripheral tolerance. 
Central tolerance in the process in which autoreactive lymphocytes are deleted from the 
repertoire, this occurs with regard to autoreactive T cells in the thymus. At the same time 
special subtypes of regulatory T cells (dampening autoreactive reactions) are created in the 
thymus in the central tolerance process. 
Peripheral tolerance in the process in which autoreactive lymphocytes, which have escaped 
central tolerance mechanisms are kept under control in the periphery, e.g. by processes 
of Activation Induced T Cell Death (AITCD), negative signaling or by regulatory T cells 
expanded in the periphery from naïve T cells.
2.1. Central intrathymic tolerance 
The thymus can spatially be subdivided into three main areas: cortex, medulla and cortico-
medullary junction (Figure 1). The cortex consists mainly of thymocytes, cortical epithelial 
cells and, phagocytic ‘tingible body’ macrophages. The cortico-medullary junction mainly 
contains DC. The medulla contains more mature T cells, prominent medullary epithelial cells, 
Hassall’s corpuscles, macrophages, dendritic cells and B cells. 
The thymus being a prime central lymphoid organ acts as the T cell education center 
ensuring that T lymphocytes capable of reacting with foreign antigens are positively selected 
forming a recruitable population in our repertoire, while potentially strong autoreactive 
T effector lymphocytes are largely deleted from the repertoire (negative selection) or, when 
escaping negative selection are kept under control. 
13
Chapter I General Introduction
The first checkpoint during T cell differentiation in the thymus is the so-called β-selection, 
which occurs upon pre-TCR signaling and ensures that only DN thymocytes which have 
successfully rearranged their TCRβ locus proceed to the DP (CD4+CD8+) thymocyte stage.15 
When the DP stage has successfully been reached TCRα is rearranged and all further selection 
of thymocytes is dictated by peptide-MHC class II (p-MHC) interaction on stromal cells 
within the thymus. Below I will discuss positive selection and negative selection.
2.1.1. Positive selection
Positive selection refers to the active process of rescuing MHC-restricted thymocytes 
from programmed cell death. Positive selection of thymocytes occurs when the thymocyte 
TCR interacts with p-MHC in a certain window of affinity/avidity. If this is interpreted as an 
unnecessary specificity, meaning a lack of self-MHC restriction (non-recognition), the result 
will be so-called “death by neglect” of thymocytes and the thymocytes will go into apotosis 
via an intrinsic death program. The loss of thymocytes during positive selection is mitigated 
by two mechanisms. First, TCRs normally randomly generated have an intrinsic affinity for 
their polymorphic MHC ligands. Second, the TCRα locus is able to recombinate several times 
within the 3-4 day life span of a DP thymocytes, allowing different TCR specificities to be 
generated and tested. This increases the chance of an appropriate TCR/p-MHC match and 
thereby thymocyte survival and the creation of a meaningful repertoire. Nonetheless most of 
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Figure 1. Cellular composition of the thymus.
The major cell types and the sequential cell-cell interactions along the development pathway of a thymocyte are 
depicted. Figure adopted from Kyewski et al. (2006).
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the thymocyte apoptosis is attributed to death by neglect, leading to a loss of thymocytes of 
approximately 90-95% and thus only 5-10% of developing thymocytes recognize a meaningful 
p-MHC on antigen-presenting cells in the cortex. Positive selection is generally thought to be 
mainly mediated by the MHC expressing thymus epithelial cells (TEC) in the cortex,16 though 
we will give evidence in this thesis for a special sub-set of macrophages in the thymus cortex 
of the rat (the so-called branched cortical macrophages), which are also involved in positive 
selection. 
2.1.2. Negative selection
Negative selection refers to the deletion or inactivation of potentially strong autoreactive 
effector thymocytes by interaction of these thymocytes with thymus APC expressing relevant 
autoantigens. 
The medulla and cortico-medullary junction are thought to be the prime sites of getting 
rid of potentially autoreactive effector thymocytes. Three strong arguments support this view. 
First, at the double-positive stage the TCR is not fully up-regulated in the cortex. This low 
TCR is beneficial in the cortex, since this causes a bias towards low-avidity interactions with 
p-MHC, tipping the balance towards positive selection. Second, during transition into the 
medulla, full TCR up-regulation (T cell intrinsic) and co-stimulatory expression by DCs 
and medullary TECs (T cell extrinsic) provide a bias towards high-avidity signals. Third, 
the medulla provides the ideal environment, since self-antigens are expressed here. Negative 
selection depends a.o. on the tissue-specific antigen expression governed by the transcription 
factor Aire (highly expressed in medullary TECs). Because negative selection is imperfect, 
normal individuals harbour potential autoreactive effector T lymphocytes. 
Next to the TECs thymic DC are thought to play a role in negative selection. 
Thymic DC are mainly localized at the cortico-medullary junction and in the medulla of the 
thymus. The first evidence for a role of bone-marrow derived cells (not being epithelial cells) 
in negative selection came from studies using radiation induced bone-marrow chimeras. 
Presently several experiments suggest DC to be involved in negative selection: 
DC introduced in thymus organ cultures induce tolerance to alloantigen.17 Furthermore 
selective expression of MHC class II I-E molecules on DCs under the control of the CD11c 
promoter resulted in the deletion of I-E-reactive CD4+ T cells.18
In the mouse thymus two myeloid DC lineages contribute to the DC in the thymus. 
The CD11c+CD8α+CD11b− sub-set develops within the thymus from early thymocyte 
precursors (the lymphoid lineage) and is the most predominant population, whereas the 
CD11c+CD8α−CD11b+ sub-set (the myeloid lineage) derives from myeloid DC precursors 
most likely circulating in the blood.19 In the human thymus three distinct thymic DC are 
existing: the plasmacytoid DC and two myeloid DC sub-sets. The two myeloid DC are the 
CD11c+CD11b- sub-set and the CD11c+CD11b+ sub-set.20 The human lymphoid DC lineage 
probably also occurs in the thymus, but specific markers for this sub-set are lacking.21 The role 
of the different thymic DC sub-sets is at present ill-defined.
2.1.3. The expression of autoantigens in the thymus
Antigens are expressed intrathymically by thymic APCs, i.e. the cortical and medullary 
thymic epithelial cells (cTECs and mTECs), thymic DCs, macrophages, and B cells. 
15
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Another way that antigen gains access to the thymus is via the circulation. The most prominent 
cell type expressing antigens is the mTEC. mTECS have recently been attributed a great 
deal of attention, since they express and present a vast array of tissue-restricted antigens. 
Therefore they are excellently equipped to perform a main task, the negative selection of 
potentially autoreactive effector T cells. Aire is presently the only known gene expressed in 
the thymus governing autoantigen expression, but the molecular and gene expression in the 
thymus regarding the expression of autoantigens is at present poorly understood.11 Within the 
thymus Aire is highly expressed in mTECs, but also in DC, be it at much lower levels.22 Aire is 
mutated in the rare autoimmune disorder autoimmune polyglandular syndrome type 1 (APS-1). 
Studies in Aire-/- mice have demonstrated that the Aire protein induces thymic-specific 
transcription of tissue-specific genes, which are involved in the establishment of central 
tolerance, such as oxytocin, insulin-like growth factor 2, insulin and neuropeptide Y.23
Interestingly, members of the major autoantigen in T1D, the insulin family, are all expressed 
in the thymus stroma according to a specific hierarchy and cellular topography. Insulin-like 
growth factor 2 (IGF-2) expression by TECs is the highest followed by IGF-1 expression 
by macrophages and INS expression by mTEC and/or DC.24-26 Considering this specific 
hierarchial gene expression pattern, IGF-2 is better tolerated than INS. These observations are 
important in view of the fact that thymic expression of autoantigens increases self-tolerance 
and increases resistance against autoimmunity.23,27 
2.1.4. The CD4+CD25+ T cells
Apart from playing a role in positive and negative selection shaping the T cell repertoire, 
the thymus also creates naturally occurring regulatory T cells preventing autoimmunity. 
This is essential since negative selection is imperfect and autoreactive T effector cells have 
escaped to the periphery. We will here briefly discuss the CD4+CD25+ T cells, the ART2+ 
regulatory T cells of the rat and the Invariant Natural Killer T (i-NKT) cells.
The recent interest in CD4+CD25+ T cells as a specific sub-population of thymus-derived 
regulatory T cells has a historical association with the day-3-mouse thymectomy model.28,29 
Day 3 neonatal thymectomy-induced autoimmune disease is due to a lack of CD4+CD25+ 
T cell migration into the periphery, since these regulatory cells typically migrate out of the 
thymus in this early period and since injection of purified CD4+CD25+ T cells into neonatally 
thymectomized mice prevents the development of autoimmunity. CD4+CD25+ T cells 
develop in the thymus via a distinct pathway of thymic selection requiring the expression 
of endogenous TCRα chains on the cells for selection since CD4+CD25+ T cells are absent 
in TCR transgenic mice on a RAG-deficient background. A feature of CD4+CD25+ T cells 
is that the cells themselves are “anergic” to mitogenic stimuli, but are in addition capable to 
suppress the proliferation of CD4+CD25- T cells when cultured together. Such suppression 
can be abrogated by the addition of interleukin (IL)-2, IL-15 or stimulation with anti-CD28 
antibodies. The mechanisms of suppression by CD4+CD25+ T cells are not clarified yet, but 
are presently subject of intensive research.30,31 
Naturally occurring CD4+CD25+ Treg cells are defined by the constitutive expression of 
the high-affinity IL-2 receptor α chain (CD25) and IL-2 is indeed required for triggering their 
suppressive function.32,33 
In human fetuses CD4+CD25+ Tregs can already be detected at an gestational age of 
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13 weeks and are already fully functional, able to maintain homeostasis at this early life-
stage.34 The differentiation of the majority of Tregs in the thymus commences upon induction 
of Foxp3 in a sub-set of thymocytes expressing αβ TCR having increased affinity for self 
p-MHC complexes.35 The transcription factor forkhead box p3 (Foxp3), a gene coding for a 
member of the forkhead/winged-helix family of transcriptional regulators has been shown 
to be a specific marker for naturally occurring CD4+CD25+ Treg, playing a role as a key 
regulator in the programming of nTregs.36,37,38 The continuous expression of Foxp3 is necessary 
to actively maintain a suppressive phenotype.39 Additional signaling through the common 
γ chain (γc) and CD28 facilitates the Foxp3 dependent Treg development.40 When analyzing 
Foxp3+ cells histologically, they are primarily localized within the thymic medulla, a region 
containing mature thymocytes.38,41 In accordance with this more than 90% of the Foxp3+CD4+ 
SP cells express low levels of CD24 (HSAlo), a marker for mature thymocytes.35 Next to CD25 
expression naturally occurring Tregs are characterized by high surface expression of CTLA-4 
and GITR.
Recently, an IL-7 like cytokine (TSLP, thymic stromal lymphopoietin), expressed by 
epithelial cells of the Hassall’s corpuscles (HSC), is suggested to play a role in Treg selection. 
The TSLP-R (IL-7-like R) expressed by thymic DC has been suggested to positively select 
CD4+CD25+Foxp3+ Tregs in the human thymic medulla.42 A recent report in mice confirms 
the role of TSLP in Treg induction: TSLP strongly promotes Foxp3+ Tregs in mouse thymic 
organ cultures.43 
2.1.5. ART2+ regulatory T cells
ART2+ cells (formerly known as RT6+) are known for quite some time to be important 
in the prevention of autoimmune diabetes in the BB rat model, since the adoptive transfer 
of these cells in BB-DP rats (lacking ART2+ cells) prevented autoimmune diabetes, while 
ART2 depletion induced autoimmune diabetes in BB-Diabetes Resistant (DR) rats, a sub-line 
of BB rats having ART2+ cells and without diabetes. Hillebrands et al. recently showed that 
there are two distinct potent ART2+ Treg populations: CD4+ART2+CD25+Foxp3+CD45RC-
PD-1+ and CD4+ART2+CD25-Foxp3-CD45RC-PD-1+ T cells.44 The former overlaps with the 
natural occurring Treg cells being hyporesponsive and suppressive both in vivo and in vitro, 
while the latter is suppressive in vivo, but is not hyporesponsive and not suppressive in vitro. 
Both ART2+ Treg populations were capable of preventing diabetes in BB-DP rats.
Until now not much is specifically known about the induction of these ART2+ cells in the 
rat. Future work must uncover the exact mechanisms responsible for the induction of these 
important Treg populations in the rat.
2.1.6. Invariant Natural Killer T cells and other naturally occurring Tregs
Invariant (i)-NKT cells comprise a unique sub-set of T cells that co-express an invariant 
(i) TCR and natural killer (NK) cell related surface marker, including NK1.1.45 i-NKT cell 
development is thymus dependent or independent and the liver serves as a candidate site for 
the extrathymic development of i-NKT cells, although this issue is controversial. 
The strongest evidence in support of a role for i-NKT cells in the regulation of autoimmunity 
is provided by studies of autoimmune diabetes in humans,46 NOD mice47,48,49 and BB rats.50 
Considerable evidence suggests that NOD mice and T1D patients suffer from numerical and 
17
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functional deficiencies in i-NKT cells. In BB rats i-NKT cells numbers are reduced to 10% 
as compared with Diabetes Resistant rats.50 It is thought that i-NKT cells can stimulate the 
maturation of dendritic cells, indirectly leading to Treg induction.51 
Other Treg sub-sets include the CD4+CD25+CD27+CD70−CD62L+CTLA4high (CD27+Treg) 
and CD4+CD25−CD27−CD70+CD62L−CTLA4intermediate (CD27-Treg) cells. CD27 is a member 
of the tumor necrosis factor-receptor family.5 Among CD8+ T cells regulatory T cells 
sub-sets are also existing, like the CD8+CD28-.53 This sub-set was effective in prevention of 
experimentally induced EAE54 and Inflammatory Bowel Disease.55 
2.2. Peripheral tolerance 
 
2.2.1. Tolerogenic DC and Treg cell maintenance and induction
Recently more insight has been gained on the importance of tolerogenic DC. 
Several tolerogenic DC populations and tolerogenic DC states have been described 
(Figure 2). 
Although most early reports suggest that ‘’immature DC’’ act as tolerogenic DC by virtue 
of their anergy induction, more recent reports show that in particular also so-called steady 
state and semi-mature DC (i.e. naturally traveling DC not activated by “danger signals”) are 
particularly tolerogenic and the main inducers of Tregs, while DC activated by danger signals 
via their Toll-Like Receptors (TLR, e.g. TLR4 via LPS stimulation) are the ones instrumental 
in the expansion of effector T cells from naïve T cells.56,57,58 The nomenclature of immature 
DC vs. mature DC is thus an oversimplification. There exist even mature DC stimulated by 
bacterial products that are tolerogenic. In fact DC encounter during their differentiation and 
depending on their localization (skin, liver, gut, lungs, etc.) and milieu (neuro-endocrine/
DC DC DC
T T T
Immature DCs
(Class IIlow, B7low, IL-12_,
IL-6_, IL-10_)
Functional
unresponsiveness
TGF-� IL-10
Regulatory T cells
(Tr1, CD4+CD25+)
Effector cells
AITCD
CTLA4
PDL
Fas-FasL
Semi-mature DCs
(Class IIhi, B7hi, IL-12_,
IL-6_, IL-10_/+, TNF-�_)
Fully mature DCs
(Class IIhi, B7hi, IL-12++,
IL-6+, TNF-�+)
IL-2 IFN-�
Figure 2. The maturation state of a DC determines the T cell response.
Immature DC induce unresponsiveness of T cells, while semi-mature DC induce regulatory T cells (naturally occurring 
CD4+CD25+ T cells and the adaptive regulatory Tr1 cells). Mature DC induce effector T cells and Activation Induced 
T Cell Death (AITCD) via CTLA-4, PDL and Fas-FasL interaction. Adopted from Lutz et al. (2002).
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hormonal and microbial) various signals via their large array of surface receptors; these 
signals are then integrated resulting in either an immunogenic or tolerogenic DC phenotype.
One of the first populations of tolerogenic DC described in vitro and in vivo is the semi-
mature DC which arise after maturation of immature DC (iDC) with TNF-α.59,60 These in vitro 
generated semi-mature DC resemble steady state migratory DC61,62 transporting self-antigens 
for peripheral tolerance in vivo. These semi-mature DC are able to induce CD4+ Tr1 cells.63 
Next to myeloid DC, plasmacytoid DC are capable to act as tolerogenic DC. 
Plasmacytoid DC can induce both CD4+ and CD8+ Tr1 cells. Particularly in the lung 
environment plasmacytoid DC have been shown to be important in the maintenance of 
tolerance. In the lung environment plasmacytoid DC are able, in an ICOS-L dependent way, 
to directly stimulate the formation of Treg and are able to suppress the potential of mDC to 
generate effector T cells.64
Also the mature myeloid DC populations, in particular, have been shown to be effective in 
expanding Tregs especially in an antigen-specific in vitro setup.56,57 
Some populations of tolerogenic DC express IDO (indoleamine 2,3-dioxygenase), an 
enzyme degrading tryptophan, which is an essential amino acid. The mechanism of action 
of IDO expressing DCs is the inhibition of T cell proliferation by depleting the T cells of the 
essential amino acid tryptophan. Apart from that, IDO also generates quinolinic acid, while 
degrading tryptophan. This compound is thought to have a direct effect on the generation of 
adaptive Treg cells from naïve T cells.
Suffice now to say, that the book on tolerogenic DC has not been closed and that many 
more populations/states are and will be described influencing Treg cell development and 
tolerance induction.
2.2.2 Adaptive Tregulator cells
Adaptive Tregs, unlike naturally occurring CD4+CD25+ Tregs, originate from uncommitted 
naïve or memory Th cells upon activation by tolerogenic APC. We will discuss just two well-
known populations, the Tr1 and Th3 cells.
2.2.2.1. Tr1 cells
The hallmark of Tr1 cells is their high production of IL-10. Tr1 cells are inducible in an 
antigen-specific manner via an IL-10 dependent process in the periphery from naïve CD4+ 
T cells (but it has also been suggested that they are able to arise from Th1 and Th2 cells) and 
can therefore be considered adaptive Tregs. Studying Tr1 cells has been hampered by a lack 
of a specific marker for this particular sub-set. Tr1 cells, unlike nTregs, do not constitutively 
express Foxp3.
Specific IL-10 producing DC and plasmacytoid DC play an important role in the induction 
of Tr1 cells, the latter for the induction of CD8+ Tr1 cells. An important growth/survival factor 
for Tr1 cells is IL-15. The mechanism of suppression by Tr1 cells is by the secretion of the 
cytokines IL-10 and TGF-β. IL-10 can mediate tolerance directly and indirectly. IL-10 with 
or without IFN-α can directly stimulate development of Tregs from human naïve T cells in 
vitro.65 IL-10 indirectly suppresses cytokine production and proliferation of CD4+ T cells by 
inhibiting the antigen-presenting capacity of APCs (DC, Langerhans cells and macrophages). 
Furthermore IL-10 inhibits the full maturation of DC and down-regulates MHC class II 
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expression and the capacity to produce IL-12.66 Finally IL-10 treated DC with/without TGF-β 
can become regulatory DC, which consequently are able to induce Tr1 cells.66 
2.2.2.2. Th3 cells
Th3 cells are another adaptive Treg sub-set, defined by their high production of TGF-β. 
In this way Th3 cells are able to directly regulate T cell function by inhibiting T cell proliferation 
and indirectly by induction of Foxp3+ Tregs in the periphery. Like the naturally occurring 
CD4+CD25+ Treg, Th3 cells express the transcription factor Foxp3. Unlike natural Treg, 
IL-2 is dispensable for induction and Th3 cells can differentiate from the same precursor as 
pathogenic T cells.67 
Th3 can affect DCs, since DC that encounter TGF-β1 down-regulate expression of CD80, 
CD86, TLR468 and, importantly, CCR769. Low expression of CCR7 inhibits MIP-3β-induced 
migration to lymph nodes. Therefore, T lymphocyte stimulation is inhibited. The inability to 
recognize pro-inflammatory microbial products combined with decreased signaling capacity 
likely renders TGF-β1-treated dendritic cells ineffective in driving T lymphocyte immunity. 
TGF-β is also important for the maintenance of peripheral Tregs. Several groups showed 
that in vitro sorted CD4+CD25- T cells stimulated with TGF-β, resulted in the generation of 
CD25+Foxp3+ comprising 10-50% of the proliferating cells.70,71,72 In addition it was shown 
that IL-2 was a prerequisite for the TGF-β mediated induction of Tregs.73,74 
2.2.3. Activation induced T lymphocyte death (AITCD)
Apart from maintenance of naturally occurring Treg cells and the induction of adaptive 
Treg cells AITCD plays an important role in keeping autoreactive T cells under control. 
After an effective immune response the activated T cells have to be removed, since they may 
be dangerous due to their secretion of inflammatory molecules and their cytotoxic activity. 
Further full TCR stimulation of already activated and expanded T cells can result in the 
efficient induction of AITCD, an apoptotic process.74 AITCD occurs via stimulation through 
CD9576, TNFR177 and TRAILR78 and is induced by fully mature DC.
3. SOME FREQUENTLY USED ANIMAL MODELS OF 
SPONTANEOUSLY DVELOPING AUTOIMMUNE DISEASE
Efforts to understand the patho-physiology of endocrine autoimmune diseases have 
involved animal models of the diseases that develop “spontaneously”, or are induced by either 
environmental perturbations, or by genetic manipulations (transgenes and knockouts) (Table I). 
Of the spontaneous animal models the Bio-Breeding Diabetes-Prone (BB-DP) rat and 
the Non Obese Diabetes (NOD) mouse are the best studied models, and in this thesis we will 
concentrate on the BB-DP rat.
3.1. The BB-DP rat
The BB-DP rat is primarily used as a model for autoimmune diabetes.79 In fact, this animal 
model is a model for autoimmune polyglandular syndrome (APS) type 3a, since the animal 
also has autoimmune thyroiditis.
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The spontaneous diabetic BB rat was discovered in a commercial breeding colony in 
Canada in the 1970’s. Inbred diabetes-prone BB (BB-DP) rats spontaneously develop in 
a couple of days a T cell dependent insulitis, leading to a ketosis-prone diabetes, which is 
clinically very similar to T1D in humans. In generating the BB-DP line the animals were 
subject to inbreeding of different lines with a variable frequency of diabetes. During 
the course of this work it was discovered that the rats had profound T cell lymphopenia. 
The lymphopenia is a recessive trait and the animals are lymphopenic from birth onwards due 
to a mutation in one of the Immune-associated nucleotide (Ian) genes on rat chromosome 4.80,81 
The diabetes develops in most DP lines at around the age of 8-12 weeks. Histologically 
infiltrative insulitis develops for each islet rapidly (in a few days), but each islet is not affected 
at the same time. Insulitis is not characterized by a large peri-insular accumulation of lymphoid 
cells, as in the NOD mouse (see below). Females and males are equally affected. 
There also exist sub-lines of the BB-DP rat, that are not lymphopenic and do not develop 
diabetes. These lines are referred to as Diabetes Resistant or BB-DR rats. The peripheral 
lymphopenia of the BB-DP rat is primarily due to a lack of ART2+ T cells.82 ART2 is a marker 
for a sub-set of regulatory T cells (see before). Transfers of ART2+ T cells from BB-DR rats to 
BB-DP rats prevent disease.83 Although diabetes-resistant BB-DR rats are sufficient in ART2+ 
T cells, they are still prone to diabetes: infection with Kilham Rat Virus (KRV) is a known 
inducer of autoimmune diabetes in these rats.84 The virus does not infect islet cells, but the 
macrophages of the animal and perturbs the immune system of the BB-DR rats resulting in 
changes in the balance from Th2 to Th1 mechanisms.85 Also treatment with poly I:C induces 
diabetes in these rats. A standardized approach is to treat the BB-DR rats with monoclonal 
anti-ART2 antibodies (depleting ART2+ T cells) and poly I:C (stimulating TLR3), a treatment 
that effectively accelerates the onset of insulitis and diabetes. Reciprocal cross-intercross 
breeding to establish a congenic BB-DR rat with lymphopenia showed that the Ian5 gene 
mutation only was sufficient to induce spontaneous diabetes in all rats provided that the rats 
were kept specific pathogen free.86 
BB-DP rats also suffer from a form of focal lymphocytic infiltrations that under normal 
conditions do not lead to hypothyroidism.87 Yet thyroid failure becomes apparent after hemi-
thyroidectomy of the animals. Aggravation of focal infiltrations can also be observed when 
the animals are fed a high iodine diet.88,89 The thyroiditis is genetically linked to the MHC 
class II RT1u haplotype rather than to the Ian5 gene mutation.90
3.2. The NOD mouse 
The NOD mouse is predominantly studied for its autoimmune diabetes and autoimmune 
sialo-adenitis. The NOD mouse has been extensively reported on since the 1980’s. NOD mice 
develop on an early age (from 5 weeks of age onwards) an initially non-destructive peri-
insular accumulation of DC, accessory macrophages, T cells and B cells (peri-insulitis) that 
persists for several weeks before it develops into a destructive form of insulitis (from 12 weeks 
of age onwards). Mild diabetes follows. Animals can survive without insulin administration 
and keto-acidosis seldom occurs, unlike the BB-DP rat and humans. Typically female mice 
are more severely affected.
In general the incidence of thyroiditis is very low in the NOD mouse (unlike in the 
BB rat), but it varies from colony to colony.91 Certain dietary iodine regimens, however, have 
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a triggering effect on thyroiditis development. In mice with a pre-existing iodine-deficient 
goiter, a single administration of a high dose of iodine has a necrotic effect on hyperplastic 
iodine-deficient glands, but such dietary manipulation does not lead to thyroid autoimmunity 
in normal, non-autoimmune strains. In contrast in NOD mice it does lead to autoimmune 
thyroiditis following the initial phase of thyrocyte necrosis.91 This shows the importance of 
a local triggering factor (high antigen release, necrosis) acting upon a dysregulated immune 
system (the NOD mouse background) in the development of at least this endocrine organ-
specific autoimmune disease.91,92 Like the BB rat, this model is in fact also a model for APS 
type 3a.
There does, however, exist a sub-line of NOD mice, which has under normal dietary 
conditions a prevalence of around 5% of thyroiditis, but when kept on a continuously high 
iodine diet “spontaneously” develops autoimmune thyroiditis in virtually all animals.93 
This sub-line is characterized by an alternative MHC haplotype, viz. the IAk allele instead of 
the regular IAg7 on the NOD background, and the mice are called NOD-H-2h4 mice. 
3.3. The multigenic, multi-environmental nature of autoimmune thyroiditis and 
autoimmune insulitis in the BB-DP rat and the NOD mouse
The studies in the two above-described animal models have shown that the pathogenesis 
of an autoimmune failure of the thyroid or the islets of Langerhans are multistep processes, 
requiring several genetic and environmental abnormalities (or variants) to converge before 
full-blown disease develops. Hence, autoimmune thyroiditis and autoimmune insulitis are 
the outcome of an unfortunate combination of various genetic traits and environmental 
circumstance that by themselves do not need to be harmful, and may even be advantageous.
Studies of the initial etio-pathogenic phases of autoimmune thyroiditis and autoimmune 
insulitis are difficult in man, there is, apart from the limited study on still unaffected family 
members, obviously only one reasonable alternative, i.e. the study of the very early phases 
of the diseases in the spontaneous animal models. In this thesis the focus is on the BB-DP 
rat model for type-1 diabetes, specifically focusing on DC abnormalities present in the initial 
phases of the disease. 
4. BB RAT GENES 
Four diabetes susceptibility genes (iddm) have been localized in the BB-DP rat genome 
and are commonly referred to as iddm1, iddm2, iddm3 and iddm4. Table II lists the rat diabetes 
susceptibility genes in relation to the genes important in the human and the NOD mouse.
4.1. Iddm1
The most important diabetes susceptibility gene iddm1 is the MHC class II complex locus 
with the (diabetes and thyroiditis) susceptible haplotype RT1u on chromosome 20.94 This RT1u 
haplotype is an orthologue to the human HLA-DQ. Also in the human the genes showing the 
strongest linkage to susceptibility/resistance to diabetes are located in the MHC/HLA region 
on human chromosome 6p21 (mouse: chromosome 17). In humans, a positive association 
(susceptibility) with the disease is certain for HLA-DR3, DR4 and DQ8, while a negative 
association (resistance) is apparent for HLA-DR2. The peptide binding pockets P1, P4 and P9 
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of the MHC class II molecules are the main determinants in susceptibility versus protection 
in type-1 diabetes.95
NOD mice have the susceptible MHC class II haplotype IAg7 (murine orthologue for HLA-
DQ). IAg7 is special as it has a proline and serine at positions 56 and 57, instead of the histidine 
and aspartic acid found in most murine IAβ chains. The human DQ and IAg7 show striking 
similarities. Both have the same preference for amino acids binding in the pockets, because 
the pockets (except for P1) are quite similar. 
4.2. Iddm2
Iddm2 is a very selective and important gene for the diabetes of the BB-DP rat. Selective 
breeding of an outbred colony from which the BB strain was derived led to the development 
of two sub-lines, the diabetes prone (DP) rat and the diabetes resistant (DR) rat (see before).96 
The major genetic difference between the BB-DP rat and the BB-DR rat is at the level of the so-
called lyp gene being a major diabetes susceptibility gene (iddm2) located on chromosome 4.
Inheritance of iddm2/lyp occurs in a Mendelian fashion.97 Homozygosity for the lyp 
gene, as is the case in the BB-DP rat, leads to the severe T lymphocytopenia and the lack 
in a specific sub-set of regulatory T cells, i.e. the ART2+ T cells (see before).96,97,98,99,100 
The T lymphocytopenia is only detectable in the peripheral blood. Numbers of lymphocytes 
are virtually normal in the thymus, but after export from the thymus the T cells dramatically 
decrease in numbers in the BB-DP rat. The reduction of T cells in the peripheral pool is as 
much as 80%. 
Recently the lyp/iddm2 gene was found, by positional cloning, to represent a frameshift 
mutation in the Ian5 (immune-associated nucleotide 5) gene.80,81 Due to the point mutation in 
the lyp gene the Ian5 protein is severely truncated. Ian5 belongs to an uncharacterized gene 
family of GTP-binding proteins. Defective Ian5/lyp causes loss of mitochondrial integrity, 
increased mitochondrial stress-inducible chaperonins and induces specific apoptosis of 
recent thymic emigrating T cells.101 Recently an association of functional Ian5 with the anti-
Table II.  An overview of diabetes susceptibility genes involved in spontaneous autoimmune diabetes in the 
 BB rat, NOD mouse and human T1D. 
Rat/Mouse/Human BB rat NOD mouse Human T1D 
Iddm1/idd1/IDDM1 RT1u (+) IAg7 (+)
HLA-DQ8 (+)
HLA-DR3 (+)
HLA-DR4 (+)
HLA-DR2 (-)
HLA-DQ6 (-)
Iddm2/idd2/IDDM2 Lyp/Ian5/GIMAP5 undefined INS-IGF2 VNTR
Iddm3/idd3/IDDM3 Body Weight gene il2 IGF-1R#
Iddm4/idd4/IDDM4 TCRVβ4# 
Lmp2(PSMB6/β1i)/ ALOX15/
STAT5#
Fgf3#
Iddm5/idd5/IDDM5 - ctla4 SUMO4 #
IDDM12 - - CTLA-4 
(+) susceptibility gene
(-)  resistance gene
#  candidate genes
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apoptotic proteins Bcl-2 and Bcl-xL was shown.102 The truncated mutated Ian5 of the BB-DP 
rat is thought to loose its mitochondrial-binding domain, resulting in an increased apoptosis 
of T cells. These findings suggest Ian5 to be, under physiological conditions, an anti-apoptotic 
protein. A recent report using EGFP-Ian5, however suggest that the Ian5 protein is located 
at ER.103 Another recent report using antiserum against Ian5, disputes the localization of 
the Ian5 protein at mitochondria and ER or Golgi complex, their data support a sub-cellular 
localization outside these organelles, however the data also shows that Ian5 is still necessary 
for maintaining mitochondrial membrane integrity (Ian5 protein is thought to act upstream of 
mitochondria in this report).104
4.3. Iddm3 and iddm4
Iddm3, a gene stretch related to the development of autoimmune diabetes in rats, was found 
to co-localize with body weight regulating genes on chromosome 2.105 Iddm4 on chromosome 4
was found in close proximity to the lyp region, although it is distinct from the lyp region.106 
A recent study suggests TCRVβ4 as a candidate gene for iddm4.107 
5. CELLULAR AND MOLECULAR ABERRANCIES IN CENTRAL 
TOLERANCE MECHANISMS OF THE BB-DP RAT 
5.1. Thymus morphology
The BB rat thymus shows several morphological abnormalities. In BB-DP and BB-DR 
rats so-called ‘empty spaces’ exist in thymus: thymus epithelium is absent from these areas, 
as are MHC class II expressing cells (DC/macrophages).108 This phenomenon develops after 
and is present in four-week old BB rats. These ‘empty spaces’ cover 3-5% of total thymus 
volume in BB rats109 and are thought to contribute to the development of autoreactive T cells, 
since the absence of TEC and APC in the medulla theoretically may lead to a failure to delete 
(potentially) autoreactive T effector cells. Likewise the empty spaces may also be involved in 
the failure to positively select regulatory T cells.
Interestingly, NOD mice show abnormalities in thymus morphology as well, as they 
contain large peri-vascular spaces (PVS). These PVS contain a dense network of the ECM 
proteins laminin, fibronectin and type IV collagen around the lumen of vessels.110 The cells 
found inside PVS mainly consist of mature T cells and some B cells.111 Another defect includes 
a decrease in thymus medullary epithelial cells and a preliminary involution of NOD thymus 
at an age of 5 weeks (normal mice 8-10 months) accompanied by a disorganization of thymic 
reticulum.110 This premature involution in NOD mice is accompanied by the presence of large 
cystic cavities across the thymus reticulum from 5 weeks onwards.112
5.2. Apoptosis of recent thymus emigrants 
BB-DP rats (lyp/lyp) are deficient in TCRαβhighCD4-CD8+ thymocytes.113,114,115 These recent 
thymus emigrants (RTE: Thy1-ART2-) disappear within 7 days of export in spleen and lymph 
nodes due to apoptosis.115,116 Only very few cells finally express the mature T cell phenotype 
(Thy1-ART2+).117 The life span of RTE in BB-DP rats is extremely shortened due to a mutation 
in the lyp gene.
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5.3. Reductions in peripheral Treg cells (CD4+CD25+, NKT cells, ART2+ T cells)
The lyp gene has a strong impact on T cell longevity in BB-DP rats. The CD4+CD25+Foxp3+ 
thymocytes were investigated, and normal numbers were found.118 However these cells were 
incapable of homeostatic expansion and survival upon transfer to nude BB rats, while Foxp3 
expression levels were reduced in mature CD4+CD25+ T cells, thus suggesting that they are 
mostly activated T cells. This notion was supported by the finding that these T cells were 
incapable of suppressing CD4+CD25- T cells. The lyp gene leads to the altered survival and 
function of Tregs, which results in the clonal expansion of diabetogenic autoreactive T cells 
among the CD4+CD25+ T cells. 
In the NOD mouse a reduction in number of CD4+CD25+ Tregs have been found at 3, 
8 and 15 weeks in spleen (and thymus) compared to Balb/c mice.119 Contrary result have 
also been found when analyzing the percentage CD25+ among CD4+ cells and significant 
differences where not found in the Tregs of 6-week-old NOD mice.120 While a reduction of 
the percentage/number of Treg is under debate in the NOD mouse, there is consensus about 
the disturbed function of Tregs. During ageing (8 vs. 16 weeks) NOD Tregs loose the ability 
to suppress diabetogenic T cells (and prevent diabetes) upon transfer into NOD scid mice.121 
This loss-of-function is, at least in part, caused by loss of membrane-bound TGF-β from the 
surface of CD4+CD25+ T cells.122 
Similar findings, as in the NOD mouse, have been observed in Tregs from diabetic patients, 
where the function is impaired. Co-cultures of Tregs with CD4+CD25- T cells showed that 
diabetic Tregs where 2-fold less able to inhibit proliferation of CD4+CD25- T cells as compared 
to Tregs from HLA-identical controls. The cytokine profile in the co-cultures of T1D patients 
showed a pro-inflammatory profile (more IFN-gamma, less IL-10).123
 
6. THE HISTOPATHOLOGY OF ISLET AUTOSENSITIZATION IN 
THE BB-DP RAT: A PRIME ROLE FOR AN EARLY LOCAL APC 
ACCUMULATION
Increased numbers of APC have been found in the very early stages of the autoimmune 
insulitis, autoimmune thyroiditis and autoimmune sialo-adenitis in the BB-DP rat and the 
NOD mouse prior to large lymphocytic infiltration. Similar observations have been done in 
the other animal model of spontaneous endocrine autoimmunity (the OS chicken),124,125 in 
the thymectomy mouse model,1 the virus- and chemically-induced models,126,127 and the RIP-
LCMV mouse model.128 Also in the glands of patients with Graves’ disease, Hashimoto goiter129 
autoimmune insulitis130 and sialo-adenitis131 MHC class II-positive DC and macrophages are 
present inside and outside the lymphocytic accumulations, but here only later stages of the 
diseases have been studied.
DC are antigen-presenting cells (APC) par excellence, and well equipped for the stimulation 
of naïve T cells.124,132 Macrophages have various functions, ranging from the production of 
factors for wound healing and remodelling of tissues,133 via the phagocytosis and degradation 
of unwanted material, the regulation of immune responses to a superb capability to stimulate 
T cells. It must be noted that DC have also been implicated in the remodelling of 
tissues.134,135
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The (local) presence of APC has been shown to be indispensable for the development 
of autoimmune insulitis, since prevention of their accumulation in the pancreas of NOD 
mice,136,137 in the pancreas of BB-DP rats results in a prevention of insulitis/diabetes.138 
Also splenic lymphocytes from macrophage-depleted NOD mice fail to transfer diabetes to 
recipients.139 
The destiny of the majority of APC accumulated in tissues is to enter the lymphatics126,134 
and to travel to the draining lymph nodes while transporting antigens to these nodes and, 
under steady state, i.e. non-inflammatory, non-danger conditions, inducing tolerance induction 
primarily by supporting autoantigen specific naturally occurring Treg cells (Figure 3). In the 
spontaneous animal models, however, a sensitization reaction is induced in the local draining 
lymph nodes after the very early accumulation of APC in the thyroid or around the islets.140,141 
This apparently occurs in the absence of any obvious “inflammatory condition” of the gland. 
An expansion of autoreactive CD8+ and CD4+ T cells takes place in the reacting draining 
lymph nodes as well as the production of autoantibodies of IgG class. Later, however, such 
immune reactivity is taken over by a lymphoid tissue that locally develops in the glands 
themselves, e.g. a local thyroid lymphoid tissue in the thyroid gland of the BB-DP rat140,141 
and the earlier mentioned peri-insular lymphoid tissue in the NOD mouse.142 These tissues 
are often erroneously called “focal thyroiditis” and “peri-insulitis” respectively, since they 
are not destructive inflammations, but have a high degree of histological architecture, with 
clearly distinguishable T cell areas, B cell follicles and germinal centres, and areas and cords 
of plasma cells in the periphery of the lymphoid tissue. The plasma cells in this tissue produce 
specific antibodies, such as anti-thyroglobulin (anti-Tg) antibodies in the BB rat thyroid.140,141 
Such local lymphoid tissue can also be found in human glands affected by autoimmune 
disease and are also there generally non-destructive and show a peaceful coexistence with 
adjacent endocrine/exocrine cells.140 In fact, the adjacent endocrine/exocrine cells often show 
signs of metabolic and proliferative stimulation. In the early peri-insular lymphoid tissue of 
the spontaneous NOD mouse model, the BDC2.5 TCR Tg mice and the RIP-LCMV mouse a 
predominance of Th2 type cytokines has been shown, again underlining the anabolic nature 
of this locally developed lymphoid tissue.143
7. AIMS OF THIS THESIS
7.1. AIM I: To find abnormalities in the function of bone-marrow derived DC and 
thymus DC of the BB-DP rat
In previous studies of our group relatively mild defects in the function of spleen DC of the 
BB-DP rat were found. In a first study by Delemarre et al. spleen low-density non-adherent 
DC ingested more bacteria (which points to a more macrophage-like phenotype) and the 
spleen DC had a reduced MHC class II expression. Functionally the abnormal spleen DC of 
BB-DP rats had a decreased capability to stimulate T cells to proliferate and more importantly 
the cells showed a defective capability to support the expansion of the regulatory ART2+ 
T cell population of the rat.144 In a later study of Delemarre et al. spleen DC of the BB-DP rat 
showed a lower homotypic clustering capability, a close correlate of maturation, as compared 
to control Wistar rats.145 
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In another study Simons et al. isolated non-adherent low-density APC from the thyroids of 
BB-DP rats; it appeared that fewer prototypical MHC class II+ DC were found in these isolates 
(5-10%) as compared to non-adherent low-density cells from thyroids of Wistar rats control 
rats (15-20%). At the same time more ED1+ (monocyte/macrophage-like) cells (70%) were in 
Figure 3. The initial phase in type 1 diabetes.
In the initial phase DCs are the very first immune cells to accumulate around β cells, where they take up autoantigen(s). 
Thereafter DC migrate with these autoantigens to the draining pancreatic lymph node (LN) where they present the 
autoantigen(s) to CD4+ T cells, CD8+ T cells and B cells. Part of the B cells differentiate into antibody-producing 
plasma cells (P) (top of the Figure). 
In the expansion phase of type 1 diabetes DCs, CD4+ T cells, CD8+ T cells and B cells may form aggregates around 
the β cells in sort of local lymphoid tissue (bottom of the Figure).
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the isolates as compared to Wistar rat thyroids (30-35%).134 
In sum, our reports previous to this thesis work, provide evidence that spleen and thyroid 
DC of the BB-DP rat are abnormal, more macrophage-like with a poor APC function and 
particularly less capable of inducing ART2+ regulatory T cells. However abnormalities found 
were not outspoken and many animals were needed to obtain significant differences.
Investigations regarding bone-marrow precursor derived DC and studies on thymus DC 
had not been performed in these previous studies in the BB-DP rat model. Furthermore linkage 
studies between DC aberrancies and gene abnormalities in the BB rat had not been performed. 
We hoped that these bone-marrow derived DC would show a clearer and more solid picture of 
aberrancies and therefore embarked on such studies.
This thesis therefore addressed the following questions:
-  Are bone-marrow derived DC of the BB-DP rat defective in differentiation and function
  (Chapter 2)? 
-  Do bone-marrow derived DC of the F344.lyp/lyp rat show similar DC defects as bone-
 marrow derived DC of the BB-DP rat and are we able to make a detailed linkage of the
 found DC defects with the genetic background (Chapter 3)?
-  Are thymus DC of the BB-DP rat defective in function (Chapter 4)?
7.2. AIM II: Targeting antigens to endocytical proteases in human monocyte-derived 
DC
The internalization and the subsequent processing of autoantigens leading to the generation 
of autoantigenic peptides presented on the MHC class II molecule have hardly been studied in 
type-1 diabetic DC. To approach this field I started to study the internalization and processing 
of antigen in human DC.
We used human monocyte-derived DC (MO-DC), since MO-DC provide attractive cellular 
tools in human autoimmune disorders. Myeloid DC internalize exogenous autoantigen and 
deliver it to the MHC class II-associated proteolytic machinery to generate antigenic peptides 
for the MHC class II-mediated activation of T cells. The generation of antigenic peptides is 
governed by endocytic proteases (cathepsins). The main endocytic proteases present in APC 
belong to the family of papain-like cysteine proteases. The pattern of endocytic proteases that 
is encountered by antigen internalized by intact human MO-DC is unknown. Understanding 
the rules that govern the transport of antigen to endocytic proteases and the successive 
processing pathway in MO-DC might help us to better exploit the therapeutic potential of 
these cells by maximizing the access of antigen to the MHC class II processing compartment, 
by inhibiting endocytic proteases responsible for the generation of the major immunogenic 
epitope in immunogenic DC or by facilitating the generation of the major immunogenic 
epitope in tolerogenic DC.
In previous studies MO-DC are usually exposed to soluble antigen or antigenic peptide, 
which is internalized by non-specific means, processed by endocytic proteases and loaded on 
MHC class II so that ultimately, antigen-specific T cells can be triggered. The phagocytosis 
of internalized material in DC has been difficult to study. Previous studies have focused on 
isolating lysosomes, late endosomes and early endosomes and showed that they differ with 
respect to the pattern of active proteases in all major types of APC. However such approaches 
have disrupted major determinants important in the regulation of protease activity like 
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endocytic pH, redox potential, protease inhibitors, thus being of little value in the study of the 
rendezvous between antigen and active proteases.
The use of chemical tools has recently overcome this limitation recently with the 
introduction of activity-base probes (ABP) facilitating the study of antigen delivery to the 
endolysosomal compartment.
The delivery of the endocytosed antigens (mimicked by the ABP) to the endocytic 
proteases (cathepsins) can be studied in intact viable DC. ABP specifically and irreversibly 
binds to the active centre of papain-like cysteine proteases and this enables the visualization 
of the targeted proteases via a detection tag.
The visualization of the active proteases occurs in a Western blot-like approach. 
While in Western blot both the inactive and the active form of the protease are visible and 
indistinguishable from each other, the activity-based probe approach solely allows the active 
form of the protease to be detected, since only the active form of the protease has an active 
center allowing irreversible binding and visualization with the ABP.
This thesis therefore also addressed a 4th experimental question related to antigen processing 
by DC:
- Which cathepsins are targeted by the endocytosis of antigen (ABP) and is this pattern altered
 when the antigen (ABP) is coupled to a cell-penetrating peptide (Chapter 5)?
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ABSTRACT 
BB rats develop various organ-specific autoimmune diseases, e.g. 
autoimmune diabetes and thyroiditis and have proven important to dissect 
genetic factors that govern autoimmune disease development. The lymphopenia 
(lyp) gene (iddm2) is linked to autoimmune disease development and is a 
major genetic difference between diabetes-resistant (DR) and diabetes-prone 
(DP) BB rats. To study the effects of the lyp gene and other genes on dendritic 
cell (DC) differentiation from bone-marrow precursors, such differentiation 
was studied in BB-DP, BB-DR, Wistar and F344 control rats.
DC of BB-DP rats showed a lower MHC class II expression as compared 
to BB-DR, Wistar and F344 rats. LPS maturation did not restore this low 
MHC class II expression. DC of BB-DP rats also showed a poor capability to 
terminally differentiate into mature T cell stimulatory DC under the influence 
of LPS and produced significantly lower quantities of IL-10, yet these 
aberrancies were also found in BB-DR rats but did not occur in control rats.
This study thus shows that various aberrancies exist in the differentiation 
of myeloid DC from bone-marrow precursors in the BB rat model of organ-
specific autoimmunity. These aberrancies are multigenically determined and 
partly associated with iddm2 (lyp gene) and partly associated with other genes 
in the BB rat. 
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INTRODUCTION
Dendritic cells (DC), the antigen-presenting cells par excellence, play a pivotal role in the 
pathogenesis of organ-specific autoimmune diseases. In animal models that spontaneously 
develop such diseases, such as the BioBreeding-Diabetes Prone (BB-DP) rat and the 
Non-Obese Diabetic (NOD) mouse, MHC class II+ DC accumulate in the thyroid gland, 
the pancreas and the salivary glands from the earliest phases of the disease onwards.1-7 
These DC take up relevant autoantigens and travel with these to the draining lymph nodes, 
where the specific autoimmune response is initiated. Indeed, the very early accumulation of 
DC in the target glands of the animal models is followed by an enlargement of the lymph 
nodes draining the glands and the production of autoantibodies by plasma cells located in 
these lymph nodes.1,3 This lymph node reaction is followed later in time by a further infiltration 
of the target gland by large numbers of lymphocytes. It is likely that also in patients with 
type-1 diabetes mellitus, autoimmune thyroid disease and Sjögren’s syndrome DC play a 
pivotal role as antigen-presenting cells (APC), since the cells are seen in large numbers in the 
target glands.1,8-11
With regard to the BB rat model we previously reported that ex vivo preparations of spleen 
DC and of thyroid DC displayed abnormalities. The spleen DC of the BB-DP rat showed a 
lower MHC class II expression, had a lower capability to form homotypic cell aggregations and 
had a reduced capability to stimulate T cells in syngeneic (syn)-MLR.12,13 The DC preparation 
of the thyroid gland of the BB-DP rat contained more monocyte-like precursors and fewer 
cells with the characteristics of typical MHC class II+ DC as compared to cell preparations of 
thyroids of control Wistar rats.14 We took these abnormalities in both the DC populations as 
signs of defects in the differentiation/maturation of BB-DP DC.12-14
In vitro studies on the differentiation of DC from bone-marrow precursors have not been 
previously performed in BB-DP rats and this report describes such studies. To study the in 
vitro differentiation of DC from GM-CSF/IL-4 stimulated bone-marrow precursors, we used 
a culture procedure initially described for the Wistar rat and sampled the non-adherent cells, 
which are typical DC showing crucial markers and functional characteristics of this sub-set 
of APC. To further terminally differentiate these immature DC to mature DC we additionally 
stimulated the cells with LPS.
One of the advantages of studying the BB-DP rat model is the presence in this model of 
a well-defined regulatory T cell population. These regulatory T cells are characterized by 
ART2 expression and play a crucial role in the pathogenesis of the organ-specific autoimmune 
diseases in the BB-DP rat.15 BB-DP rats are severely lymphopenic and lack in particular 
the ART2+ regulatory T cells. There exists a sub-line of BB rats, the so-called BB-Diabetes 
Resistant (DR) rats, that are not lymphopenic, have ART2+ regulatory T cells and do not 
develop organ-specific autoimmunity. Depletion of ART2+ cells in the BB-DR rat induces 
organ-specific autoimmunity,16 while transfer of these cells from BB-DR rats to BB-DP rats 
prevents organ-specific autoimmunity.17 The major genetic difference between the BB-DP and 
BB-DR rats is the lymphopenia (lyp) gene, which is a major diabetes susceptibility gene for 
the rat (iddm2) located on chromosome 4. Homozygosity for the lyp gene, as is the case in the 
BB-DP rat, leads to the severe T lymphocytopenia and in particular a lack in ART2+ regulatory 
T cells.18,19 Recently, the lyp gene was found to carry a frameshift mutation in the gene for 
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Ian5. Due to the mutation in the lyp gene the predicted Ian5 protein is severely truncated.20,21
In this report we describe various abnormalities in the in vitro differentiation of DC from 
bone-marrow precursors in the BB-DP rat model as compared to BB-DR rats and non-
autoimmune Wistar and F344 control rats. We used 3 different BB-DP rat sub-lines, i.e. the 
NB sub-line, the Groningen sub-line and the Seattle sub-line. To study the DC abnormalities 
in relation to the expression of the lyp gene we consider the Seattle sub-line the best, since 
the BB-DP/Seattle rat has been developed as a congenic strain on the BB-DR/Seattle rat 
background and only possesses a small lyp region containing part of chromosome 4 of the 
BB-DP rat (76.35-77.67 Mb). BB-DP/Seattle rats are lymphopenic and type-1 diabetes occurs 
in 100% of the Seattle BB-DP rats. We here also describe that we were able to link one of the 
found abnormalities in the bone-marrow derived DC, i.e. the lower MHC class II expression 
on DC, to the expression of the lyp gene containing part of chromosome 4 of the BB-DP rat. 
Other DC abnormalities, such as a poor capability of the DC to terminally differentiate into 
mature DC after LPS stimulation and to produce IL-10, appeared to be linked to non-lyp genes 
in the BB rat background.
 
MATERIALS AND METHODS
Animals
BB-DP rats from the NB sub-line were provided by BRM Inc. (Massachusetts, USA). 
BB Groningen rats (DP and DR) were provided by Dr. Jan Rozing (University of Groningen, 
The Netherlands). BB-DP/Seattle (BB-DP/S), BB-DR/Seattle (BB-DR/S) and Fischer/
F344 control rats were developed and maintained at the Robert H. Williams Laboratory at 
the University of Washington, Seattle, U.S.A. Animals were housed under SPF conditions. 
All rats were kept under controlled light conditions (12/12 h light/dark cycle) throughout 
this study. A standard pelleted diet (0.35 mg iodine/kg; AM-II, Hope Farms BV, Woerden, 
The Netherlands) and tap water were provided ad libitum. For all experiments female animals 
were used and as controls age and sex matched F344 rats (R.H. Williams Laboratory) and/or 
Wistar rats (Harlan, Zeist, The Netherlands) were used. Use and care of laboratory animals 
was performed according to guidelines of the Dutch national law.
Bone-marrow derived DC culture
Rat bone-marrow was obtained from tibia and femur. Erythrocytes were lysed by NH
4
Cl 
containing KHCO
3
 and EDTA. After erythrocyte lysis cells were resuspended in RPMI 
1640 containing 25mM HEPES buffer (Life Technologies), 10% FCSi, 50 μM β-mercapto-
ethanol (Merck, Munich, Germany), and antibiotics. Cells were brought to a concentration of 
10 x 106/10 ml and cultured in 25 cm2 culture bottles (Nunc, Roskilde, Denmark) for 9 days 
(37°C, 5% C0
2 
incubator). To obtain DCs from bone-marrow precursor cells rat recombinant 
GM-CSF (17 μg/ml) and rat recombinant IL-4 (20 μg/ml) were added (Biosource, Camarillo, 
CA, USA) to the culture medium. Medium was refreshed twice at day 4 (with cytokines) and 
day 7 (without cytokines to enrich for DCs: deplete granulocytes). At day 7 the non-adherent 
cells were either resuspended in medium to obtain immature DC or in LPS (1 μg/ml) to obtain 
mature DC and were further cultured for 48 h. and were harvested by rinsing the bottles with 
medium twice.
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Methods for quantitative PCR
Quantitative PCR was performed on an Mx4000 instrument (Stratagene, La Jolla, CA, 
USA) using DNAse treated RNA (100 ng of total RNA) in triplicate using the Brilliant Single-
Step Quantitative RT-PCR Core Reagent Kit (Stratagene) along with serially diluted standard 
samples. The standards used were 1:4 serial dilutions of BB-DR/Seattle rat spleen poly A+ 
RNA.
Samples were multiplexed with a rat Ian5 probe and a rat cyclophilin probe. The rIan5-Q2 
probe was designed to the 3´ end of exon 3, beyond the coding region.
Probes and primers were from Integrated DNA Technologies, Inc. (Coralville, IA, USA). 
The probe for rat Ian5 was rIan5-Q2: 5’-FAM-TTT CAC TAT CAT TTG ACT CCT GTG 
CA-BHQ-1-3’. The probe for rat cyclophilin was 5’-HEX-CTG CTT CGA GCT GTT TGC 
AGA C-BHQ-1-3’. These probes were carefully designed, assuring that they did not match 
any other gene in the rat database.
The primers for probe rIan5-Q2 were rIan5-Q2f: 5’-CAT GTT AGG GAA GCT CAG TC-3’ 
and rIan5-Q2r: 5’-GAA GGG TTC TAC TGT GTC TCA-3’. The primers for rat cyclophilin 
were rCyc-Qf: 5’-CAC CGT GTT CTT CGA CAT-3’ and rCyc-Qr: 5’-TTT CTG CTG TCT 
TTG GAA CT-3’. Resulting C(t) values were converted to picograms and normalized to the 
values of cyclophilin from the same well and expressed as the average of triplicate samples G 
one standard deviation. Total RNA was isolated using Qiagen RNeasy (Qiagen, Chatsworth, 
CA, USA) or Stratagene Absolutely RNA RT-PCR Miniprep kits (Stratagene). To remove trace 
genomic DNA, Ambion DNA-free (Ambion, Austin, TX, USA) treatment was performed on 
samples extracted with Qiagen RNeasy kit.
Antibodies
The following mAbs were used: anti-MHC class II conjugated to phycoerythrin (PE) 
(1:400, MRC OX6; Serotec), anti-B7-1 (undiluted, CD80; BD Pharmingen, Flanders, NJ), 
anti-B7-2 (undiluted, CD86; BD Pharmingen), anti-CD40 (1:10, BD Pharmingen), anti-rat 
DC-FITC (undiluted, MRC OX62; Serotec), anti-rat CD11c-FITC (undiluted, Serotec), ED1 
(1:10, DC, monocytes, MФs; Serotec), ED2 (1:100, monocytes, MФs; Serotec), ED3 (1:1000; 
Serotec), CD90 (undiluted, MRC OX7; Serotec).
Flowcytometric analyses
Cells were added in round-bottom 96-well plates (Nunc) at a concentration of ~105 
cells/well and washed twice in PBS/0.5% BSA/20 mM sodium azide. Pelleted cells were 
resuspended in 20 μl solution with labelled primary Abs, incubated for 10 min., and followed 
by two washing steps. Using unconjugated Abs, a second step was incorporated with rabbit 
anti-mouse-FITC Abs (Dako, Glustrup, Denmark) with 1% normal rat serum or rabbit anti-
mouse-PE Abs (CLB, Amsterdam) with 1% normal rat serum. For the visualizing of biotin-
conjugated Abs, streptavidin-tricolor (Caltag Laboratories, San Francisco, CA, USA) was used. 
For cell analysis, 10,000 events were recorded with a FACS (FACSCalibur, Becton Dickinson, 
Sunnyvale, CA, USA). Dead cells, recognized by their uptake of 7-AAD and their specific 
forward- and side-scatter pattern, were excluded from analysis. For determination of back-
ground staining, cells were incubated with either labelled irrelevant Abs or with secondary 
Abs.
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MLR
T cells from Wistar and Fischer rats were enriched using a nylon wool column. In short, 
spleens were minced and teased through a 105-μm filter, and the erythrocytes were removed by 
lysis. Cells were washed and loaded onto a nylon wool column (3 g; Polyscience, Eppelheim, 
Germany) packed into a 60 ml plastic syringe. After 1 h. in 5% CO
2
 incubator, T cells (80-
90% CD3+ cells) were harvested by collecting the effluent. For the MLR, DCs were added 
at various ratios to T cells (fixed number of 150,000 T cells/well) in flat-bottom 96-well 
plates (Nunc). Subsequently, these cells were cultured for 3 days in RPMI 1640 containing 
50 mM HEPES buffer (Life Technologies), 10% FCSi, 110 μg/ml sodium pyruvate (Merck), 
0.5% (v/v) β-mercapto-ethanol (Merck), and antibiotics. In the MLR, T cell proliferation was 
measured via tritiated thymidine ([3H]TdR) incorporation (0.5 μCi/well during the last 16 h. 
of total culture period). Finally, cells were harvested on filter papers, and radioactivity was 
counted in a liquid scintillation analyzer (LKB Betaplate, Wallac, Turun, Finland).
IL-10, IL-12p40 and IL-12p70 production
Supernatants were obtained from DCs by culturing them in 24-well plates (Nunc) for 
24 h. Cells were resuspended in serum free medium (SF-1) at a concentration of 0.5 x 106/
ml. SF-1 medium was made by dissolving 1 ml SF-1 in 9 ml RPMI 1640 with antibiotics. 
Cells were either cultured in SF-1 medium alone for basal production, SAC (Staphylococcus 
aureus Cowan strain) for IL-10 production or SAC and IFN-γ for IL-12p40 and IL-12p70 
production.22 Rat IL-10, IL-12p40 and IL-12p70 ELISA kits were commercially available 
(Biosource).
Statistical analyses
Mean values ± SD are shown. Statistical analyses were performed using either Mann-
Whitney test for two groups or Kruskal-Wallis test for multiple groups.
RESULTS
GM-CSF/IL-4 culture of bone-marrow precursors yields an adherent and a non-adherent 
DC population. The non-adherent population has all the characteristics of prototypic 
DC
The culture of bone-marrow precursor cells in GM-CSF/IL-4 yields two populations: an 
adherent colony-forming cell population and a non-adherent floating single cell population 
(Figure 1A, B; this figure shows characteristics of the Wistar DC, but similar results were 
found for BB and Fischer rat DC (data not shown)).
Both populations expressed the rat DC-specific markers OX62 (MFI non-adherent: 
3291 ± 1207; adherent: 3199 ± 844) and CD11c (MFI non-adherent: 3334 ± 1769; adherent: 
3398 ± 1010) and both populations expressed MHC class II, the adherent population stronger 
than the non-adherent population (Figure 1C). Despite the higher MHC class II expression 
the adherent population appeared functionally considerably less able to stimulate T cell 
proliferation in MLR as compared to the non-adherent population (Figure 1D). The non-
adherent population also contained many more cells, which were of veiled/dendritic shape 
(Figure 1B).
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Figure 1. Characteristics of rat bone-marrow derived DC. 
When bone-marrow precursors are cultured in GM-CSF/IL-4 two OX62+CD11c+ populations are obtained: 
(A) a population of adherent (colony-forming) cells and (B) a non-adherent population of floating single cells. 
Although the non-adherent cells show a definite, but lower expression of MHC class II (C) as compared to adherent 
cells, the cells have a much higher capability to stimulate T cells to proliferate (D, mean ± standard deviations are 
shown; n=10). The T cell stimulatory capacity was measured in syngeneic MLR and expressed as the incorporation 
of 3H-thymidine (c.p.m.) in the stimulated T cells. The adherent cells also have various macrophage characteristics 
like a higher ED1 (E), ED2 (F) and ED3 (G) expression and a stronger and ‘‘spotty’’ acid phosphatase activity (A). 
We therefore consider the non-adherent cells as the typical DC. The grey tone in (C, E, F and G) represents the non-
adherent cells. The black line in (C, E, F and G) represents the adherent cells. The isotype control is depicted as a grey 
line. Representative figures are shown in (C, E, F and G) (n=18). Wistar rat DC are shown (similar results are found 
for BB and Fischer rats; data not shown). For colour figure see Appendix page 143.
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To further underscore the non-dendritic cell character of the adherent population it had 
various characteristics reminiscent of macrophages, such as a stronger expression of acid 
phosphatase and the monocyte/macrophage markers ED1, ED2 and ED3 (Figure 1A, E-G). 
We therefore considered the non-adherent cell population as the more prototypic immature 
DC population and focused on this population in our subsequent experiments. We will refer to 
this population as immature DC throughout the further text. The adherent population probably 
represents precursors for the immature DC (also because one sees in culture the detachment 
of veiled cells from these colony-forming adherent cells).
Marker expression: immature DC of BB-DP rats show a lower expression of surface MHC 
class II molecules as compared to BB-DR rats, irrespective of their state of maturation
When studying the expression levels of the various markers in BB-DP rats we found that 
the most consistent abnormality was a lower expression of MHC class II on the GM-CSF/
IL-4 generated immature DC (Figure 2). This lower expression was evident in all three BB-
DP sub-lines and was statistically significant as compared to the expression level on the 
DC of the matching BB-DR rat strain tested in the same series of experiments. The lower 
expression was also statistically significant as compared to the control Wistar and F344 strains 
(apart from the immature DC of the Groningen sub-line rats) (Figure 2).
100 101 102
MHC class II (log fluorescence intensity) 
103 104
Marker Rat strain NB Groningen Seattle Seattle
immature DC immature DC immature DC mature DC
MHC BB-DP 2388 ± 1412a  2053 ± 948c    1437 ± 254b,c   2295 ± 575c
class II BB-DR n.d.   3483 ± 1711 2285 ± 851 3251 ± 74 
Wistar/F344 3258 ± 1138 2332 ± 425   2407 ± 1102  2178 ± 600 
Figure 2. Immature DC of BB-DP rats are consistently lower in surface MHC class II molecules as compared 
to immature DC of BB-DR (see table). 
Statistical analysis using the Kruskal-Wallis test for multiple groups showed the following statistically 
significant differences: (a) p<0.05 BB-DP vs. Wistar, (b) p<0.05 BB-DP vs. F344, (c) p<0.05 BB-DP vs. BB-DR. 
The figure shows a representative example of MHC class II expression, the immature DC of BB-DP (thin black 
line), the immature DC of BB-DR (shaded) and the immature DC of F344 (thick black line). The isotype control is 
depicted as a grey line.
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With regard to the other tested molecules such as the rat DC-specific markers OX62 and 
CD11c, the monocyte/DC marker ED1 and the co-stimulatory molecules CD80, CD86 and 
CD40, consistent abnormalities could not be found in the expression levels on immature DC 
populations of the BB-DP vs. those of the BB-DR, Wistar or F344 control rats (there was only 
some lower expression of CD80, CD40 and ED1 on the immature DC of the BB/Seattle rats 
vs. its controls, data not shown).
To investigate whether the low expression of MHC class II on the immature DC of the 
BB-DP rat was still present after a final differentiation (maturation) of the cells, we first looked 
for a proper maturation factor for rat bone-marrow derived immature DC. In a preliminary 
set of experiments we used several maturation factors (LPS, TNF-α and Mycobacterium 
tuberculosis (MBT)) to find the optimal maturation factor for Wistar DC. TNF-α (Figure 3A) 
and MBT (data not shown) had no effect on MHC class II expression, while LPS slightly 
increased the MHC class II expression with an optimal concentration of 1 μg/ml (Figure 3B). 
In this optimal concentration LPS induced a strong up-regulation of the T cell stimulatory 
capacity of rat immature DC. TNF-α and MBT had no effects. We therefore used LPS in 
further experiments as a maturation factor.
When using LPS maturation in the BB rat model, there was a clear up-regulation of MHC 
class II expression in both the BB-DP/S and BB-DR/S rats due to the LPS exposure, but the 
lower expression level in the BB-DP/S rat vs. that of the BB-DR/S rat was not corrected 
(Figure 2).
T cell stimulatory function: the inability of DC of both the BB-DP/S and BB-DR/S rats 
to terminally differentiate to strong T cell stimulators after LPS stimulation 
Figure 4 shows the T cell stimulatory capacities of the immature DC and mature DC of 
BB-DP/S and BB-DR/S rats as compared to those of Wistar and F344 rats. Although the 
100 101 102
MHC class II (log fluorescence intensity) 
103 104 100 101 102 103 104
A B
Figure 3. Maturation with LPS was the most effective maturation factor for rat DC. 
(A) The non-stimulated DC (dark grey tone) vs. TNF-α-stimulated DC (black line) and (B) the non-stimulated DC 
(dark grey tone) vs. LPS-stimulated DC (black line). BB-DR rats were used in (A and B) (n=4-34). Similar effects 
are seen in Wistar (n=3-5) and Fischer rats (n=45) (data not shown). The figure illustrates that TNF-α-stimulated DC 
do not show an up-regulation of MHC class II (A), while LPS-stimulated DC do (B). The isotype control is depicted 
as a grey line. 
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MHC class II expression of immature DC of BB-DP/S rats was lower as compared to that 
of immature DC of BB-DR/S and of Wistar and F344 rats (see previous section), their T cell 
stimulatory capacity was not reduced (Figure 4A). As expected, after LPS maturation the 
T cell stimulatory capacities of mature DC of both the Wistar and F344 control strains were 
clearly higher as compared to T cell stimulatory capacity of the immature DC of the same 
strains (see above and Figure 4B). Remarkable was that this phenomenon, i.e. an increase in 
the T cell stimulatory capacity by maturation did not occur for the DC in both the BB-DP/S 
and DR/S sub-lines.
IL-12 and IL-10 production: the IL-10 of immature DC of BB-DP/S and DR/S rats is 
lower as compared to that of F344 control rat DC. Only in BB-DR/S rats is the defective 
IL-10 production partially corrected after LPS maturation
With regard to the IL-12p70 production capability of the rat DC populations, we found 
this production very low and values were not suitable for a reliable statistical evaluation 
and data are thus not shown. The IL-12p40 and IL-10 production were considerable and 
Table 1 shows this cytokine production of immature and mature DC of BB-DR/S, BB-DP/S 
and F344 control rats (Wistar rats were not used in this series of experiments) in the absence 
or presence of Staphylococcus aureus Cowan strain (SAC) and SAC plus IFN-γ, which are 
effective stimulators of IL-10 and IL-12 production, respectively.22
SAC-stimulated immature DC of BB-DP/S and BB-DR/S rats produced lower quantities 
of IL-10 (Table 1) as compared to such cells of F344 control rats, indicating a defect in 
IL-10 production that is not linked to the lyp gene but to other genes in the BB rat
Figure 4. Poor maturation of BB rat immature DC to T cell stimulatory mature DC. 
The T cell stimulatory capacity of immature DC (A) and mature DC (B) of BB-DP/S and BB-DR/S, Wistar and 
F344 rats. The T cell stimulatory capacity was measured in syngeneic MLR and expressed as the incorporation of 
3H-thymidine (c.p.m.) in the stimulated T cells. Despite the low MHC class II expression of immature DC of the 
BB-DP/S rat, such immature DC do not show a lowered capability to stimulate syngeneic T cells in MLR (as 
compared to Wistar, F344 and even BB-DR/S rats; n=4-22). Immature DC of both BB-DP/S and BB-DR/S are 
incapable to mature to high T cell stimulating mature DC under the influence of LPS (B). Immature DC of Wistar and 
F344 rats do mature to such mature DC (mean ± standard deviations are shown; n=4-8). Note: Wistar and BB DC 
were stimulated with syngeneic Wistar T cells, since F344 rats have a different MHC haplotype, they were stimulated 
with syngeneic F344 T cells.
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background. After terminal differentiation of the immature DC to mature DC with LPS the 
SAC-stimulated IL-10 production was not significantly altered for both the two BB/S strains 
and the F344 control rats (Table 1). It must be noted, however, that for the mature DC of the 
BB-DR/S rats there was a trend for a slightly higher production of IL-10 and the statistically 
significant difference with the IL-10 production of the mature DC of the F344 control rats 
was lost.
After a terminal differentiation to mature DC the spontaneous (i.e. not SAC and IFN-γ 
stimulated) IL-12p40 production was clearly raised for the mature DC of the F344 control rats 
in line with the view that mature DC are the better IL-12 producers as compared to immature 
DC (Table 1). With regard to the IL-12p40 production of the immature and mature DC of the 
BB-DP/S and BB-DR/S rats, this was in general not significantly different from that of the 
immature and mature DC of F344 rats (Table 1). However, in all instances there were clear 
trends for a reduced production capability of IL-12p40 by the immature and mature DC of 
both the BB rat strains (Table 1).
Ian5 is not expressed in myeloid DCs
We studied the expression of the Ian5 transcripts in the immature DC, their OX7+ bone-
marrow precursors and in the non-fractioned bone-marrow population. We found that the 
non-fractioned bone-marrow population and the OX7+ DC precursors expressed Ian5 mRNA, 
but at an extremely low level as compared to T cells (Figure 5). The descending immature 
DC did not express Ian5 mRNA (see Figure 5). Since the non-fractioned bone-marrow cell 
population had a higher Ian5 mRNA expression as compared to OX7+ DC precursors and 
since both populations are contaminated with some T cells (the non-fractioned bone-marrow 
cell population with around 10%, the OX7+ bone-marrow DC precursors with around 5%), we 
consider the Ian5 mRNA expression in the precursor cells as due to the T cell contamination.
Table 1. The IL-10 and IL-12p40 cytokine production of bone-marrow derived immature DC (iDC) and 
mature DC (mDC) of BB-DP, BB-DR and F344 rats (n=3-7)
Cytokine Rat strain iDC iDC mDC mDC
(pg/ml) (unstimulated) (stimulated) (unstimulated) (stimulated)
IL-10 BB-DP/S 18 ± 8   479 ± 177 91 ± 37 471 ± 240
BB-DR/S 18 ± 13   486 ± 127 98 ± 87 627 ± 376
F344 24 ± 14    856 ± 215c 99 ± 39  934 ± 322b
IL-12p40 BB-DP/S 93 ± 86 1088 ± 729       131 ±92  577 ± 438
BB-DR/S 39 ± 25   942 ± 483 54 ± 51  322 ± 149
F344 82 ± 24 1979 ± 117  714 ± 229a      2151 ± 372
Statistical analysis using the Kruskal-Wallis test for multiple groups showed the following statistically significant 
differences: ap<0.05 F344 vs. BB-DR; bp<0.05 F344 vs. BB-DP; cp<0.05 F344 vs. BB-DP and BB-DR.
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DISCUSSION
Here, we firstly show effects of the presence of the lyp region of BB-DP chromosome 4 on 
the differentiation of DC from bone-marrow precursors in the BB rat model of autoimmune 
thyroiditis/diabetes. In BB-DP rats a consistently lower expression of MHC class II on 
generated immature and mature DC was found as compared to such APC of BB-DR rats (and 
as compared to such cells of control rat strains).
Which mechanisms might be responsible for this lower expression of MHC class II 
associated with the lyp gene? Direct effects of the mutated Ian5 gene can practically be ruled 
out, since it was not expressed in myeloid DC and their precursors (this report). Direct effects 
of the other Ian genes, such as Ian1, Ian2, Ian3, Ian6 and Ian7, which are also expressed in 
the lyp gene region cannot be ruled out, since we did not investigate their expression in the 
DC. Indirect effects not related to gene expression are also possible. Here, it must be noted 
that the DP rat sub-lines from which the bone-marrow was collected all displayed a severe 
lymphopenia. Bone-marrow cultures normally contain approximately 10% of T cells, but the 
cultures of DP animals contained approximately 5% of T cells (data not shown) and a relative 
lack of T cell products in the culture might have accounted for the defective DC differentiation. 
That T cell factors are important for DC development has been shown in experiments with 
RAG2-/- T cell-deficient mice. These mice exhibit a deficiency in epidermal Langerhans cells 
and lymph node lymphoid- and myeloid-related DC. An adoptive transfer of normal T cells 
corrected these DC deficiencies.23 Macrophage-like cells are also present in the bone-marrow 
cultures and it must be noted that macrophages of BB-DP rats are special in that they show 
Figure 5. Low Ian5 mRNA expression in rat DC precursors and DC. 
The expression of Ian5 mRNA in T cells, DC precursors (OX7+), total BM (BM) and bone-marrow derived DC 
(BMDC). The y-axis represents the Ian5 expression (relative to T cells, which were set to 100%).
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an excessive production of L-arginine, NO24-26 and other reactive oxygen species.27 All these 
factors are known to be involved in the differentiation and maturation of DC.28,29 Clearly, the 
effects of and the production of T cell factors, such as IFN-γ, and macrophage factors (NO and 
other reactive oxygen species) need to be investigated in the GM-CSF/IL-4-induced bone-
marrow cultures of the BB rats in future experiments to solve this item.
Secondly, we show here a set of abnormalities in bone-marrow precursor derived DC 
characteristic of both BB-DP and BB-DR rats and different from Wistar and F344 control 
rat DC. Such abnormalities must thus be due to genes in the BB gene background other 
than those associated with the lyp gene. The aberrancies include a low IL-10 production of 
the DC and a poor terminal differentiation of immature to mature T cell stimulatory (and 
fully IL-12 producing) DC under the influence of LPS (TLR4 stimulator). The poor terminal 
differentiation of BB rat DC could either be due to unresponsiveness of the mDC to LPS, or 
due to an intrinsic maturation defect of the cells. To distinguish between these two possibilities 
other maturation protocols need to be tested using alternative maturation factors like TLR2 
stimulators (peptidoglycan or lipoteichoic acid), TLR3 stimulators (dsRNA or poly I:C) or a 
TLR9 stimulator (CpG).
What could be the genes responsible for these DC aberrancies characteristic of both the 
BB-DP and BB-DR rat? One or more of the major diabetes susceptibility (iddm) genes such 
as iddm1 (the MHC class II (RT1u)) on chromosome 2030, iddm3 (which co-localizes with 
body weight regulation genes) on chromosome 231 and iddm4 located on chromosome 4 in 
close proximity to iddm232,33 are candidates to govern these aberrancies, since they are shared 
by BB-DP/S and BB-DR/S rats in comparison to control non-autoimmune strains. Clearly, 
to unravel whether these genes are involved, similar studies as reported here but with rats 
congenic for these iddms need to be performed (e.g. studies on the congenic WF.iddm4 rats 
carrying the BB rat (‘‘d’’) allele, which become hyperglycemic in ~70% of animals after 
treatment to induce diabetes33).
Interestingly, the here found aberrancies in the differentiation and function of antigen-
presenting cells are not specific for the BB rat model of autoimmune thyroiditis/diabetes. 
Similar aberrancies have been found in the other important rodent model of autoimmune 
diabetes, the NOD mouse, and in type-1 diabetes patients.
In the NOD mouse model studies have mainly concentrated on the GM-CSF induced 
development of DC from bone-marrow precursors. This development was found aberrant 
as compared to control animals in the majority of the studies, leading to the generation of 
immature DC with a macrophage-like phenotype and a low capability to stimulate T cells.34-36
A further terminal differentiation of such NOD immature DC with LPS was hampered similar 
to the here reported defect in the BB rat strain. Contradictory findings have, however, also been 
made in the NOD mouse regarding the aberrant development of immature DC and mature DC 
from precursors: a hyperactive NF-κB in NOD bone-marrow derived DC (and macrophages) 
has also been found, which led to a strong T cell stimulatory capacity.37-39 Although this is 
perhaps partially compatible with a more pro-inflammatory macrophage-like character of the 
generated NOD DC, we found it also dependent on the culture conditions used, e.g. seeding 
concentrations of the cells, application of additional growth factors (IL-4) and plastics used.34 
The hyperactive NF-κB in NOD MФs and DC also led to an increased production of the pro-
inflammatory cytokines IL-12p70, TNF-α and IL-1α.40
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In type-1 diabetes patients and high-risk first-degree relatives aberrancies in the 
differentiation and function of monocyte-derived DC have been reported as well.41 Also, the 
generation of another similar antigen-presenting cell (APC) population, i.e. of macrophage-
like veiled cells, was found hampered in type-1 diabetic and autoimmune thyroiditis patients.42 
This hampered differentiation resulted in a low T cell stimulatory capacity of the APC. 
Other reports show a decreased in vitro IL-10 and IL-4 production by peripheral blood cells 
of first-degree relatives at a high risk of type-1 diabetes.43 Additional evidence for an IL-10 
production aberrancy comes from twin studies: type-1 diabetes-discordant twins with a raised 
risk (i.e. islet cell antibody-positive) show a reduced IL-10 response to hsp60 as compared 
to twins at low risk.44 In addition there appears to be a defect in the production of IL-10 (and 
IL-4) in the pancreas of recently diagnosed type-1 diabetes mellitus patients.45
Collectively our rat data and those of others in mice and humans thus suggest that 
individuals prone to type-1 diabetes are characterized by an aberrant differentiation of antigen-
presenting cells from precursors. How might such aberrancies in APC lead to proneness for 
auto-aggressive self-reactivity?
It is not difficult to envisage the reduced IL-10 production of the immature and mature 
DC of rats of the BB background (and those described in humans) as contributing to the 
autoimmune status, since IL-10 is an important immune suppressive molecule. However, the 
poor T cell stimulatory function and the relatively low IL-12 production of mature DC is more 
difficult to view as a factor promoting autoimmunity. There are, however, a few indications in 
the literature that poorly differentiated DC of the BB-DP rat and the NOD mouse contribute 
significantly to imbalances in the T cell system in such a way that autoimmunity prevails. 
First of all, transfers of properly terminally differentiated DC prevent diabetes development 
in the NOD mouse.46 Dahlen et al. suggested that such transfers worked due to the correction 
of the low level of co-stimulation given by defective NOD DC: the transferred maturated DC 
would give a full activation of autoreactive T cells and would consequently induce Activation 
Induced T cell Death (AITCD) and/or the up-regulation of CTLA-4, an important switch-off 
signal for activated T cells.35 However, other mechanisms might play a role as well: properly 
terminally differentiated mature DC are also better equipped to skew T cell responses towards 
Th2 immune responses47 and to directly expand CD4+CD25+ regulatory T cells.48,49 Indeed, in 
the BB-DP rat model the poorly differentiated lymph node and spleen DC of the BB-DP rat 
showed a reduced potential of expanding the important ART2+ regulatory T cell population 
of the rat.12 That indeed a full stimulation of T cells via the co-stimulatory pathways leads 
to a prevention of autoimmunity is further illustrated in experiments directly interfering in 
the CD28 stimulating pathway. When the BB-DP rat is treated with a stimulating anti-CD28 
antibody (thus correcting the poor stimulating activity of the animals APC and activating 
the T cells), autoimmunity does not develop.50 Also, in the NOD mouse interventions in 
the activation pathway between functionally active DC and T cells (by deleting CD80-
CD28 interactions) disrupt existing faulty tolerance even further, thus accelerating diabetes 
development. Interestingly, these interventions in the NOD mouse led to a hampered generation 
of CD4+CD25+ regulatory T cells.51
In conclusion, the here-presented study provides evidence that the differentiation of 
immature and mature DC from bone-marrow precursors is hampered in the BB-DP rat 
model of autoimmune thyroiditis/diabetes. One of these disturbances is lyp (iddm2) gene 
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associated, i.e. the low MHC class II expression of DC arising from bone-marrow precursors. 
The others are governed by BB rat genes not associated with the lyp gene and also occurred in 
BB-DR/S rats, such as the low IL-10 production of the DC and a poor terminal differentiation 
of immature DC to mature T cell stimulatory DC under the influence of LPS.
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ABSTRACT 
BB-Diabetes Prone (BB-DP) rats, a model for endocrine autoimmune 
diseases, are severely lymphopenic, especially lacking ART2+ regulatory 
T cells. BB-Diabetes Resistant (DR) rats are not lymphopenic and do not 
develop autoimmunity. BB-DP and BB-DR rats only differ at the lymphopenia 
(lyp) gene (iddm2) on chromosome 4. Since BB-DP rats also show aberrancies 
in the differentiation of dendritic cells (DC) from bone-marrow precursors, 
we tested the hypothesis that F344 rats congenic for a BB-DP chromosome 4
region (42.5-93.6 Mb; including the lyp gene, but also iddm4) display an in 
vitro DC differentiation different from normal F344 rats.
Here we show that the 42.5-93.6 Mb BB-DP chromosome 4 region is 
linked to an increased DC precursor apoptosis, a low MHC class II expression, 
a reduced IL-10 production and a reduced T cell stimulatory capacity of DC.
From our previous report on DC differentiation defects in BB rats (only 
differing in iddm2) and the present report, we deduce that the abnormal 
apoptosis and low MHC class II expression is linked to iddm2. The reduced 
T cell stimulatory capacity is linked to other genes on chromosome 4 (candidate 
gene: iddm4). The reduced IL-10 production has a complex linkage pattern. 
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INTRODUCTION
Dendritic cells (DC), the antigen-presenting cells par excellence, play a pivotal role in the 
pathogenesis of organ-specific autoimmune diseases. In animal models that spontaneously 
develop such diseases, such as the BioBreeding-Diabetes Prone (BB-DP) rat and the Non-
Obese Diabetic (NOD) mouse, MHC class II+ DC accumulate in the earliest phases of the 
disease in the thyroid gland, the pancreas and the salivary glands.1-7 These DC take up and 
travel with relevant autoantigens to draining lymph nodes, where a specific autoimmune 
response is initiated by the stimulation of naïve autoreactive T cells. Indeed an early 
accumulation of DC in glands later targeted by the autoimmune response is followed by an 
enlargement of the lymph nodes draining the glands and the production of autoantibodies by 
plasma cells located in these lymph nodes.1,3 This lymph node reaction is later followed by 
an infiltration of the target gland by large numbers of lymphocytes. In patients with type-1 
diabetes mellitus, autoimmune thyroid disease and Sjögren’s syndrome, DC are also seen in 
large numbers in the target glands.1,8-11
The advantage of studying the BB-DP rat model of organ-specific autoimmunity is 
the presence of a well-defined suppressor/regulatory T cell population expressing the Ag 
ART2 in the rat.12 These T cells play a crucial regulatory role in the pathogenesis of organ-
specific autoimmunity.12 BB-DP rats are severely lymphopenic, in particular lacking ART2+ 
T cells. There exists a sub-line of BB rats, the so-called BB-Diabetes Resistant (DR) rats, 
that are not lymphopenic and do not develop diabetes and thyroid autoimmunity because 
of the presence of ART2+ T cells. Depletion of these cells in the BB-DR rat induces organ-
specific autoimmunity,13 while transfer of these cells obtained from BB-DR rats into BB-DP 
rats prevents organ-specific autoimmunity in the latter.14 The genetic difference between the 
BB-DP rat and the BB-DR rat is at the level of the lymphopenia (lyp, iddm2) gene, a major 
diabetes susceptibility gene located on chromosome 4. Homozygosity for the defective lyp 
gene, as is the case in the BB-DP rat, leads to severe T lymphocytopenia and the lack of 
ART2+ regulatory T cells.15-19 Recently, the lyp gene (also called Ian5, Gimap5, Ian4L1) in 
BB-DP rats was found to carry a single nucleotide deletion causing a frameshift mutation and 
a severe truncation of the protein.20,21
In addition to T lymphocytopenia, DC are defective in the BB-DP rat. We previously 
reported abnormalities in ex vivo preparations of spleen DC and thyroid DC. The spleen DC 
of the BB-DP rat showed a lower MHC class II expression, had a lower capability to form 
homotypic cell aggregations and had a reduced capability to stimulate T cells in syngeneic 
MLR.22,23 The DC preparation isolated from the thyroid gland of the BB-DP rat contained 
fewer cells with the characteristics of typical MHC class II+ DC. Also more of monocyte-
like precursors were present in the BB-DP thyroid isolates as compared to cell preparations 
of thyroids of control Wistar rats.24 We viewed these abnormalities as signs of defects in 
the differentiation and maturation of DC from precursors in the BB-DP rat. We indeed 
later found such hampered differentiation and maturation from bone-marrow precursors in 
BB-DP/Seattle (S) rats. Cultures of bone-marrow precursors in GM-CSF/IL-4 yielded DC 
with a lower MHC class II expression not only as compared to Wistar and F344 rats, but 
also in comparison to BB-DR/S rats, that only differ from the BB-DP/S rats with regard 
to a 1.3-Mb region on chromosome 4 (76.35 Mb-77.67 Mb). This observation suggests the 
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involvement of the lyp gene (iddm2) in this MHC class II expression defect of the DC, since 
this BB-DP gene is located in the 1.3-Mb region on chromosome 4. The DC of BB-DP rats 
cultured from bone-marrow precursors also showed other abnormalities, i.e. a poor capability 
to terminally differentiate into DC with a strong T cell stimulatory capacity, and the cells 
also produced lower quantities of IL-10 and IL-12p40. These latter aberrancies, however, 
were also found in the BB-DR/S rat but did not occur in the control Wistar and F344 rats. We 
therefore concluded that there exist various aberrancies in the differentiation of myeloid DC 
from precursors in the BB rat model of organ-specific autoimmunity and that various genes, 
including the lyp gene (iddm2), control these aberrancies.
We decided to study the linkage of the BB-DP rat DC aberrancies to gene regions further 
by using F344 rats congenic for the region of the BB-DP rat chromosome 4, on which the lyp 
gene is located. Congenic F344 rats homozygous for this region of the BB-DP rat chromosome 
4 (designated ‘‘F344.lyp/lyp rats’’) have a similar extent of T lymphocytopenia and other 
T cell abnormalities as the BB-DP rat (an increased number of CD25+ and Thy1+ T cells; 
nearly absent ART2+ T cells and increased numbers of circulating granulocytes, large granular 
lymphocytes and natural killer cells).25,26 The rats do not, however, develop organ-specific 
autoimmunity, since they apparently lack important iddm genes on other chromosomes for 
such development.
Recent studies indicate that the congenic region of F344.lyp/lyp rats is large (51.1 Mb) 
and covers a considerable part of the BB-DP rat chromosome 4, i.e. the region from 42.5 Mb 
to 93.6 Mb. This also implies that the congenic F344 rats share both the iddm2 and the iddm4 
gene with the BB-DP rat. The latter is located on chromosome 4 at position 64.9-69.3 Mb.
Here we report the in vitro differentiation of DC from bone-marrow precursors and their 
further maturation after LPS stimulation in rats of this congenic F344 strain. We compared 
F344 rats homozygous and heterozogous for the lyp-containing region (designated ‘‘F344.lyp/
lyp’’ and ‘‘F344.lyp/+’’ rats) versus wild-type non-congenic (‘‘+/+’’) F344 rats, enabling us to 
study the effects of genes within the 42.5 Mb-93.6 Mb region of the BB-DP rat chromosome 
4 on the differentiation and maturation of rat DC.
We found that DC precursors of F344.lyp/lyp and lyp/+ rats showed a higher apoptosis 
during culture to DC, leading to a lower yield of DC after 7 days of culture. In addition, the 
generated DC had a low MHC class II expression, a low capability to stimulate T cells in 
allogeneic (allo)-MLR and, if ‘‘lyp/lyp’’, a reduced capability to produce IL-10. Their further 
final differentiation to mature DC by LPS was not, or hardly, hampered. In a comparison to 
our earlier reported findings on abnormalities in the differentiation and maturation of DC of 
BB-DP/S rats versus those of BB-DR/S rats (see above) we are able to construct a more solid 
and detailed linkage of iddm2 and other genes to the DC aberrancies typical of the BB rat 
model of diabetes.
MATERIALS AND METHODS
Animals
Female Wistar rats were obtained from Harlan (Zeist, The Netherlands). F344.+/+, F344. 
lyp/+ and F344.lyp/lyp rats26 were developed and maintained at the Robert H. Williams 
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Laboratory at the University of Washington, Seattle, USA. The animals were housed under 
SPF conditions. All rats were kept under controlled light conditions (12/12 h light/dark cycle) 
throughout this study. A standard pelleted diet (0.35 mg iodine/kg; AM-II, Hope Farms BV, 
Woerden, The Netherlands) and tap water were provided ad libitum. For all experiments, age 
matched F344 rats were used.
Bone-marrow derived dendritic cell culture
Rat bone-marrow was obtained from tibia and femur. Red blood cells were lysed by NH
4
Cl 
containing KHC0
3
 and EDTA. After red blood cell lysis cells were resuspended in RPMI 1640 
containing 25 mM HEPES buffer (Life Technologies), 10% FCSi, 50 μM β-mercapto-ethanol 
(Merck), penicillin (100 U/ml; Seromed, Biochrom, Berlin, Germany), and streptomycin 
(0.1 mg/ml; Seromed). Cells were brought to a concentration of 10 x 106/10 ml and cultured 
in 25 cm2 culture bottles (Nunc, Roskilde, Denmark) for 9 days (37°C, 5% CO2 incubator). 
To obtain dendritic cells from bone-marrow precursors rat recombinant GM-CSF (17 μg/ml) 
and rat recombinant IL-4 (20 μg/ml) was added (Biosource, Camarillo, CA, USA) to the 
culture medium. Medium was refreshed at day 4 (with cytokines) and day 7 (without cytokines 
to enrich for dendritic cells and to deplete granulocytes). At day 7 the non-adherent cells were 
further cultured for 48 h. (either resuspended in medium to obtain immature DC or in LPS 
(1 μg/ml) to obtain mature DC) and were harvested by rinsing the bottles with medium 
twice.
Methods for quantitative PCR
Quantitative PCR was performed on an Mx4000 instrument (Stratagene, La Jolla, CA, 
USA) using DNAse treated RNA (100 ng of total RNA) in triplicate using the Brilliant Single-
Step Quantitative RT-PCR Core Reagent Kit (Stratagene) along with serially diluted Standard 
samples. The standards used were 1:4 serial dilutions of BB-DR/Seattle rat spleen poly AC 
RNA.
Samples were multiplexed with a rat Ian5 probe and a rat cyclophilin probe. The Ian5 
probe was designed to the 3’ end of exon 3, beyond the coding region.
Probes and primers were from Integrated DNA Technologies, Ine. (Coralville, IA, USA). 
The probe for rat Ian5 was: 5’-FAM-TTT CAC TAT CAT TTG ACT CCT GTG CA-BHQ-1-3’. 
The probe for rat cyclophilin was 5’-HEX-CTG CTT CGA GCT GTT TGC AGA C-BHQ-1-
3’. These probes were carefully designed, assuring that they did not match any other gene in 
the rat database. The primers for Ian5 were f: 5’-CAT GTT AGG GAA GCT CAG TC-3’ and 
r: 5’-GAA GGG TTC TAC TGT GTC TCA-3’. The primers for rat cyclophilin were 
f: 5’-CAC CGT GTT CTT CGA CAT-3’ and: 5’-TTT CTG CTG TCT TTG GAA CT-3’. 
Resulting C(t) values were converted to picograms and normalized to the values of cyclophilin 
from the same well and expressed as the average of triplicate samples G one standard deviation. 
Total RNA was isolated using Qiagen RNeasy (Qiagen, Chatsworth, CA, USA) or Stratagene 
Absolutely RNA RT-PCR Miniprep kits (Stratagene, La Jolla, CA, USA). To remove trace 
genomic DNA, Ambion DNA-free (Ambion, Austin, TX, USA) treatment was performed on 
samples extracted with Qiagen RNeasy kit.
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Antibodies
The following mAbs were used: anti-MHC class II conjugated to phycoerythrin (PE) 
(1:400, MRC OX6; Serotec), anti-B7-1 (undiluted, CD80; BD Pharmingen, Flanders, NJ), 
anti-B7-2 (undiluted, CD86; BD Phar-mingen), anti-CD40 (1:10; BD Pharmingen), anti-rat 
DC-FITC (undiluted, MRC OX62; Serotec), anti-rat CD11c-FITC (Serotec), ED1 (1:10, DC, 
monocytes, MФ; Serotec), ED2 (1:100, monocytes, MФ; Serotec), ED3 (1:1000; Serotec), 
CD90 (undiluted, MRC OX7; Serotec). Unconjugated antibodies were labelled with FITC via 
a second step using rabbit anti-mouse-FITC Abs.
Flowcytometric analyses
Cells were added in round-bottom 96-wells plates (Nunc) at a concentration of 
~105 cells/well and washed twice in PBS/0.5% BSA/20 mM sodium azide. Pelleted cells 
were resuspended in 20 μl solution with labelled primary Abs, incubated for 10 min., and 
followed by two washing steps. Using unconjugated Abs, a second step was incorporated 
with rabbit anti-mouse-FITC Abs (Dako, Glustrup, Denmark) with 1% normal rat serum or 
rabbit anti-mouse-PE Abs (CLB, Amsterdam, The Netherlands) with 1% normal rat serum. 
For the visualizing of biotin-conjugated Abs, streptavidin-tri-color (Caltag Laboratories, 
San Francisco, CA, USA) was used. For cell analysis, 10,000 events were recorded with a 
FACS (FACSCalibur, Becton Dickinson, Sunnyvale, CA, USA). Dead cells, recognized by 
their uptake of 7-AAD and their specific forward- and side-scatter pattern, were excluded 
from analysis. For determination of background staining, cells were incubated with either 
labelled irrelevant Abs or with secondary Abs. Due to the considerable auto-fluorescence of 
the tested dendritic cell populations we used FACS instrument settings to correct for that 
(reduced voltage in the fluorescent channel) and to increase specificity of the marker signal. 
This, however, also reduced the magnitude of the specific marker signal and expression levels 
of 500 (Mean Fluorescence Intensity) are hence high and maximal. The expression level of 
the isotype control antibodies was 3 + 1 (for FITC) and 10 + 1 (for PE).
DNA staining for cell cycle and cell apoptosis analysis
Cells were added in round-bottom 96-wells plates (Nunc) at a concentration of ~105 
cells/well and washed twice in PBS/0.5% BSA/20mM sodium azide. Pelleted cells were 
resuspended in 100 μl PBS with 100 μl 0.5% PFA to fixate the cell, incubated for 60 min. at 4°C 
followed by one washing step. After washing, cells were resuspended with 200 μl PBS/0.2% 
Tween20 and incubated for 15 min. at 37°C to permeabilize the cells followed by two washing 
steps. Cells were resuspended in 200 μl PBS/0.2% Tween20. 100 μl was taken out and 200 μl 
7-AAD was added (30 μg/ml) for DNA staining. For cell analysis, 10,000 events were recorded 
with a FACS (FACSCalibur, Becton Dickinson, Sunnyvale, CA, USA).
MLR
T cells from F344 and Wistar rats were enriched using a nylon wool column. In short, 
spleens were minced and teased through a 105-μm filter, and the erythrocytes were removed by 
lysis. Cells were washed and loaded onto a nylon wool column (3 g; Polyscience, Eppelheim, 
Germany) packed into a 60-ml plastic syringe. After 1 h. in 5% C0
2
 incubator, T cells (80-90% 
CD3+ cells) were harvested by collecting the effluent.
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For the MLR, BM derived DC were added at various ratios to T cells (fixed number of 
150,000 T cells/well) in flat-bottom 96-wells plates (Nunc, Roskilde, Denmark). Subsequently, 
these cells were cultured for 3 days in RPMI 1640 containing 50 mM HEPES buffer (Life 
Technologies), 10% FCSi, 110 μg/ml sodium pyruvate (Merck, Munich, Germany), 0.5% (v/v) 
β-mercapto-ethanol (Merck), penicillin (100 U/ml; Seromed, Bio-chrom, Berlin, Germany), 
and streptomycin (0.1 mg/ml; Seromed). In the MLR, T cell proliferation was measured via 
tritiated thymidine ([3H]TdR) incorporation (0.5 μCi/well during the last 16 h. of total culture 
period). Finally, cells were harvested on filter papers, and radioactivity was counted in a liquid 
scintillation analyzer (LKB Betaplate, Wallac, Turun, Finland).
IL-10 and IL-12 production
Supernatants were obtained from dendritic cells by culturing them in 24-well plates 
(Nunc, Roskilde, Denmark) for 24 h. Cells were resuspended in serum free medium 
(SF-1) at a concentration of 0.5 x 106/ml. SF-1 medium was made by dissolving 1 ml SF-1 in 
9 ml RPMI 1640 with antibiotics. Cells were either cultured in SF-1 medium alone for basal 
production, SAC (Staphylococcus aureus Cowan strain) for IL-10 production or SAC and 
IFN-γ for IL-12p40 and IL-12p70 production.27 Rat IL-10, IL-12p40 and IL-12p70 ELISA 
kits were commercially available (Biosource, Camarillo, CA, USA).
Statistical analyses
Mean values ± SD are shown. Statistical analyses were performed using Mann-Whitney 
test.
RESULTS
GM-CSF/IL-4 culture of bone-marrow precursors yields an adherent and a non-adherent 
DC population. The non-adherent population has all the characteristics of prototypic DC.
The culture of bone-marrow precursor cells in GM-CSF/IL-4 yields two populations: an 
adherent colony-forming cell population and a floating non-adherent single cell population 
(Figure 1A and B shows characteristics of the Wistar rat DC). Similar results were found for 
Fischer rat DC (data not shown).
Both populations expressed the rat DC-specific markers OX62 (mean fluorescence 
intensity, MFI, non-adherent cells: 3291 ± 1207; adherent cells: 3199 ± 844) and CD11c 
(MFI non-adherent cells: 3334 ± 1769; adherent cells: 3398 ± 1010) and both populations 
expressed MHC class II, the adherent population stronger than the non-adherent population 
(Figure 1C). Despite the higher MHC class II expression the adherent population appeared 
functionally considerably less able to stimulate T cell proliferation in MLR as compared to 
the non-adherent population (Figure 1D). The non-adherent population also contained many 
more cells, which had the typical veiled/dendritic shape known of DC (Figure 1B).
To underscore the non-dendritic cell character of the adherent population we found it to 
also have various characteristics reminiscent of macrophages, such as a stronger expression 
of acid phosphatase and of the monocyte/macrophage markers ED1, ED2 and ED3 
(Figure 1A, E-G). We therefore considered the non-adherent cell population as the more 
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prototypic immature DC population and focused on this population in our subsequent 
experiments. We will refer to this population as immature DC throughout the further text.
The adherent population probably represents precursors for the immature DC because one 
sees in culture the detachment of veiled/dendritic cells from these colony-forming adherent 
cells.
To be able to link putative aberrancies in DC and DC development in lyp gene carrying 
animals directly to gene influences, we also studied whether immature DC, their OX7+ bone-
marrow precursors and the non-fractioned bone-marrow population express the Ian5 molecule. 
We found that the non-fractioned bone-marrow population and the OX7+ DC precursors 
expressed Ian5 mRNA, but at an extremely low level as compared to T cells (Figure 1H). 
The descending immature DC did not express Ian5 mRNA (see Figure 1H). We therefore 
consider the Ian5 mRNA expression in the precursor cells as due to T cell contamination of 
this population, because the non-fractioned bone-marrow cell population had a higher Ian5 
mRNA expression as compared to OX7+ DC precursors, and because both populations are 
contaminated with some T cells (the non-fractioned bone-marrow cell population with around 
10%, the OX7+ bone-marrow DC precursors with around 5%).
DC bone-marrow precursors of congenic F344.lyp/lyp and lyp/+ rats show a higher 
apoptosis and the precursor derived DC show a lower expression of surface MHC class II 
molecules and a lower capability to stimulate T cells. These latter aberrancies are lost after a 
final differentiation of the cells with LPS.
Figure 2 shows that the F344.lyp/lyp and lyp/+ DC precursors exhibited a higher apoptosis 
as compared to +/+ cells in culture (Figure 2A). This resulted in a slightly lower (statistically 
not significant) yield of non-adherent floating DC (Figure 2B) after 7 days of culture (the yield 
of adherent cells was equal).
When studying the marker expression on bone-marrow precursor derived DC of the 
homozygous (lyp/lyp) and heterozygous (lyp/+) congenic F344 rats versus those of F344.+/+ 
animals, we found that the cells differed in their expression of MHC class II molecules on 
their surface: the lyp carrying animals had lower numbers of MHC class IIbright cells, resulting 
in more MHC class IIdull cells as compared to the +/+ animals (Table 1 and Figure 2C). 
With regard to the other tested important marker molecules such as OX62 and CD11c (the 
rat DC-specific markers) CD80, CD86, and CD40 (the co-stimulatory molecules) and ED1 
(a monocyte/DC marker): neither the expression levels of these molecules, nor the percentages 
of positive cells for these markers differed between cells from lyp/lyp, lyp/+ and +/+ rats 
(Table 1).
Figure 1. Characteristics of rat bone-marrow derived DC. When bone-marrow precursors are cultured in 
GM-CSF/IL-4 two OX62+CD11c+ populations are obtained: a population of adherent (colony-forming) cells 
and a non-adherent population of floating single cells.
Although the non-adherent cells show a definite, but lower expression of MHC class II (C) as compared to adherent 
cells, the cells have a much higher capability to stimulate T cells to proliferate (D; n=10). The adherent cells also 
have more macrophage characteristics like a higher ED1 (E), ED2 (F) and ED3 (G) expression and a stronger and 
‘‘spotty’’ acid phosphatase activity (A). We therefore consider the non-adherent cells as the typical DC. Interestingly, 
Ian5 mRNA is not expressed in myeloid DC (H). The grey tone in (C), (E)-(G) represents the non-adherent cells. 
The dotted line represents isotype control. Representative figures are shown in (C), (E)-(G) (n=18). Experiments 
shown were performed in Wistar rats. The magnification for (A) and (B) is 64x and 96x, respectively. For colour 
figure see Appendix page 144.
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The T cell stimulatory capacities of immature DC of F344.lyp/lyp, lyp/+ and +/+ rats 
were tested in an (allo)-MLR (Figure 3A). As can be seen, the T cell stimulatory capacity of 
immature DC of lyp/lyp and lyp/+ rats was considerably lower than that of +/+ rats, particularly 
at DC to T cell ratios 1:5 and 1:10.
To see whether the reduced expression of MHC class II molecules and the reduced T cell 
stimulatory capacity for T cells was still present for the F344.lyp/lyp and lyp/+ rats after a 
final differentiation (maturation) of the cells, we further differentiated the DC using LPS. 
In a preliminary small set of experiments, we had used several maturation factors (LPS, 
IFN-γ, TNF-α, and Mycobacterium tuberculosis (MBT)) to find the optimal maturation factor 
for rat DC (see Table 2). We had found 1 μg/ml LPS to be the best maturation factor to induce 
mature DC with a higher surface expression of MHC class II molecules and co-stimulatory 
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Figure 2. Apoptosis and cell cycle in DC precursors and MHC class II expression of DC. 
The apoptosis (A) of precursor DC at day 4 of culture in F344.lyp/lyp rats as compared to F344.lyp/+ and F344.+/+ 
rats and measured by 7-AAD staining (n=5-6). There is a higher apoptosis of precursor DC of F344.lyp/lyp rats. 
The yield of cells (B) after 7 days of culture of bone-marrow precursors in GM-CSF/IL-4 in F344.lyp/lyp rats as 
compared to F344.lyp/+ and F344.+/+ rats (n=10-15). The yield is lower in F344.lyp/lyp rats, though not statistically 
significant. MHC class II expression of F344.lyp/lyp (solid grey fill) versus F344.+/+ (black line) of iDC (C) and 
mDC (D). Dotted line represents isotype control. It is clear that the number of MHC class IIdull cells is higher in the 
iDC preparation of lyp/lyp versus +/+ rats.
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molecules and a clearly raised potency to stimulate T cells (Table 2).
With regard to the LPS maturation of the immature DC of the F344.lyp/lyp and lyp/+ rats 
it appeared that after LPS maturation the MHC class IIdull population of DC had disappeared 
in the lyp/lyp and lyp/+ condition; all DC now expressed higher levels of MHC class II in the 
lyp/lyp, lyp/+ and +/+ conditions (Figure 2D and Table 3). The expressions of CD80, CD86 
and CD40 were also not different between the mature DC of lyp/lyp, lyp/+ and +/+ animals 
(Table 3). In accord with the restoration of the MHC class II expression due to LPS maturation, 
the T cell stimulatory capacity of the lyp/lyp and lyp/+ rats was also restored by the LPS 
maturation (Figure 3B).
Of note is that we isolated in a separate small series of experiments a crude DC fraction 
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Figure 3. The T cell stimulatory capacity of iDC and mDC. 
The T cell stimulatory capacity of iDC (A) and mDC (B) of F344.lyp/lyp, F344.lyp/+ and F344.+/+ rats. The T cell 
stimulatory capacity was measured in allogeneic MLR and expressed as the incorporation of 3H-thymidine (c.p.m.) in 
the stimulated T cells. iDC of lyp/lyp animals have a poor T cell stimulatory capacity as compared to the +/+ animals 
(p<0.05; n=4-10). The same holds true for lyp/+ animals, although this was not statistically significant. This defect is 
restored by maturation of the cells with LPS, while all mDC gain in T cell stimulatory capacity. Note: F344 DC were 
not stimulated with Wistar T cells (allogeneic MLR:MHC haplotypes are different between F344 and Wistar rats).
Table 1. The Mean Fluorescence Intensity (MFI) of important marker molecules on the cell surface of bone
 marrow derived DC (n=5-12).
Marker F344.lyp/lyp F344.lyp/+ F344.+/+
OX62 339 ± 133 292 ± 66 379 ± 153
CD11c 58 ± 19 23 ± 4 66 ± 48
MHC class II 133 ± 63*  144 ± 25* 241 ± 110
CD80                  17 ± 9 12 ± 4                  20 ± 7
CD86 22 ± 11                   19 ± 12 30 ± 13
CD40  24 ± 18 16 ± 6 37 ± 21
ED1  31 ± 29                   11 ± 10 45 ± 10
* represents p values of <0.05 as compared to the +/+ condition
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(low-density cells) from the spleen of F344.lyp/lyp and +/+ rats (for isolation details, see 
ref. 22). Spleen DC can be considered as belonging to the series of mature DC28, which 
have received their maturation signals in vivo. Figure 4 shows that the OX62+ cells in the 
spleen low-density fraction of F344.lyp/lyp animals contained more MHC class IInegative cells 
as compared to such fractions of F344.+/+ rats (thus showing a reduced expression of MHC 
class II on spleen DC), yet the T cell stimulatory capacity was equal between the spleen low-
density cell fraction of F344.lyp/lyp versus +/+ rats (and similar to that of mature in vitro 
bone-marrow derived DC). Hence, we must conclude that LPS exposure in vitro, but only 
with regard to MHC class II expression, is more effective to induce a further differentiation 
of immature DC of the F344.lyp/lyp rats than the physiological maturation factors acting in 
vivo (fitting in with the idea that such cells are not fully mature, but in fact semi-mature29). 
Only DC of homozygous of F344.lyp/lyp rats show a lower capability to produce IL-10, the 
cells have a normal IL-12p40 production. The lower capability to produce IL-10 is partially 
restored after a final differentiation of the cells with LPS.
With regard to the cytokine production by the bone-marrow derived DC we tested the 
most relevant DC-related cytokines IL-12p70, IL-12p40 and IL-10 and used as stimulator 
S. aureus strain Cowan (in combination with IFN-γ for IL-12p70 and IL-12p40 production), 
since we had previously found that this was the most optimal stimulation for DC to produce 
Table 3.  The Mean Fluorescence Intensity (MFI) of important marker molecules on the cell surface of bone-
marrow derived DC of Wistar rats after LPS maturation (n=3-8) (statistically significant differences 
were not found between the three sub-lines).
Marker F344.lyp/lyp F344.lyp/+ F344.+/+
OX62               345 ± 276  474 ± 175 265 ± 139
CD11c                 95 ± 11 n.d. 55 ± 12
MHC class II               203 ± 61                229 ± 58               218 ± 60
CD80                 22 ± 7                  20 ± 3 35 ± 11
CD86                 26 ± 9                  28 ± 13 36 ± 14
CD40 32 ± 14                  30 ± 6 33 ± 10
ED1 14 ± 14                    8 ± 3                 10 ± 0
Table 2.  The Mean Fluorescence Intensity (MFI) of important marker molecules on the cell surface of bone
 marrow derived DC of Wistar rats after LPS, TNF-α and IFN-γ maturation (n=3) together with the
 T cell stimulatory capacity (MLR).
Marker iDC LPS-mDC IFN-γ-mDC TNF-α-mDC
MHC class II   207 ± 35  317 ± 22*  462 ± 95*           365 ± 113
CD80   27 ± 6  45 ± 1*  31 ± 2*             31 ± 11
CD86     54 ± 33  84 ± 14  74 ± 10             68 ± 27
CD40     45 ± 19  61 ± 27             57 ± 14             48 ± 14
MLR     3464 ± 2343  43,990 ± 36,867         1788 ± 941         2963 ± 746
* represents p values of <0.05 as compared to the iDC
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these cytokines.27
The IL-12p70 production by our DC populations was low, and there was no statistically 
significant difference between lyp carrying and +/+ bone-marrow derived DC, irrespective 
of their state of maturation (data not shown). The IL-12p40 production was, however, 
considerable, but did not differ between lyp/lyp, lyp/+ and +/+ conditions (Table 4), neither 
in the case of immature DC nor in the case of mature DC. It was evident that mature DC did 
produce more IL-12p40, as is expected from mature DC.
The IL-10 production of the rat DC populations was also considerable when stimulated 
with SAC. Interestingly, the IL-10 production capability of the bone-marrow derived DC of 
lyp/lyp animals was significantly lower compared to that of the DC of lyp/+ and +/+ animals 
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Table 4.  The IL-12p40 cytokine production of bone-marrow derived immature DC (iDC) and mature DC
  (mDC) of the various sub-lines of the F344 rats (statistically significant differences were not found
 between the three sub-lines (n=3)).
Cytokine
(pg/ml)
Rat strain IL-12 iDC 
(not stimulated)
IL-12 iDC 
(SAC/IFN-γ)
IL-12 mDC 
(not stimulated)
IL-12 mDC 
(SAC/IFN-γ)
IL-12p40   F344.lyp/lyp  57 ± 23  1646 ± 384  1294 ± 889  2254 ± 1492
F344.lyp/+ 68 ± 9  1880 ± 203  624 ± 90 2121 ± 336
F344.+/+  82 ± 24  1979 ± 117    714 ± 229 2151 ± 372
Figure 4. The low-density cell fraction (a fraction enriched for DC) of the spleen of F344.lyp/lyp rats contains 
a higher number of OX62 cells (prototypic DC) with a reduced MHC class II expression as compared to such 
fractions of F344.+/+ rats. 
Dot plots of spleen low-density cells of F344.+/+ (A) and F344.lyp/lyp (B) rats with OX62 on the x-axis and MHC 
class II on the y-axis. The spleen low-density cells of the F344.lyp/lyp rat show a higher number of OX62+ MHC class 
IInegative cells as compared to such low-density cells of F344.+/+ rats. Percentages are indicated in the dot plots.
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(Figure 5A). A final differentiation with LPS corrected this low IL-10 production capability 
in DC populations of some of the animals, since there was an increase in the average IL-10 
production, yet with a considerable standard deviation (Figure 5B), resulting in no significant 
difference between mature DC of lyp/lyp and +/+ animals.
DISCUSSION
This study shows that the 42.5 Mb - 93.6 Mb region of chromosome 4 of the BB-DP 
rat, which contains both iddm2 (the lyp gene) and iddm4, is not only responsible for the 
severe T lymphocytopenia of the rat15-19, but is also linked to an aberrant differentiation of 
DC from bone-marrow precursors. While homozygosity for this region is essential for severe 
T lymphocytopenia, it turned out that heterozygosity for the genes on this region of chromosome 
4, is sufficient to result in an enhanced apoptosis of DC precursors, a reduced MHC class II 
expression on precursor derived DC and a low capability of the DC to stimulate T cells in 
(allo)-MLR. A reduced IL-10 production capability of the cells was only found in congenic 
F344 homozygous for the 42.5 Mb to 93.6 Mb region of chromosome 4 of the BB-DP rat.
Previously we reported on effects on the DC differentiation and maturation in the presence 
of the iddm2 (lyp gene) containing 1.3 Mb region of BB-DP chromosome 4 on the BB-DR 
rat background, thus representing the effects of only this small region on DC differentiation/
maturation and thus likely closely linked to iddm2. Table 5 gives these data in relation to the 
effects of the larger 51.1 Mb region of BB-DP chromosome 4 (including iddm2 and iddm4) 
on the wild-type F344 rat background here found.
As can be seen, the enhanced apoptosis of DC precursors and the reduced MHC class II 
expression on precursor derived DC can be linked to iddm2, since it occurs both in BB-DP/S 
and in congenic F344.lyp/lyp rats versus the BB-DR/S and F344.+/+, respectively.
Table 5 also shows that we are able to detect a set of abnormalities in the DC, which are 
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Figure 5. The IL-10 production capacity of iDC and mDC. The IL-10 production capacity of iDC (A) and mDC 
(B) of F344.lyp/lyp, F344.lyp/+ and F344.+/+ rats. 
The IL-10 production capacity was measured after stimulation of the cells with SAC and measured in ELISA and 
expressed as pg/ml production over a 24-h period. iDC of lyp/lyp animals have a poor IL-10 production as compared 
to the lyp/+ and +/+ animals (p<0.05; n=6-8). This defect is partially restored by maturation of the cells with LPS.
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characteristic of both BB-DP/S and BB-DR/S rats and are different as compared to control 
Wistar and F344 rats. Such abnormalities must thus be due to genes in the BB gene background 
other than those on the larger 51.1 Mb region of BB-DP chromosome 4 (including iddm2 and 
iddm4). These aberrancies included a high yield of DC from precursors in the GM-CSF/
IL-4 culture and a poor capacity of the generated immature DC to respond to LPS and to 
differentiate into strong T cell stimulatory mature DC (see Table 5).
There is also a DC abnormality, i.e. the poor T cell stimulatory capacity of DC, which was 
found in congenic F344.lyp/lyp rats but not in F344.+/+ rats. It is thus linked to the large 51.1 
Mb region of BB-DP chromosome 4 containing both iddm2 and iddm4. However, the T cell 
stimulatory capacity of DC is normal in BB-DP/S rats and not different from that of BB-DR/S 
rats. It is thus not linked to the small iddm2 containing 1.3 Mb region of BB-DP chromosome 
4. Hence, iddm4 is a likely candidate gene for the poor capability of DC to stimulate T cells.
Finally, one of the DC abnormalities i.e. the reduced IL-10 production capacity, shows 
a complex linkage pattern. The IL-10 production was not different between BB-DP/S and 
BB-DR/S rats and is thus not linked to the small iddm2 containing 1.3 Mb region of BB-DP 
chromosome 4. It is different in the F344 homozygous lyp/lyp rats versus the +/+ rats, hence 
iddm4 or another gene on chromosome 4 is involved. However, it is also different between 
BB-DR/S and normal F344.+/+ rats and this observation indicates a linkage with additional 
genes in the BB-background (Table 5). Clearly to investigate whether these genes are really 
involved, similar studies as reported here but with rats transgenic for such iddms need to 
be performed. A new and opposite approach introducing functional genes into rats could be 
another elegant research tool. Recently, Michalkiewicz and co-workers30 were able to restore 
Ian5 transcript and protein levels by creating a transgenic rat, completely rescuing the T cell 
lymphopenia in F344.lyp/lyp rats.
Table 5.  Linkage of DC phenotype with the genetic background of the various sub-lines of the F344 and BB
  rats.
Genes involved F344.+/+ F344.lyp/lyp BB.+/+ BB.lyp/lyp
Genotype Normal 
genes
Normal genes 
plus BB genes 
on chromosome 4 
(42.5-93.6 Mb)
BB genes 
minus iddm2
BB genes 
plus iddm2
Iddm2 (lyp) Apoptosis precursors normal increased normal increased
MHC class II normal decreased normal decreased
expression
BB genes not on
the 42.5 Mb-93.6
Mb region of
chromosome 4
Yield of DC normal normal increased increased
In vitro maturation normal normal decreased decreased
capacity after LPS
iddm4 (candidate) T cell stimulation normal decreased normal normal
Complex linkage IL-10 production normal decreased decreased decreased
(but equal to 
BB.+/+)
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It is not difficult to envisage the reduced IL-10 production of DC of F344.lyp/lyp rats and 
rats of the BB-background as contributing to the autoimmune status of the animals, since 
IL-10 is an important immune suppressive molecule. Also in human diabetes, IL-10 production 
defects have been described. But how might a low MHC class II expression and a low T cell 
stimulatory capacity of DC contribute to proneness for the auto-aggressive self-reactivity 
of the BB-DP rat? There are a few indications in the literature that poorly differentiated 
DC contribute to imbalances in the T cell system in such a way that autoimmunity prevails. 
First of all, transfers of properly terminally differentiated DC prevent diabetes development 
in the NOD mouse. Dahlen et al.31 suggested that such transfers worked due to the correction 
of the low level of co-stimulation given by defective NOD DC: the transferred mature DC 
would give a full activation of autoreactive T cells and would consequently induce Activation 
Induced T Cell Death (AITCD) and/or the up-regulation of CTLA-4, an important switch-off 
signal for activated T cells. However, other mechanisms might play a role as well: properly 
terminally differentiated mature DC are also better equipped to skew T cell responses towards 
Th2 immune responses32 and to directly expand CD4+CD25+ regulatory T cells.33,34 Indeed in 
the BB-DP rat model, the poorly differentiated lymph node and spleen DC of the BB-DP rat 
showed a reduced potential of expanding the important ART2+ regulatory T cell population 
of the rat.22 That indeed a full stimulation of T cells via the co-stimulatory pathways leads 
to a prevention of autoimmunity is further illustrated in experiments directly interfering in 
the CD28 stimulating pathway. When the BB-DP rat is treated with a stimulating anti-CD28 
antibody (thus correcting the poor stimulating activity of the animals APC and activating the 
T cells), autoimmunity does not develop.35
Although the gene dose-effects (differences between lyp/lyp and lyp/+) of the DC 
aberrancies linked to iddm2 suggest a direct effect of the gene on DC differentiation and 
maturation, it must be noted that we were not able to detect the expression of Ian5 in the 
DC or its precursors (the mutated Ian5 is considered the crucial abnormality determining the 
lymphopenia status). Which other indirect mechanisms could be responsible for the observed 
aberrancies in the differentiation of DC in the lyp/lyp and lyp/+ animals? In the lyp/lyp and 
lyp/+ animals, the lack of T cells or T cell products in the cultures to generate DC could have 
played a role. The bone-marrow cultures of the +/+ and lyp/+ animals contained approximately 
10% T cells, while the cultures of the lyp/lyp animals contained approximately 5%. That a 
deficiency in T cell factors in the culture is a possibility for an aberrant DC differentiation 
has been shown in experiments with RAG2-/- T cell-deficient mice that exhibit a striking 
deficiency in Langerhans cell numbers in the epidermis and significantly lower numbers and 
a deficient function of both lymphoid- and myeloid-related DC in the draining lymph node, 
all of which were corrected by an adoptive transfer of normal T cells.36 A T cell factor that 
could account for an appropriate DC differentiation from precursors could be an essential 
interaction with the co-stimulatory CD40L on T cells present in the culture; CD40L is able to 
induce a final differentiation of DC.37,38 Also T cell cytokines such as IL-439,40 and IFN-γ41,42 
might play a role. However, IL-4 was added to our cultures, but IFN-γ was not. This cytokine 
stimulates DC to up-regulate co-stimulatory/activation markers and the cell’s capability to 
stimulate T cells.41
Macrophage-like cells are also present in our DC cultures and OX7+ bone-marrow 
precursors can also give rise to macrophages, if stimulated appropriately with M-CSF. 
Some macrophage populations do express Ian5 (our unpublished observations) and it must 
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be noted that macrophages of lymphopenic BB-DP rats are special in that they show an 
excessive production of L-arginine, NO43-45 and other reactive oxygen species.46 The TNF-
α production by macrophages of the BB-DP rat is conjectural, a low47 as well as a high 
TNF-α production48 have been described. All these factors are known to be involved in the 
differentiation and maturation of DC. Moreover, bone-marrow derived DC, unlike spleen 
DC, are able to produce high levels of NO similar to peritoneal macrophages49 and it has been 
shown that such oxidative radicals do suppress the differentiation of DC50,51 and inhibited the 
T cell proliferation exerted by DC.46 Clearly the production of IFN-γ, NO and other reactive 
oxygen species needs to be investigated in the GM-CSF/IL-4 induced bone-marrow cultures 
of the lyp/lyp and lyp/+ animals.
In conclusion we here show that the 42.5 Mb - 93.6 Mb region of chromosome 4 of the 
autoimmune prone BB-DP rat, which contains both the rat iddm2 (the lyp gene) and iddm4, 
is linked to an increased apoptosis of DC bone-marrow precursor cells, a low MHC class II 
expression on DC differentiated from bone-marrow precursors, a reduced T cell stimulatory 
capacity, and a reduced IL-10 production of the DC.
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ABSTRACT 
 
BB-diabetes prone (DP) rats spontaneously develop organ-specific 
autoimmunity, are severely lymphopenic and particularly deficient in ART2+ 
regulatory T cells. A special breed, the so-called BB-diabetes resistant (DR) 
rats, are not lymphopenic and do not develop organ-specific autoimmunity. 
The genetic difference between both strains is the lymphopenia (lyp) gene. 
Intrathymic tolerance mechanisms are important to prevent autoimmunity 
and next to thymus epithelial cells, thymus antigen-presenting cells (APC) 
play a prominent part in this tolerance. 
We here embarked on a study to detect defects in thymus APC of the 
BB-DP rat and isolated thymus APC using a protocol based on the low-density 
and non-adherent character of the cells. We used BB-DP, BB-DR, wild-type 
F344 and F344 rats congenic for the lyp gene containing region. 
The isolated thymus non-adherent low-density cells (LDC) appeared 
to be predominantly ED2+ branched cortical macrophages and not OX62+ 
thymus medullary and cortico-medullary dendritic cells. Functionally these 
ED2+ macrophages were excellent stimulators of T cell proliferation, but 
more importantly rescued double-positive thymocytes from apoptosis. 
The isolated thymus ED2+ macrophages of the BB-DP and the F344.lyp/lyp rat 
exhibited a reduced T cell stimulatory capacity as compared with such cells of 
non-lymphopenic rats. They had a strongly diminished capability of rescuing 
thymocytes from apoptosis (also of ART2+ T cells) and showed a reduced Ian5 
expression (as lyp/lyp thymocytes do). 
Our experiments strongly suggest that branched cortical macrophages play 
a role in positive selection of T cells in the thymus and point to defects in these 
cells in BB-DP rats.
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INTRODUCTION
BB-diabetes prone (DP) rats spontaneously develop autoimmune insulitis, autoimmune 
thyroiditis and other organ-specific autoimmunity. The advantage of studying the BB 
rat model of organ-specific autoimmunity is the involvement of a well-defined, thymus 
derived regulatory T cell population. These regulatory T cells express the molecule ART2.1 
BB-DP rats are severely lymphopenic and particularly deficient in ART2+ regulatory T cells.2-6 
A special breed of BB rats, the so-called BB-diabetes resistant (DR) rats, are not lymphopenic 
and do not develop organ-specific autoimmunity, because of the presence of ART2+ regulatory 
T cells. Depletion of these cells in the BB-DR rat induces organ-specific autoimmunity,7 while 
transfer of these cells obtained from BB-DR rats into BB-DP rats prevents organ-specific 
autoimmunity.8 Recently this ART2+ regulatory T cell population was investigated in more 
detail and it was shown that one sub-set was CD4+CD25-Foxp3-PD-1+ART2+, and this 
population was as capable of preventing the development of diabetes in the BB-DP rat as the 
presently well established CD4+CD25+Foxp3+PD-1+ART2+ regulatory T cell sub-set.9
The genetic difference between the BB-DP rat and the BB-DR rat is the lymphopenia 
(lyp, iddm2) gene, which is a major rat diabetes susceptibility gene located on chromosome 4. 
Homozygosity for the defective lyp gene, as is the case in the BB-DP rat, leads to the severe 
T lymphocytopenia and the lack of ART2+ regulatory T cells.10,11 Recently the lyp gene (also 
called Ian5, Gimap5, Ian4L) was found to carry a frameshift mutation and a severe truncation 
of the protein.11,12 Ian5 is thought to be involved in apoptosis, being associated with the anti-
apoptotic proteins Bcl-2 and Bcl-xL.12-14
Intra-thymic tolerance mechanisms are important mechanisms to prevent organ-specific 
autoimmunity. Next to thymus epithelial cells, thymus antigen-presenting cells (APC), 
i.e. dendritic cells (DC) and macrophages, play a prominent role in these central tolerance 
mechanisms. Interestingly thymus transplantation experiments by Georgiou et al. showed a 
pivotal role of defects in antigen presentation by bone-marrow derived cells in the thymus of 
BB-DP rats.15-17 These defects in antigen presentation were crucial for the T cell lymphopenia 
of the rat and the ultimate development of organ-specific autoimmunity. 
A direct in vitro approach has not been used to study the defects of thymus bone-marrow 
derived APC in the BB-DP rat and we embarked on such a study. We isolated APC from 
the rat thymus using a protocol based on the low-density and non-adherent character of the 
cells, as this protocol is known to result in a population of APC, previously identified as 
thymus DC on the basis of their dendritic morphology, expression of MHC class II molecules 
in the absence of T and B cell markers, and their excellent T cell stimulatory capacity.18,19 
The low-density cell (LDC) isolation is a well-accepted method to isolate spleen DC and 
is in use since the early days of DC studies.20 In our experiments BB-DP and BB-DR rats 
of the Seattle sub-line and wild-type F344 rats and F344 rats congenic for the region of the 
BB-DP rat chromosome 4, on which the lyp gene is located, were used. BB-DP/Seattle rats are 
lymphopenic, and autoimmune diabetes occurs in 100% of the Seattle BB-DP rats. Congenic 
F344 rats homozygous for the lyp region of the BB-DP rat chromosome 4 (designated “F344.
lyp/lyp rats”) have a similar extent of T cell lymphopenia and other cellular abnormalities as 
the BB-DP rat, including nearly absent ART2+ T cells.21,22 The rats do, however, not develop 
organ-specific autoimmunity, since they lack other important iddm genes for such development 
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on other chromosomes. 
We here describe that thymus LDC are phenotypically rather reminiscent of branched 
cortical macrophages than of thymus medullary and cortico-medullary DC. The population 
of thymus LDC of the BB-DP and the F344.lyp/lyp rat had a strongly diminished capability 
of rescuing (double-positive) thymocytes from apoptosis and a reduced Ian5 expression as 
compared with such LDC of non-lymphopenic rats. 
MATERIALS AND METHODS
Animals
Male and female BB-DP, BB-DR, F344.+/+ and F344.lyp/lyp rats were from the Seattle 
colony. Wistar rats were purchased from Harlan (Zeist, The Netherlands). All rats were kept 
under controlled light conditions (12/12 h light/dark cycle) throughout this study. A standard 
pelleted diet (AM-11, Hope Farms BV, Woerden, The Netherlands) and tap water were 
provided ad libitum. One hundred percent of the BB-DP rats became diabetic. BB-DP rats 
were daily tested for glucosuria (Gluketur test sticks; Boehringer Mannheim BV, Almere, 
The Netherlands). For all experiments, age matched rats were used.
Cell preparations
Thymus LDC, spleen LDC, spleen macrophages and bone-marrow derived DC 
Thymus LDC and spleen LDC were enriched according to the method of Knight et al.20 
and Delemarre et al.,23 with slight modifications. Briefly, thymi and spleens from BB-DP/
BB-DR and F344 rats were minced and digested for 1 h. at 37°C in RPMI 1640 medium 
(Life Technologies, Breda, The Netherlands) with 25 mM glutamax-1 and 25 mM HEPES 
(hereafter referred to as RPMI+) containing: 125 U/ml collagenase (type III; Worthington 
Biochemical, Freehold, NJ, USA) and 0.1 mg/ml DNase (Boehringer Mannheim BV). 
The remaining tissue was teased through a 105-µm filter, and the erythrocytes were removed 
by lysis. Finally, the separated cells were washed and cultured in RPMl+ supplemented with 
10% inactivated FCS (FCSi), penicillin (100 U/ml; Seromed, Biochrom, Berlin, Germany), 
and streptomycin (0.1 mg/ml; Seromed). After an overnight culture period in culture flasks 
(Costar Europe, Badhoevedorp, The Netherlands; 37°C, 5% C0
2
 incubator), the non-adherent 
cells and (in the case of the spleens) the adherent cells were harvested. The spleen adherent 
cells were for over 95% macrophages. LDC were isolated from the non-adherent cells by 
using a 14.5% (w/v) Nycodenz (Nycomed Pharma As, Oslo, Norway) density gradient (800 g 
for 20 min.). LDC were collected from the interphase and washed. 
Bone-marrow precursor derived DC were obtained as described in detail previously.24
Antibodies 
In flowcytometric analysis we used: anti-MHC class II conjugated to phycoerythrin (PE) 
(1:400; MRC OX6, Serotec, UK), anti-B7-1 (undiluted, CD80; BD Pharmingen, Flanders, 
NJ, USA), anti-B7-2 (undiluted, CD86; BD Pharmingen), anti-CD40 (1:10, BD Pharmingen), 
anti-rat DC-FITC (undiluted, MRC OX62; Serotec), ED1 (1:10, DC, monocytes, MФ; 
Serotec), ED2/anti-CD163 (1:100, MФ; Serotec) and ED3/anti-CD169 (1:1000; Serotec).
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In immunohistochemistry we used anti-MHC class II (1:5, Serotec), anti-rat DC/OX62 
(1:10, Serotec) and ED2/anti-CD163 (1:20, Serotec). All were conjugated to biotin.
Flowcytometric analysis 
Flowcytometric analysis was performed via standard procedures and as described 
previously.24
Immunocytology
Cytocentrifuge preparations were made of the isolated thymus LDC fractions and fixed 
in acetone (Fluka, St. Louis, MO, USA) for 10 min. (endogenous peroxidase was blocked 
by adding 0.05% H
2
0
2
), and thereafter, incubated with normal rabbit serum (Dako, Glostrup, 
Denmark), 10% in PBS for 10 min. before incubating for 1 h. with the biotinylated anti-
MHC class II antibody. After washing three times with PBS, the slides were incubated 
with streptavidin-biotin complex conjugated with alkaline phosphatase (Dako). The slides 
were rinsed three times in PBS and stained with Fast Blue BB Base (Sigma, Zwijndrecht, 
The Netherlands). Counterstaining was not performed. Finally, the slides were rinsed in water 
and mounted in Kaiser’s gelatine (Merck, Rahway, NJ, USA).
For double-staining, fixation and subsequent incubation with the first mAb followed 
by a rabbit-anti mouse antiserum conjugated with horseradish peroxidase was performed. 
After blocking with normal mouse serum (10%), the slides were incubated with a directly 
biotinylated second mAb. Slides were rinsed three times in PBS and incubated with streptavidin-
biotin complex conjugated with alkaline phosphatase (Dako). Slides were sequentially stained 
with Fast Blue BB Base (Sigma) and 3-amino-9-ethylcarbazole (AEC; Sigma). Finally, the 
slides were rinsed in water and mounted in Kaiser’s gelatine (Merck).
Immunohistology
mAb against ED2 and OX62 were used to stain histological sections of the thymus. As a 
control, we used non-specific murine IgG1. Histological preparations were fixed in acetone 
(Fluka) for 10 min. (endogenous peroxidase was blocked by adding 0.05% H
2
0
2
) and thereafter, 
incubated with normal rabbit serum (Dako), 10% in PBS for 10 min. before incubating for 
1 h. with the appropriate mAb. Subsequently, the slides were incubated with rabbit-anti mouse 
antiserum conjugated with horseradish peroxidase for AEC staining. Finally, the slides were 
rinsed in water and mounted in Kaiser’s gelatine (Merck).
Methods for Quantitative PCR for Ian5 expression
Quantitative PCR for Ian5 expression was performed as described in detail previously.24
MLR 
T cells from Wistar rats were enriched using a nylon wool column as described in 
detail previously.24 In short, spleens were minced and teased through a 105-µm filter, and 
the erythrocytes were removed by lysis. Cells were washed and loaded onto a nylon wool 
column (3g; Polyscience, Eppelheim, Germany). After 1h incubation, T cells (80–90% CD3+ 
cells) were harvested by collecting the effluent. For the MLR, APC from the different rats 
were added at various ratios to T cells (fixed number of 150,000 T cells/well) in flat-bottom 
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96-wells plates (Nunc, Roskilde, Denmark). Subsequently, these cells were cultured for 
3 days in RPMI+ medium including FCS
i
 and antibiotics. In the MLR, T cell proliferation 
was measured via tritiated thymidine ([3H]TdR) incorporation. Radioactivity was counted in a 
liquid scintillation analyzer (LKB Betaplate, Wallac, Turun, Finland). 
Thymocyte apoptosis assay
Thymocytes were isolated from the high-density fraction after overnight culture 
(macrophages and residual epithelial cells attach to the bottom of the flasks). These thymocytes 
were thereafter co-cultured with thymus LDC in flat-bottom 96-wells plates (Nunc) at a ratio 
of 2:1. After harvesting the cells the capacity of thymus LDC to rescue double-positive 
thymocytes from apoptosis was assessed by 7-amino-actinomycin D (7-AAD) staining using 
a flowcytometer (FACSCalibur, Becton Dickinson, Sunnyvale, CA, USA) gating on the 
CD4+CD8+ cells. For determination of background staining, cells were incubated with either 
labelled irrelevant Abs or with secondary Abs.
Statistical analyses
Statistical analyses were performed using the non-parametric Mann-Whitney test.
RESULTS
The phenotype of thymus low-density cells strongly suggests that the cells represent the 
thymus branched cortical macrophages
Analysing the thymus LDC population with DC and macrophage specific markers we 
found that the thymus LDC were, in particular, positive for the macrophage marker ED2/
CD163: 83% (median, range 76-90%, n=3) of the cells were positive in flowcytometric 
analysis in a dim-to-intermediate-staining manner (Figure 1A and F), and in immunocytology, 
approximately 80% of the LDC were clearly positive (Figure 1C and D). ED2/CD163 
(a member of the scavenger receptor cysteine-rich group B family, functioning as a scavenger 
receptor for hemoglobin-haptoglobin complexes) identifies most sub-populations of mature 
tissue MФ, including spleen red pulp MФ, thymus cortical MФ, Kupffer cells in the liver, 
resident bone-marrow MФ and central nervous system perivascular and meningeal MФ, but 
is absent on monocytes.25
Using the DC-specific marker OX62, only 31% (standard deviation 9%, n=7) of the 
thymus LDC were positive in flowcytometric analysis with a dim staining manner (Figure 1B 
and F), and in immunocytology OX62 was found to be stained weakly in 20-30% of the cells 
(Figure 1D). In double immunocytological staining it appeared that all OX62+ cells were also 
positive for ED2, a marker that showed a much stronger staining pattern (Figure 1D and F). 
About half (48% +/- 13, n=7) of the total thymus LDC was positive for MHC class II. 
This also applied to the ED2+ LDC (Figure 1A, C and F). It must be noted that the MHC 
class II+ED2+ cells were the strongest positive for ED2 (Figure 1A). Of the OX62+ 
cells, approximately two-thirds were positive for MHC class II (Figure 1B and F). 
In immunocytology, many of the MHC class II+ cells showed strong branched/dendritic 
morphology (Figure 1E). Only small minorities of the thymus LDC were positive for the 
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Figure 1. 
(A) Dot plot of thymus low-density cells (LDC) with ED2 expression on the x-axis and MHC class II on the y-axis. 
Negative cells are in the boxed area. Note that the majority of the LDC are ED2+ and approximately half are MHC 
class II+. The latter population is also the strongest positive for ED2 (for quantitative data, see Figure 1F). (B) Dot 
plot of thymus LDC with OX62 expression on the x-axis and MHC class II on the y-axis. Note that only a minority 
of LDC is intermediately positive for OX62 (for quantitative data see Figure 1F). (C) Immune cytology of thymus 
LDC with ED2 (red) and MHC class II (blue). Magnification X 1000; no counterstaining. It can clearly be seen that 
the majority of cells is ED2+, and that about half of them stain double for MHC class II (particularly the large cells).
(D) Immune cytology of thymus LDC with ED2 (red) and OX62 (blue). Magnification X 1000. A weaker staining was 
used for ED2 as compared with Figure 1C by shorter development of the staining step, since OX62 staining appeared 
rather faint; no counterstaining. It shows that part of the ED2+ cells are also faintly OX62+. (E) Immune cytology 
of thymus LDC with MHC class II (blue). Magnification X 1000. Overstaining was used by longer development 
of the staining step to clearly visualize the long, cellular protrusions (branches/dendrites). No counterstaining. 
(F) Quantification of marker positive LDC in flowcytometric analysis. For colour figure see Appendix page 146.
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macrophage markers ED1 and ED3 (Figure 1F). 
The CD80, CD86, and CD40 expression of the LDC was respectively 36 +/- 11, 41 +/- 13 and 
42 +/- 7% (mean +/- standard deviations, n=7).
It is also important to note that the LDC fractions did not contain any cells with an epithelial 
morphology.
As the LDC were branched/dendritic cells and clearly positive for ED2/CD163 (and only 
in minority for OX62) we were of the opinion that the LDC better fit the phenotypic and 
morphological description of thymus branched cortical macrophages26 than of medullary 
and cortico-medullary thymus DC, as described previously.18,19 In addition, therefore, we 
stained thymus sections for ED2 and OX62 to verify the in situ phenotype of the cells. 
Indeed, a hallmark of the branched cortical macrophages was their strong ED2 positivity, 
A
B
Figure 2.
(A) Immunohistochemistry of a F344.+/+ rat thymus stained for ED2 (magnification X 150). The ED2+ cells in the 
cortex (i.e. the branched cortical macrophages) are clearly visible. (B) Immunohistochemistry of a F344.+/+ rat 
thymus stained for OX62 (magnification X 150). The positivity for OX62 of the cortico-medullary and medullary 
dendritic cells can clearly be seen. For colour figure see Appendix page 147.
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and only few ED2+ cells were found in the medulla of the thymus (Figure 2A). OX62+ cells 
were found predominantly in the medulla and particular, at the cortico-medullary junction 
(Figure 2B), while there was some faint positivity of cells in the cortical area. Based on these 
phenotypic characteristics, we consider our isolated LDC as representing branched cortical 
macrophages. 
In addition, when we compared the phenotype of the isolated thymus LDC with classical 
DC, i.e. spleen LDC and BM-precursor derived DC using flowcytometric analysis, it is clear 
that the latter two populations contained many more of classical DC than our thymus LDC 
population, i.e. of cells brightly and intermediately positive for OX62 and clearly positive for 
MHC class II (Figure 3). 
The T cell stimulatory capacity of thymus low-density cells
With regard to the functional capability of the thymus LDC, we compared the T cell 
stimulatory capacity of thymus LDC to that of spleen LDC and BM-precursor derived DC. 
Figures 4A and B show that the thymus LDC were potent stimulators of allogeneic T cells, 
but reached half the potency of spleen LDC. Thymus LDC and spleen LDC were more potent 
than BM-precursor derived DC. The latter were in fact quite weak T cell stimulators. This is 
in accord with their relative immature character. We have reported previously that stimulating 
such BM-precursor derived DC with LPS to mature the cells further does up-regulate their 
MHC class II expression and their T cell stimulatory capacity to levels found with spleen 
LDC.24
Thymus LDC of BB-DP and F344.lyp/lyp rats show a reduced capability to stimulate 
T cells, yet have a normal phenotype except for a lower expression of CD86
T cell stimulatory capacities of thymus LDC of lyp/lyp and non-lymphopenic rats were 
tested in MLR using Wistar T cells as responder cells, representing an allogeneic MLR for 
F344 rats (Figure 4A) and a syngeneic MLR for BB rats (Figure 4B). As can be seen, the 
T cell stimulatory capacity of thymus LDC of lyp/lyp rats was significantly lower than 
that of non-lymphopenic rats, being it BB-DP or Fischer lyp/lyp rats (ratio APC/T cell: 1/5 
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Figure 3. 
Dot plots of thymus LDC (A), spleen LDC (B) and cultured bone-marrow precursor derived DC (C) with OX62 on 
the x-axis and MHC class II on the y-axis. Percentages of cells in each quadrant are indicated in the dot plots.
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(c.p.m.); mean ± SEM; non-lyp BB: 32923 ± 19240, BB.lyp/lyp: 16915 ± 9905 (n=4; p<0.05); 
non-lyp F344: 33091 ± 9462, F344.lyp/lyp: 15432 ± 5374 (n=4; p<0.05), (Mann-Whitney 
paired analyses was performed, compare open and closed circles). 
Despite this clear difference in T cell stimulatory capacity between thymus LDC of lyp/
lyp and non-lymphopenic rats, the phenotype of the LDC fractions was not different, and 
equal numbers of ED2+, OX62+, and MHC class II+ cells were found in the LDC fractions of 
lyp/lyp and non-lymphopenic rats. With regard to the co-stimulatory molecules there was a 
difference in the expression of CD86 between lyp/lyp and non-lymphopenic rats: 25 +/- 6% 
(n=7) thymus LDC of lyp/lyp rats were positive for CD86 against 33 +/- 9% (n=9) of LDC of 
non-lymphopenic rats (p<0.05). The expression of CD80 and CD40 was equal.
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Figure 4. 
The T cell stimulatory capacity of thymus LDC (circles), spleen LDC (squares) and bone-marrow derived DC 
(triangles). The black circles represent thymus LDC of lymphopenic rats. The T cell stimulatory capacity was 
measured using Wistar T cells as responder cells in allogeneic MLR for F344 rats (Figure 4A) and in syngeneic 
MLR for BB rats (Figure 4B) and expressed as 3H-Thymidine incorporation (c.p.m.) in stimulated T cells. Means 
plus/minus standard error of the mean are given (n=4). Significances (p<0.05) are given with the asterixes, meaning 
differences between thymus LDC of lymphopenic versus non-lymphopenic rats.
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Thymus LDC of lyp/lyp rats show a lower capability to rescue double-positive thymocytes 
from apoptosis as compared to non-lymphopenic rats
Thymus LDC of lyp/lyp and non-lymphopenic BB and Fischer rats were co-cultured with 
double-positive thymocytes of lyp/lyp and non-lymphopenic animals. Thymus LDC of non-
lymphopenic animals were able to rescue thymocytes from cell death (Figure 5A and D), 
further supporting the view that the thymus LDC represent branched cortical macrophages, 
since these cells are thought to be involved in positive selection.26,27 
Thymus LDC of lyp/lyp animals hardly rescued thymocytes from apoptosis (Figure 5B 
and E), indicating that such LDC are functionally defective. This defect was independent of 
the thymocyte population used, being similar for thymocytes of lyp/lyp and non-lymphopenic 
animals (not shown). Also, these two thymocyte populations showed similar survival kinetics 
when cultured in isolation, i.e. both showed a high level of apoptosis (over 95%) in the absence 
of rescuing APC. 
We also analysed by flowcytometry (in two experiments) the thymocytes exposed to 
the thymus LDC of lymphopenic and non-lymphopenic BB and Fischer rats and paid in 
particular attention to the rescue of the population of CD4+ART2+ T cells. The exposure of the 
thymocytes to thymus LDC of lymphopenic strains (BB-DP and Fischer.lyp/lyp) resulted in a 
lower percentage of CD4+ART2+ T cells in the stimulated thymocyte population as compared 
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Figure 5. 
The thymocyte rescuing capability of rat thymus LDC. After co-culture of thymus LDC with non-lymphopenic 
thymocytes, cell death of double-positive thymocytes was assessed via 7-AAD staining in CD4+CD8+ cells. 
Positivity for 7-AAD is given on the horizontal axis of the histograms and represents cell death. The upper rows 
depict experiments in F344 rats and the lower rows in BB rats. Figure 5C and F illustrate representative histograms 
of thymocytes cultured in the absence of thymus LDC. Figure 5A and D illustrate representative histograms of 
thymocytes cultured in the presence of thymus LDC of non-lymphopenic rats. Figure 5B and E illustrate representative 
histograms of thymocytes cultured in the presence of thymus LDC of lymphopenic rats. 
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with percentages found in thymocytes stimulated by thymus LDC of non-lymphopenic BB 
and Fischer rats (BB-DR and Fischer.+/+): i.e. 21% for BB-DP vs. 35% for BB-DR and 13% 
for Fischer.lyp/lyp vs. 23% for Fischer.+/+. This shows that the cortical branched macrophages 
of lyp/lyp rats are also less capable of rescuing T cell populations of the thymus, which contain 
an important fraction of the special regulatory T cells of the rat. 
Ian5/Gimap5/lyp is highly expressed in thymus LDC and is decreased in thymus LDC of 
lymphophenic rats
We studied the expression of Ian5 transcripts in the thymus LDC, spleen LDC and 
bone-marrow precursor derived DC and spleen macrophages. We found that the thymus 
LDC expressed high levels of Ian5 mRNA comparable with the expression levels in thymus 
T cells (Figure 6). Spleen macrophages also showed high expression levels of Ian5 mRNA. 
Classical DC (spleen LDC and bone-marrow precursor derived DC) expressed low levels of 
Ian5 mRNA (Figure 6). These data further support the idea that thymus LDC are macrophages 
rather than DC. Interestingly thymus LDC of lymphopenic (lyp/lyp) rats showed a decreased 
Ian5 mRNA expression (45% as compared with thymus LDC of +/+ rats), while thymus LDC 
of lyp/+ rats showed an intermediate Ian5 mRNA expression (74% as compared with thymus 
LDC of +/+ rats) (Figure 6). Similar observations of reduced Ian5 mRNA have been made for 
lyp/lyp T cells.10,11        
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Figure 6.
The expression of Ian5 mRNA in thymus LDC of F344.+/+, lyp/+ and lyp/lyp rats and in spleen macrophages, 
spleen LCD, bone-marrow precursor derived DC (BMDC), and thymocytes of F344.+/+ rats. The Ian5 expression is 
normalized against cyclophilin expression. 
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DISCUSSION
Within the thymus, non-lymphoid cells play an important role in the generation of 
thymocytes. Sessile epithelial and mobile accessory cells are the two prominent groups of 
cells within this non-lymphoid compartment. The latter appear as two distinct cell types, the 
thymus DC and the thymus macrophages.28 The thymus DC are predominantly located in the 
medulla, express characteristic markers of DC (such as OX62 in the rat, see this report) and 
play a role in the negative selection of thymocytes. With regard to the thymus macrophages 
two different sub-populations can be identified: large rounded macrophages (in the rat 
positive for ED1) with a high phagocytic activity present in the cortex and medulla (and 
probably playing a role in the removal of apoptotic thymocytes) and non-phagocytic, large, 
branched cortical macrophages.29 In rats these latter cells are characterized by their dendritic 
morphology and labelling with mAb to ED2/CD163.25 The branched cortical macrophages 
have a slow turnover (in contrast to the other thymus macrophage population and the thymus 
DC) and probably originate from bone-marrow precursors (although an intra-thymic precursor 
has also been suggested for part of the cells).30 Functionally, the cells have intimate contact 
with the cortical thymocytes and are capable of forming cell complexes with double-positive 
thymocytes in vitro. In addition the cells are largely positive for MHC class II molecules, and 
it has therefore been suggested that branched cortical macrophages play a role in thymocyte 
maturation and/or differentiation in the cortex.30
Our data show that the thymus LDC, which we isolated, fitted best the phenotype and 
suggested function of the rat branched cortical macrophages: the cells were predominantly 
positive for ED2 (and only for a proportion weakly positive for the DC marker OX62), had 
a branched/dendritic morphology, half the cells were positive for MHC class II, and the cells 
were excellent T cell stimulators and rescued double-positive thymocytes from apoptosis. 
Thymus LDC have been isolated from the rat thymus before by the group of Ardavin and 
by Ilic et al.18,19 In the reports of these investigators, the LDC were considered to be the thymus 
medullary DC on the basis of their branched morphology, their MHC class II positivity, and 
excellent T cell stimulatory capacity. We found these qualities as well. However, we also 
found the cells hardly positive for OX62, and OX62 proved to be a good marker for rat 
medullary thymus DC in situ. We are therefore of the opinion that thymus LDC fractions 
predominantly contain ED2+ branched cortical macrophages and not classical DC (Banuls 
et al. also noted some ED2 positivity of the thymus LDC).18 On the other hand we must note 
that Banuls et al.18 and Ilic et al.19 used slightly different isolation techniques to obtain thymus 
LDC, and this might have resulted in a predominant yield of medullary thymus DC. Banuls 
et al. predominantly isolated thymus DC from the thymus LDC by using two consecutive 
adherence steps18, while Ilic et al. obtained mainly thymus DC by culturing thymus LDC 
for 3 days with conditioned medium derived from medullary thymic epithelial cells, which 
contained the cytokines IL-1, IL-6, TNF-α and IL-2.19
A second novel observation we made was that the thymus LDC populations of the BB-DP 
and F344.lyp/lyp rat were deficient in function as compared with the thymus LDC of non-
lymphopenic BB-DR and F344 rats: the cells had a reduced T cell stimulatory capacity and, 
more importantly for branched cortical macrophages, a reduced capability to rescue double-
positive thymocytes from apoptosis. This phenomenon of a reduced capability to rescue 
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double-positive thymocytes from apoptosis is of interest, as it could explain at least part of 
the severe lymphopenia characteristic of these rats. Classically, the lymphopenia is thought 
to be a result of a shortened life span of recently emigrated thymocytes because of a high 
“spontaneous” apoptosis of such cells. There are, however, previous reports that BB-DP 
thymocytes can at least be rescued partially from such a shortened life span. Ramanathan et 
al. showed that an early exposition to antigen could partially rescue recent thymic emigrants 
of the BB-DP rat from programmed cell death.31 In particular, thymus branched cortical 
macrophages would be capable of delivering such early antigenic signals to developing 
thymocytes. 
Is this inability of branched cortical macrophages in the BB-DP rat linked to the proneness 
for autoimmunity? Since our LDC fraction did not contain epithelial cells, we hold the APC 
as responsible for the rescue of the double-positive thymocytes. The mechanisms via which 
thymic APC induce tolerance are presently not known. Next to the MHC class II+ thymus 
epithelial cells, the thymus APC shape the T cell repertoire via positive selection, including 
that of regulatory T cells, and via negative selection deleting strongly autoreactive T cells.
Several reports of Georgiou et al.15-17 support the idea that appropriately functioning 
antigen-presenting cells in the thymus are able to prevent type-1 diabetes by partially restoring 
T cell abnormalities. These investigators showed that the transplantation of a non-lymphopenic 
thymus led to the restoration of T cell proliferative function in the BB-DP rat, significantly 
reduced the incidence of insulitis, and prevented the development of diabetes. It appeared 
from their experiments that a defect in bone-marrow derived thymus APC contributed to an 
abnormal maturation of BB-DP T lymphocytes, which in turn, predisposed the animals to 
autoimmune insulitis, since the transplantation of ‘healthy’ thymus APC restored the T cell 
population and prevented disease. In the NOD mouse Georgiou et al. showed that the neonatal 
transfer of ‘healthy’ thymus macrophages also prevented disease.32,33 It is thus tempting to 
speculate, in view of our data, that the lymphopenia-restoring and diabetes-preventing APC 
of the transplant experiments of Georgiou et al. are able to act as the here-described thymus 
cortical branched macrophages rescuing double-positive thymocytes from apoptosis. Since 
these macrophages also rescue ART2+ T cells (see this report), which harbour thymus-derived 
regulatory T cells, they might, in this way, contribute to prevention of disease. 
With regard to the expression of relevant autoantigens in the thymus (e.g. the insulin 
peptide family) Kecha-Kamoun et al. reported that thymic macrophages express, in particular, 
insulin-like growth factor 1 (IGF-1), while IGF-2 is predominantly expressed by thymus 
epithelial cells and insulin by thymic DC and medullary epithelial cells.34 The investigators 
showed that in the BB-DP rat model, IGF-2 expression was defective in 11 of 15 thymuses 
in close concordance with the diabetes incidence in their rat strain (while IGF-1 and insulin 
expression were intact). Hence, their experiments do not point to a defective function of 
thymus macrophages in the BB-DP rat, at least at the level of autoantigen expression.
Which mechanisms might be responsible for the decreased function of branched thymus 
cortical macrophages of BB-DP and the Fischer.lyp/lyp rats? Interestingly the thymus LDC 
of lyp/lyp rats showed a reduced expression of Ian5 mRNA as compared with thymus LDC 
of +/+ rats with lyp/+ rats showing intermediate levels. A similar expression pattern exists 
in lyp/lyp, lyp/+ and +/+ thymocytes in the BB rat model, and the severely reduced levels 
of Ian5 in lyp/lyp thymocytes lead to an enhanced apoptosis. We did not study whether the 
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lyp/lyp LDC had an increased apoptosis rate, but it is interesting that Rees and Dijkstra have 
described an in situ reduction in the number of thymus cortical ED2+ macrophages in BB-DP 
rats.35 Obviously, we need to test the exact yield and apoptosis rate of LDC isolated from BB-
DP and F344.lyp/lyp rats in future experiments. 
In conclusion, we found that non-adherent LDC isolated from the thymus represent ED2+ 
branched cortical macrophages and that in the BB-DP and F344.lyp/lyp rat such cells had a 
reduced Ian5 expression, T cell stimulatory capacity, and a strongly diminished capability 
to rescue thymocytes from apoptosis, including that of ART2+ T cells. It is likely that these 
defects, in this important macrophage population of the thymus, are at least in part responsible 
for the severe T cell lymphocytopenia and the lack of regulatory T cells in the periphery of 
lyp/lyp gene-carrying rats. 
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ABSTRACT 
The way the MHC II-associated proteolytic system of APC handles 
exogenous antigen is key to the stimulation of T cells in infections and 
immunotherapy settings. Using cell-impermeable, activity-based probe 
(ABP) for papain-cathepsins, the most abundant type of endocytic proteases, 
we have simulated the encounter between exogenous antigen and endocytic 
proteases in live human monocyte-derived dendritic cells (MO-DC). 
Although cathepsinS (CatS), -B, -H, and -X were active in DC-derived 
endocytic fractions in vitro, the peptide-size tracer was routed selectively to 
active CatS after internalization by macropinocytosis. Blocking of the vacuolar 
adenosine triphosphatase abolished this CatS-selective targeting, while LPS-
induced maturation of DC resulted in degradation of active CatS. Conjugation 
of the ABP to a protein facilitated the delivery to endocytic proteases and 
resulted in labelling of sizable amounts of CatB and CatX, although CatS still 
remained the major protease reached by this construct. Conjugation of the 
probe to a cell-penetrating peptide (CPP) routed the tracer to the entire panel of 
intracellular cathepsins, independently from endocytosis or LPS-stimulation. 
Thus, different means of internalization result in differential targeting of active 
cathepsins in live MO-DC. CPP may serve as vehicles to target antigen more 
efficiently to protease-containing endocytic compartments. 
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INTRODUCTION
Dendritic cells (DC) internalize exogenous antigen and deliver it to the MHC II-associated 
proteolytic machinery to generate antigenic peptides for the MHC II-mediated activation 
of T cells.1-3 Human monocyte-derived DC (MO-DC) also provide attractive cellular tools 
for the manipulation of autoimmune disorders or the delivery of antigen-based cancer 
vaccines in vivo.4 In such therapeutic vaccination protocols, MO-DC are usually exposed to 
soluble antigen or antigenic peptide, which is internalized by non-specific means, processed 
by endocytic proteases and loaded on MHC II so that ultimately, antigen-specific T cells 
are triggered. Understanding the rules that govern the transport of antigen to endocytic 
proteases and the successive processing pathway in MO-DC might help us to better exploit 
the therapeutic potential of these cells by maximizing the access of antigen to the MHC II 
processing compartment or by facilitating the generation of the major immunogenic epitope 
in such therapeutic vaccines.
Soluble peptide or protein antigen is internalized by MO-DC in an nonselective fashion 
via macropinocytosis and subsequently, reaches the endocytic compartment.1 The majority of 
proteases in the endocytic compartment of DC belongs to the family of papain-like cysteine 
proteases [cathepsins (Cat) B, S, H, L, X], together with the aspartate proteases CatD and E, as 
well as the asparagine-specific endopeptidase AEP.5-7 This proteolytic system is not redundant 
in general, as genetic elimination of individual cathepsins resulted in defects in the processing 
and presentation of selected antigens as well as invariant chain (Ii) in vitro and in vivo.8-16 
As CatS is expressed selectively in professional APC and controls the rate-limiting step in 
Ii degradation, it is considered the key endocytic protease for antigen presentation in DC.5,17 
The initial proteolytic attack on internalized antigen predetermines the subsequent processing 
pathway and can result in either destruction or generation of immunodominant epitopes.18-20 
Thus, identification of this dominant “unlocking” protease(s) is crucial for the understanding 
of the processing pathway of a given antigen.
Fractionation studies revealed that lysosomes, late endosomes and early endosomes 
differ with respect to the pattern of active proteases in all major types of APC.9,21-23 However, 
these types of studies required the disruption of major regulators of protease activity such 
as the endocytic pH gradient and the redox potential, so that they are of limited value for 
an analysis of the encounter between antigen and active proteases in intact cells. The use of 
chemical tools has overcome this limitation recently and allowed us to monitor the delivery 
of internalized material directly to endocytic proteases in viable APC.24 Activity-based probes 
(ABP) bind specifically and irreversibly to the active centre of papain-like cysteine proteases 
and enable the visualization of the targeted proteases via a detection tag.25 ABP delivered 
to the endocytic compartment of live, murine bone-marrow derived APC via phagocytosis 
interacted progressively with different cathepsins, namely CatS, upon phagosome maturation 
in murine bone-marrow (BM) derived monocytes but not DC.24 Human and murine APC and 
in particular, different types of DC vary significantly with respect to expression, activity, 
distribution and regulation of endocytic proteases.6,8-10,21-23,26,27 The pattern of endocytic 
proteases that is encountered by antigen internalized by intact human MO-DC, is unknown.
Cell-penetrating peptides (CPP) serve as a carrier to cross the plasma membrane by direct 
permeation or endocytosis.28 It has been suggested that CPP might also facilitate endocytosis, 
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so that they could represent a strategy to increase the transport of exogenous material to 
protease-containing MHC II peptide-loading compartments in vaccination approaches. 
Indeed, the efficiency of a cancer vaccine in vivo was increased substantially by attaching 
antigenic material to a CPP prior to vaccination.29 However, neither the effect of CPP on the 
internalization of peptide-like antigen nor its influence on the pattern of proteases, which is 
targeted by such CPP-facilitated internalization, has been assessed directly in DC. 
We here used ABP to address the delivery of exogenous material to active, papain-like 
cathepsins in human MO-DC. Internalization of ABP as soluble tracer, in conjugation with 
latex beads or protein, or facilitated by CPP modulated the patterns and efficiency of the 
delivery of exogenous material to endocytic proteases in intact, viable DC.
MATERIALS AND METHODS
Generation and characterization of dendritic cells
PBMC (peripheral blood mononuclear cells) were isolated by Ficoll/Paque (PAA 
Laboratories, Austria) density gradient centrifugation of heparinized blood obtained from 
buffy coats. Isolated PBMC were plated (1x 108 cells/8 ml flask) into tissue-culture flasks 
(Cellstar 75 cm2, Greiner Bio-One GmbH, Germany) in RPMI 1640 (Gibco, Grand Island, 
NY, USA) supplemented with 10% FCS, and antibiotics. After 1.5 h. of incubation at 37°C, 
nonadherent cells were removed, and the adherent cells were cultured in complete medium 
supplemented with GM-CSF (Leukomax, Sandoz, Hanover, NJ, USA) and IL-4 (R&D 
Systems, Minneapolis, MN, USA) for 6 days.22 This resulted in a cell population consisting 
of approximately 70% DC, as judged by flowcytometry. For induction of DC maturation, 
medium was supplemented with LPS (Sigma Chemical Co., St. Louis, Mo, USA) at day 6 
for an additional 24 h. Murine BM-derived DC were prepared according to the protocol of 
Lutz et al.30 from bone-marrow cells of BALB/c mice cultured in the presence of 200 U of 
granulocyte-macrophage colony-stimulating factor (GM-CSF; produced by mouse myeloma 
strain P3X63)/ml for a total of 9 days. More than 90% of these cultures expressed CD11c as 
assessed by flowcytometric analysis, and characteristic clustering of DC was observed by 
light microscopy. Human monocytes were enriched from buffy coats using a percoll gradient 
as described, resulting in 60-80% pure preparations of CD14+ cells. 
Flowcytometry analysis was performed using a FACSCalibur. Antibodies for 
immunophenotyping (Becton Dickinson, San Diego, CA, USA), OVA-FITC (Sigma Chemical 
Co.) and fluorochrome-coupled streptavidin latex beads (YG, Polysciences Inc., Warrington, 
PA, USA) were obtained commercially. 
Affinity-labelling of active cysteine proteases 
General labelling procedure in cell lysates and endocytic fractions
JPM-565 and DCG-0N, a derivative of DCG-04 with identical labelling characteristics, 
were synthesized and purified as previously described.25,31 Crude endocytic extracts of at 
least 5x107 monocytes or human MO-DC were prepared according to the method described 
previously.23 DC lysates were prepared from 5x105 immature DC in 2x lysis buffer 
(100 mM citrate/phosphate, 2 mM EDTA, 1% Nonidet P40 (NP-40), pH 5) and were lysed for 
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30 min. at 4°C, followed by removal of membrane fragments by centrifugation. Total endocytic 
protein (1.5 μg) of primary monocytes or 3 μg DC cell lysate protein was incubated with 10 
μM DCG-0N, PS457 or DCG-0N preincubated in a ratio of  2:1 with streptavidin and 50 mM 
DTT at ambient temperature for 30 min. Reactions were terminated by addition of 6x SDS- 
reducing sample buffer and immediate boiling at 95°C for 10 min. Samples were resolved by 
12.5% SDS-PAGE gel, and then blotted on a polyvinylidene difluoride (PVDF) membrane 
(Amersham Biosciences, Piscataway, NJ, USA). After blocking with PBS-0.2% Tween 20 
and 10% Roti®-Block (Roth, Karlsruhe, Germany) and extensive washing with PBS-0.2% 
Tween 20, the membrane was probed with Vectastain® (Vector Laboratories, Burlingame, 
CA, USA) in PBS-0.2% Tween 20 for 60 min, followed by washes with PBS-0.2% Tween 20. 
The ECL detection kit (Amersham Biosciences) was used for visualization.
For the flowcytometric-based analysis of the internalization of the respective constructs, 
YG-coupled strepatividinlatex beads were purchased, which were otherwise identical to the 
particles used below (Polysciences Inc.), as well as FITC-coupled OVA (Sigma Chemical 
Co.). Con B was a kind gift from Hidde Ploegh (Department of Pathology, Harvard Medical 
School, Boston, MA, USA). N-morpholinurea-homophenyl-leucyl-vinylsulfone (LHVS) was 
synthesized essentially as described.32 E-64 and CA-074 were obtained from Sigma Chemical 
Co.
Labelling with DCG-0N coupled to streptavidin-coated latex beads
Crude endocytic fractions were prepared as described above. Streptavidin-coated, 
carboxylated latex beads (1 µm diameter, Polysciences Inc.) were incubated with different 
concentrations of DCG-0N for 1 h. at room temperature. Beads were washed three times 
with PBS. The efficiency of the coupling and the washing steps were controlled by labelling 
cell lysates with beads pelleted after centrifugation or with the supernatant after washing, 
respectively, as described above. To label cysteine proteases in live cells with DCG-
0N coupled to streptavidin-coated latex beads, essentially, the procedure published for 
murine APC was used.24 Streptavidin-coated carboxylated latex beads were incubated with 
100 µM DCG-0N for 1 h. at room temperature. Beads were washed three times with PBS and 
resuspended in complete medium. Cells were plated on 24-well plates (1x107 cells/ well) and 
pulsed for 1h at 37°C with 300 µl medium containing DCG-0N-coated beads. After the pulse, 
excess beads were removed by centrifuging them four times at 2000 rpm for 2 min. over an 
FCS cushion. Cells were washed with PBS and lysed with 100 µl of 2x hot, reducing SDS 
sample buffer supplemented with 100 μM-free JPM-565. Lysates were boiled, and the DNA 
was sheared with a syringe and sonification. Samples were analyzed by 12.5% SDS-PAGE 
and streptavidin blotting. 
Labelling of cysteine proteases in live cells with soluble DCG-0N and PS457
At least 1x106 DC per time point were pulsed in complete culture medium (300 μl per time 
point) for different times at 37°C with 25 μM DCG-0N or 10 µM PS457, if not mentioned 
otherwise. After the pulse, cells were washed to remove excess label at 4°C for four times 
in PBS. Where a chase was performed, cells were taken up in 37°C medium and then 
incubated for the indicated additional times. After labelling, medium was removed and cells 
were lysed with 50 μl 2x lysis buffer (100 mM citrate/phosphate, 2 mM EDTA, 1% NP-40, 
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pH 7), supplemented with 100 μM-free JPM-565. SDS reducing sample buffer (6x) was added 
to 50 μg total protein of each time-point and boiled immediately. Samples were resolved by 
12.5 % SDS-PAGE gel and then blotted on a PVDF-membrane (Amersham Biosciences), and 
visualized as described above.
Labelling with activity based probes conjugated to streptavidin 
Streptavidin (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) was 
preincubated with DCG-0N or PS457 in PBS in a molar ratio of 1:2 for 1 h. at room temperature 
and then added directly to the cells, which were pulsed, washed, and lysed as mentioned above. 
SDS reducing sample buffer (6x) supplemented with 18 mM biotin (Serva, Germany) was 
added to 50 μg total protein of each time-point, followed by immediate boiling. Resolution by 
SDS-PAGE and detection were performed as described above.
Antisera, metabolic labelling and immunoprecipitation
Rabbit antisera were generated against recombinant CatS and affinity-purified. Metabolic 
labelling and immunoprecipitation were performed exactly as described in refs9,21,33, using the 
Tu36 mAb, which recognizes human MHC II complexes in a conformational-specific manner. 
Equal numbers of human MO-DC were incubated in 500 µl methionine/cysteine-free medium 
supplemented with 10% FCS (Sigma Chemical Co.). Cells then were labelled by incubation 
with 500 µCi/ml [35S]methionine-cysteine (Amersham Biosciences) at 37°C for 15 min.
Medium was added in a 10-20x excess, and cells were chased at 37°C for different times. 
Cells were washed in PBS, frozen in liquid nitrogen, and stored at -80°C. After resolution by 
SDS-PAGE, the labelled polypeptides retrieved were visualized using a phosphorimager.
Synthesis of PS457
Where appropriate removal of the 9-fluorenylmethyloxycarbonyl (Fmoc)-protecting 
group was accomplished by treatment of the resin-bound peptide with piperidine in 
N-methyl pyrrolidone (NMP; 1/4 v/v) for 20 min. Peptide coupling steps were performed 
by treatment of the resin with a premixed (5 min.) solution of the appropriate acid (5 eq.),
2-(-6-chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexafluorophos-phate(5 eq.)
and N,N-diisopropylethylamine (DiPEA; 6 eq.) in NMP for 1 h. Coupling efficiencies were 
monitored with the Kaiser test and couplings were repeated if necessary. After coupling and 
deprotecting steps the resin was washed with NMP (5´). Fmoc Rink amide resin (78 mg, 
50 µmol) was elongated using automated, standard, Fmoc-based solid-phase peptide synthesis 
(SPPS) to give resin-bound (Arg(Pbf))
9
. The synthesis was continued by manual Fmoc-based 
SPPS to give protected and resin-bound PS457. The resin was washed extensively (alternating 
CH
2
Cl
2
-MeOH 3x, alternating CH
2
Cl
2
-Et
2
O 3x. An aliquot of resin (100 mg, 16 µmol) was 
transferred into a clean vial, washed with CH
2
Cl
2
 and treated with trifluoracetic acid (TFA)/
H
2
O/trisopropylsilane (0.7 ml, 95/2.5/2.5 v/v/v) for 2h. The mixture was filtered into cold 
Et
2
O and the white precipitate was collected by centrifugation and decantation. The precipitate 
was washed (Et
2
O), followed by HPLC purification of the crude product (linear gradient in 
Buffer B: 20-30% B in three-column volumes) to yield 4.3 mg (1.8 µmol, 11%) of product. 1H 
nuclear magnetic resonance (NMR; D
2
O, 295 K, DMX 600): δ, 7.08 (d, 2H, J=7.9 Hz), 6.80 
(d, 2H, J=8.2 Hz), 4.58-4.55 (m, 1H), 4.45-4.41 (m, 1H), 4.38-4.35 (m, 1H), 4.34-4.18 (m, 12H), 
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4.13-4.09 (m, 1H), 3.68 (br s, 1H), 3.48-3.45 (m, 1H), 3.30-3.25 (m, 1H), 3.24-3.09 (m, 24H), 
3.03-2.86 (m, 4H), 2.79 (s, 1H), 2.69 (s, 1H), 2.28-2.18 (m, 6H), 1.80-1.20 (m, 61H), 0.89-0.80 
(m, 6H). Electrospray interface-mass spectrometry (ESI-MS): C
105
H
189
N
45
O
24
S + 4H+ requires 
625.5, found 625.4; C
105
H
189
N
45
O
24
S + 3H+ requires 833.7, found 833.6.
Solvents used in the SPSS, DiPEA and TFA were all of peptide-synthesis grade (Biosolve) 
and used as received. The protected amino acids, Rink amide p-methylbenzhydrylamine resin 
(0.78 mmol g–1) was obtained from NovaBiochem (Switzerland). Ethyl (2S,3S)oxirane-
2,3-dicarboxylate was prepared as described. Fmoc-Lys(Mtt)-OH was from Senn Chemicals 
(Switzerland), SPPS was carried out using a 180° variable rate flask shaker (St. John Associates, 
Inc., Beltsville, MD, USA) or on a 443A peptide synthesiser (Applied Biosystems, Foster City, 
CA, USA). Liquid chromatography/MS analysis was performed on a Jasco HPLC system 
(detection simultaneously at 214 and 254 nm) coupled to a Perkin Elmer Sciex API 165 mass 
spectrometer equipped with a custom-made Electrospray Interface (ESI). An analytical Alltima 
C18 column (Alltech, 4.6 mmD , 250 mmL, 5 µm particle size) was used; buffers: A=H
2
O; 
B=CH
3
CN; C=0.5% aq TFA. For reversed-phase HPLC-purification of two and four a Biocad 
“Vision” automated HPLC system (PerSeptive Biosystems, inc., Framingham, MA, USA) 
was used. The applied buffers were A, B and C. 1H-NMR spectra were recorded with a Bruker 
DMX 600 instrument at 600 MHz with chemical shifts (δ) relative to tetramethylsilane. 
Quantification by densitometry
NIH ImageJ was used for quantification of the intensity of labelling for the active 
polypeptides visualized by affinity labelling (http://rsb.info.nih.gov/ij/).
RESULTS
Here we applied a strategy to human DC, which allows visualization of the rendezvous 
between individual, endocytic, cysteine proteases and internalized, exogenous material taken 
up by live APC via different modes of transport. An ABP for cysteine proteases is internalized 
either via endocytosis or a CPP as a shuttle, reaches endocytic compartments, and interacts 
with the local proteolytic contents by covalent binding to the catalytic center of active cysteine 
proteases. As an ABP, we used DCG-0N, a derivative of the peptide epoxides JPM-565 and 
E-64, which targets papain-like cysteine proteases specifically. The labelling characteristics 
of DCG-0N are identical to its mother compounds DCG-04 and to JPM-565 (Figure 1A).24 
Proteases reached by the probe after internalization are irreversibly bound and can be 
visualized after cell lysis and SDS electrophoresis by streptavidin blotting against the biotin 
moiety of the probe so that different signal intensities of a particular protease polypeptide 
correspond directly to different amounts of the active protease species reached by the tracer 
in the living cell.
Different patterns of active, papain-like cysteine-proteases are visualized by the active, 
site-directed probe DCG-0N in primary human monocytes and monocyte-derived DC
The affinities of DCG-0N for the different papain-like cysteine proteases are in a similar 
order of magnitude, but not identical, and also, the total amounts of a given active protease 
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vary between different types of APC. To account for differences in protease labelling, which 
might result solely from different affinities of the probe for various cathepsins, differences 
in the total amounts of an individual protease or subsaturating amounts of the probe, rather 
than from differential delivery of the probe to active cathepsins in intact APC, we performed 
titration experiments with crude endocytic fractions incubated with increasing concentrations 
of DCG-0N in vitro, followed by a streptavidin blot. The detected polypeptides in the 20- to 
40-kD range were identified via immunoprecipitation with antibodies directed against 
individual cathepsins as well as by MS-based sequencing after pull-down with streptavidin 
beads21, allowing the identification of CatB, CatH, CatL, CatS and CatX (Figure 1B). 
In endocytic fractions derived from primary monocytes, CatS was detected at the lowest 
concentration of label, followed by CatB, CatH, and CatX, with increasing amounts of DCG-
0N. In endocytic fractions of human MO-DC, CatB was the protease that could be visualized 
at the lowest concentration of DCG-0N, and CatS was only detected with higher amounts of 
DCG-0N. CatX and CatL were only visualized at increasing concentrations of DCG-0N. Thus, 
different relative amounts of individual cathepsins in a given cell type (DC vs. monocytes) 
also account for differential labelling patterns of proteases, especially at low concentrations 
of label. Of note, in human DC, active CatS appeared to be less prominent, compared with 
the remaining cysteine cathepsins, than in human monocytes, especially under the limiting 
condition of subsaturating amounts of label. These individual labelling patterns in crude 
endocytic fractions served as the basis to account for the specific delivery of label to a given 
protease after internalization by intact cells, as analyzed in the following experiments.
DCG-04 coupled to streptavidin-coated latex beads has served as a tool to assess the delivery 
of exogenous material taken up by phagocytosis to endocytic proteases in murine BM-derived 
APC.24 To control for the possibility that binding of DCG-0N to latex beads could affect 
the reactivity or selectivity of the probe, endocytic extracts from primary human monocytes 
were incubated either with the soluble probe or with DCG-0N coupled to streptavidin-latex 
beads. Labelled protease species were then visualized by SDS-PAGE and antibiotin blot 
(Figure 1C). The immobilization of DCG-0N on streptavidin beads favored labelling of CatS 
over the other cathepsins so that CatB was labelled poorly, and CatX and CatH could not be 
visualized at all. Thus, the immobilization of DCG-0N on latex beads affects the selectivity 
of labelling, which might induce artefacts when a proteolytic environment is sampled using 
DCG-0N immobilized on beads.
Figure 1. Papain-like cysteine-proteases recognized by the active site-directed probe DCG-0N in endocytic 
fractions of primary monocytes and monocyte-derived DC.
(A) Structure of the active site-directed probe JPM-565 and its biotinylated analogue DCG-0N. (B) Titration of DCG-
0N for the labelling of endocytic fractions of human monocytes (upper panel) and human monocyte-derived DC 
(lower panel) at pH 5. Lysates were incubated with increasing concentrations of DCG-0N. Proteins were separated 
by SDS-Page on a 12.5% gel and reactive polypeptides were visualized by streptavidin blotting (n=3). (C) Effect 
of the immobilization of DCG-0N by conjugation to streptavidin-coated latex beads on the selectivity of labelling. 
Endocytic extracts of monocytes were incubated for 30 min. at RT with latex beads preincubated with different 
concentrations of DCG-0N, or with the soluble tracer alone at the same concentrations, prior to visualization of the 
labelled species (n=5). 
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Human MO-DC poorly internalize latex beads via phagocytosis 
When murine BM-derived DC were incubated with fluorochrome-labelled latex beads, 
they internalized these beads efficiently by phagocytosis at 37°C, but not at 4°C, as assessed 
by flowcytometry, consistent with the published data (Figure 2A).24 By contrast, human 
MO-DC only very poorly ingested the same type of beads in vitro under otherwise identical 
conditions, highlighting the biological differences between both types of DC preparations. 
However, human MO-DC very efficiently internalized soluble fluorochrome-labelled OVA 
by endocytosis (1.4%-positive cells at 4°C compared to 83.12% at 37°C). As soluble antigen 
internalized by endocytosis represents one of the most common modes of antigen delivery 
to MO-DC in vitro in immunotherapy settings, immobilization of the ABP influences its 
labelling characteristics, and human MO-DC only poorly internalize exogenous material 
by phagocytosis in vitro, we analyzed the encounter of exogenous material internalized by 
MO-DC via endocytosis, not phagocytosis, in the following experiments.
ev
en
ts
FITC
mu BM-DC
latex beads
hu MO-DC
latex beads
hu MO-DC
OVA-FITC
4°C,
30 min.
37°C,
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Figure 2. Different efficiency of phagocytosis-mediated internalization between human MO-DC and murine 
bone-marrow derived DC.
Murine bone-marrow derived DC (mu BM-DC) or human MO-DC (hu MO-DC) were incubated with FITC-labelled 
latex beads for up to 30 min. at 4°C and at 37°C, respectively. Similarly, hu MO-DC were incubated in the presence 
of OVA-FITC. After washing of the cells at the appropriate time points, cellular fluorescence was analysed by 
flowcytometry (n=3).
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Delivery of exogenous DCG-0N to active papain-like cathepsins by endocytosis in human 
DC
To monitor the delivery of internalized material to the protease pool of MO-DC, intact DC 
were incubated for 1 h. at 37°C with 5 µM-soluble DCG-0N. As controls, we included DC 
incubated under the same conditions with streptavidin-coated latex beads previously coupled 
with DCG-0N, as well as the same amount of cells pulsed with soluble DCG-0N at 4°C. 
Excess beads were removed by extensive washing and cells were lysed at pH 7 in 2x lysis 
buffer containing excess, nonbiotinylated JPM-565 to largely exclude that proteases liberated 
upon cell lysis could bind to the probe post-lysis. For direct comparison of the fraction of 
active proteases labelled after internalization of the probe by MO-DC in vivo with the total 
protease pool present in these cells, a total cell lysate was prepared from a portion of the same 
DC sample, lysed at pH 5, and labelled with DCG-0N after cell lysis. All samples were boiled 
at 95°C in 6x reducing SDS sample buffer, resolved by electrophoresis, and analyzed by 
streptavidin blotting to visualize the DCG-0N-modified polypeptides (Figure 3A).
In contrast to murine BM-derived DC24, live human MO-DC did not result in labelling of 
active cathepsins after coincubation with DCG-0N-coated latex beads at 37°C (Figure 3A, 
Lane 3), consistent with the poor uptake of latex beads by MO-DC, as judged by flowcytometry. 
Soluble DCG-0N, however, decorated active cathepsins when intact human monocyte-derived 
DC were exposed at 37°C (Figure 3A, Lane 4), in contrast to the 4°C control (Figure 3A, 
Lane 5). Although in crude endocytic DC-fractions, active CatB was labelled much stronger 
by the probe than CatS (Figure 3A, Lane 1), internalization of the probe by live human 
DC clearly favored labelling of CatS with little targeting of CatB and without significant 
visualization of CatX after endocytosis-mediated delivery (Figure 3A, Lane 4). Thus, soluble 
DCG-0N, internalized by macropinocytosis is routed selectively to a compartment enriched 
with CatS activity in human MO-DC. 
To resolve the rendezvous between individual cysteine proteases and exogenous matter 
internalized by pinocytosis as a function of time, DC were incubated with soluble DCG-0N 
for up to 120 min. We observed a rather selective, time-dependent increase in labelling of 
active CatS between 0 and 30 min., visible already after 9 min. of uptake, consistent with 
an early endosomal localization of active CatS (Figure 3B, left). Longer incubation up to 
120 min., did not result in further changes in the labelling results (data not shown). The 
labelling intensities for CatB and CatX were low and almost stable over time, indicating 
a negligible exposure of exogenous peptide-size matter delivered by pinocytosis to these 
cathepsins in live human DC. Again, incubation of cells with soluble DCG-0N at 4°C for 
the same time did not result in significant visualization of protease polypeptides, confirming 
the active uptake of DCG-0N by live DC, as opposed to postlysis artefacts or non-specific, 
passive transition of the plasma membrane by DCG-0N. When DC were cultured for 24 h. 
with LPS and then pulsed with DCG-0N, the time-dependent increase in labelling of active 
CatS was abolished (Figure 3B, right), consistent with the low rate of endocytosis of activated 
DC, as confirmed by flowcytometry analysis (not shown). 
In contrast to monocytes, resting DC are capable of preserving intact antigen within 
endocytic compartments for several hours before antigen breakdown is initiated by DC 
activation, a feature that has been suggested to contribute to the ability of DC to provide 
antigenic memory. It was tempting to speculate that the CatS-restricted delivery of antigen to 
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endocytic proteases observed in DC might represent the molecular basis for the low rate of 
antigen processing in resting DC. We therefore assessed the delivery of soluble DCG-0N to 
endocytic proteases in primary human monocytes enriched by Percoll gradient centrifugation 
in an identical manner (Figure 3C). Similar to MO-DC, CatS was reached preferentially by 
the internalized tracer in monocytes, and CatB and CatX were decorated relatively poorly 
and in variable amounts in individual experiments, most likely representing postlysis 
artefacts. Similar to the results observed with DC, a consistent and reproducible increase in 
labelling intensity was only observed for CatS, but not for CatB or CatX. Prior stimulation 
of monocytes by LPS markedly reduced the delivery of exogenous DCG-0N to endocytic 
proteases, also paralleling the results obtained with MO-DC. Thus, the preferential targeting 
of exogenous material to active CatS is not a unique feature of DC, but can likewise be 
observed in monocytes, and is therefore unlikely to represent the basis for antigen memory 
observed in DC.
Activity of the vacuolar adenosine triphosphatase (ATPase) modulates the recruitment 
and stability of CatS targeted by internalized material
To dissect the intracellular delivery of cathepsins to the internalized ABP, intact DC were 
incubated with soluble DCG-0N at 37°C for 10 min. (pulse), followed by extensive washing 
to remove noninternalized label and a chase at 37°C for 0-30 min., respectively, at 37°C. 
Control cells were incubated at 4°C for the pulse (4°, 0), or for the pulse and the chase period 
(4°, 30), respectively. Labelled protease species were visualized by SDS-PAGE/antibiotin blot 
(Figure 4A). In untreated cells, the CatS signal increased selectively during the 
0- to 30-min. chase period (compare to 4°C, 30 min. control). Extending the chase to 
120 min. yielded comparable results and did not result in increased labelling of additional 
protease polypeptides (data not shown). This indicated that active CatS, but not CatB, CatH, or 
CatX, was preferentially routed towards or activated within DCG-0N-containing endosomes 
within 30 min. after internalization by intact human MO-DC. CatS is therefore the most likely 
candidate for the initial proteolytic attack on newly internalized, peptide-type antigens in 
human MO-DC.
Figure 3. Delivery of DCG-0N to cathepsin-containing compartments.
(A) Live DC were incubated for 1 h. at 37°C with 25 µM soluble DCG-0N or streptavidin-coated latex beads 
preincubated with DCG-0N at the same concentration. After extensive washing, cells were lysed at pH7 in lysis 
buffer containing 100 µM JPM 565 and boiled in 6x concentrated reducing sample buffer. Incubation for 1 h. at 4°C 
served as control for the active internalization of the protease label. Lysates from DC labelled with DCG-0N served 
as standards to identify the labelled protease species and to relate their signal intensity to their relative abundance 
in the cell (n=6). (B) Intact DC were incubated with soluble DCG-0N at 37°C for different periods of time, as 
indicated, with or without prior exposure to LPS for 24 h. Incubation with DCG-0N for 30 min. at 4°C served as 
control for the active internalization of the protease label. After extensive washing, cells were lysed in 2x lysis buffer 
containing 100 µM JPM-565 and labelled protease species were visualized by SDS-PAGE/anti-biotin blot. DC-and 
monocyte-derived cell lysates served as controls, as above (n=5), comparable total protein load was confirmed by 
western blot against β-actin. (C) Intact primary monocytes enriched by percoll gradient centrifugation were incubated 
with soluble DCG-0N at 37°C for different periods of time, as indicated, with or without prior exposure to LPS for 
24 h. as detailed above (n=6). Active endocytic proteases reached by the tracer were visualized as in (B). Western blot 
analysis for β-actin served as a loading control. 
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The endocytic machinery of DC is regulated largely by the activity of the vacuolar 
H+-ATPase: although low activity characterizes resting DC with high endocytic activity, 
DC maturation by stimuli like LPS results in ATPase activation and a drop in vacuolar pH. 
Addition of Concanamycin B (ConB), an inhibitor of the H+-ATPase blocks orderly transport, 
especially at the early-to-late endosomal transition.34 To further characterize the mechanism 
of the recruitment of active CatS to the internalized ABP, we added ConB to one-half of the 
sample prior to the pulse (Figure 4A, upper right). ConB blocked labelling of active CatS 
when DCG-0N was internalized by live cells but did not affect the visualization of active 
CatS when total cell lysates of MO-DC were treated with the same amount of the drug for 
60 min. directly prior to lysis. This indicated that ConB disrupted the intracellular delivery of 
internalized DCG-0N to active CatS rather than interfering with cellular CatS activity. Thus, 
the vacuolar H+-ATPase is required for the selective delivery of exogenous material to active 
CatS in intact human MO-DC.
LPS-induced DC maturation leads to increased activity of the endocytic ATPase. 
When the intracellular delivery of DCG-0N to active cathepsins was analyzed in the same 
type of pulse-chase experiment as above with DC stimulated with LPS, active CatS was 
visualized with inverse kinetics during the chase (4A, lower right): labelling intensity for 
CatS decreased continuously over the 30-min. chase. Because of the irreversible nature of 
binding of the probe to active CatS, this suggested degradation of either the bound probe, the 
labelled protease, or both. 
To differentiate between these two possibilities, we assessed the biosynthesis, maturation, 
and stability of CatS in resting and LPS-stimulated DC by metabolic labelling and 
immunoprecipitation of CatS. DC were pulse-labelled with 35S Met/Cys for 15 min. at 37°C, 
followed by different chase periods in the presence of excess, nonradioactive Met/Cys. At each 
chasepoint, cells were washed and lysed, and CatS was retrieved by immunoprecipitation using 
a specific antiserum. The bound material was eluted in 95°C-reducing SDS sample buffer, 
followed by resolution of the retrieved polypeptides by SDS-PAGE and autoradiography 
(Figure 4B). In resting DC, proCatS migrating at 32 kD was visualized exclusively after the 
pulse. After 30 and 60 min. of chase, constant amounts of proCatS were detected. Mature CatS 
emerged at the 60-min. chase point, and proCatS was still present in comparable amounts, 
suggesting that at this time-point, proCatS was still being synthesized, and mature CatS was 
converted from its zymogen. After 120 min. of chase, mature CatS remained stable, and the 
Figure 4.
(A) DC were left untreated (upper left) or either pretreated with 20 nM ConB for 60 min. (upper right) or with LPS for 
24 h. (lower right). Cells were pulsed with soluble DCG-0N at 37°C for 10 min. Following extensive washing, cells 
were chased at 37°C for the times indicated (chase). After each time point, cells were lysed, proteins were separated 
by SDS-Page on a 12.5% gel, and reactive proteases were visualized by streptavidin blotting, as above (n=4). 
(B) Analysis of the biosynthesis, maturation and degradation of CatS in DC. Cells either left unstimulated or 
stimulated with LPS for 24 h. were pulse-labelled with 35S Met/Cys for 15 min., followed by a chase for up to 2 h. 
After lysis, CatS was retrieved by immunoprecipitation using a CatS antiserum. After exposure to 95°C in 
6x concentrated reducing sample buffer, polypeptides retrieved were separated by SDS-PAGE, followed by 
autoradiography using a phosphorimager. One representative result from three independent experiments is shown 
(n=3).
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amounts of the labelled proform decreased. Thus, proCatS reaches the endocytic compartment 
roughly 60 min. after biosynthesis in resting human DC and is stable and progressively 
activated from its zymogen for at least another 60 min. LPS-stimulated DC were analyzed the 
same way: mature CatS also emerged after 60 min. of chase, suggesting that DC maturation 
did not grossly influence the conversion from proCatS to active CatS. However, already at the 
60-min. chase-point, the amount of proCatS was reduced compared with the 30-min. chase-
point or to the nonstimulated sample, and mature CatS was also present, only in lower amounts 
than in the nonstimulated sample. At the 120-min. chase-point, radiolabelled CatS and proCatS 
were consistently absent from LPS-stimulated DC, in stark contrast to nonstimulated DC, 
demonstrating degradation of CatS 1-2 h. after biosynthesis in LPS-stimulated DC. Complete 
degradation of active, newly synthesized CatS in LPS-activated human DC can therefore be 
observed within 60 min. after entering the endocytic compartment, in contrast to resting DC, 
and therefore, DC maturation controls the levels of mature CatS in an activation-dependent 
manner via endocytic degradation of the protease.
Conjugation of DCG-0N to streptavidin increases CatS-targeted delivery
Soluble peptides and whole-size proteins are being used to deliver antigen to MO-DC in 
vitro for immunotherapy. Whole-size sugars or proteins such as Dextran or HRP, at least in part, 
use endocytosis mediated by mannose receptor-binding, which might facilitate endocytosis 
and hence, delivery to endocytic proteases.35,36 Thus, to increase the delivery of exogenous 
material to active cathepsins, we generated a larger protein-like tracer by conjugating DCG-
0N to streptavidin prior to exposure to live DC, which were pulsed at 37°C for 10 min. using 
soluble 5 µM DCG-0N or the same amount of the probe prebound to 2.5 µM streptavidin prior 
to the pulse. After removal of noninternalized label by washing, cells were chased for up to 
30 min, and labelled protease species were visualized by SDS-PAGE/antibiotin blot 
(Figure 5). Conjugation of DCG-0N to streptavidin significantly improved delivery of the 
probe to active cathepsins in intact DC, compared with soluble DCG-0N. Labelling efficiency 
of CatS increased nearly fivefold with streptavidin-bound DCG-0N (lower panel), compared 
with delivery by the nonconjugated tracer. It is important that the preferential labelling of active 
CatS was also preserved when the uptake of the tracer was facilitated by prior conjugation to 
a protein: labelling of CatS remained clearly dominant over labelling of active CatX and CatB 
in intact DC, in contrast to the labelling pattern observed in the total DC lysate. As expected, 
active cathepsins were not decorated using soluble DCG-0N or the DCG-0N-streptavidin 
construct for 30 min. at 4°C. Thus, protein-size cargo is transported to active cathepsins more 
efficiently than the peptide-size, soluble tracer in live human MO-DC. It is important that both 
types of delivery result in preferential targeting of exogenous material to active CatS.
 
A cell-penetrating peptide increases delivery to cathepsin-containing compartments
Cell-penetrating peptides can increase the efficiency of peptide vaccines in vivo, possibly 
by facilitating the transport of the peptide vaccine into endocytic compartments of APC. 
To directly assess the effect of the conjugation of a peptide to a CPP on its delivery to endocytic 
proteases in DC, we synthesized a DCG-0N-derivative conjugated to a nonaarginine CPP 
(PS457, Figure 6A). Monocyte-derived endocytic fractions were incubated consecutively with 
PS457 for the visualization of the labelled polypeptides. Although no protease polypeptides 
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were visualized by PS457 in the 95°C-preheated and the 25-µM E-64-treated samples 
(Figure 6B, Lanes 1 and 2), two polypeptides were weakly visualized in the sample labelled 
with PS457 (Figure 6B, Lane 3). The signals migrated slightly higher than the respective 
signals for CatS and CatB in the DCG-0N-labelled sample (Figure 6B, Lane 6), consistent with 
the molecular weight of the PS457 probe. Note that the intensity of labelling with DCG-0N 
(Figure 6B, Lane 6) is substantially higher compared with labelling with PS457 at equimolar 
concentrations in crude endocytic fractions (Figure 6B, Lane 3). Addition of the CatS inhibitor 
LHVS (25 nM) and the CatB inhibitor CA-074 (1 µM) eliminated labelling of active CatS 
and reduced labelling of active CatB (Figure 6B, Lane 4) and eliminated active CatB labelling 
(Figure 6B, Lane 5), respectively, consistent with the identity of these polypeptide species as 
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Figure 5. Conjugation of DCG-0N to streptavidin increases the efficiency of protease delivery.
Upper panel: DC were pulsed with soluble DCG-0N or with DCG-0N (5 µM each) preincubated with streptavidin 
at a 2:1 molar ratio at 37°C for different periods of time. After extensive washing, cells were lysed in 2x lysis buffer 
containing 100 µM JPM-565, and the targeted active polypeptides were visualized as above (n=2). Labelling of 
DC and monocyte lysates with soluble DCG-0N as well as with streptavidin-prebound DCG-0N (1 μM) served as 
controls.
Lower panel: Densitometric quantification of the relative amounts of active CatS targeted by either soluble or 
streptavidin-bound DCG-0N in live human DC, as deduced from the upper panel.
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CatS and CatB in PS457-labelled cell lysates.
To test protease delivery of PS457 in intact DC, we pulsed DC with 10 µM soluble DCG-
0N or PS457 for 1 h. at 37°C with 4°C controls and labelling of cell lysates, respectively, as 
before (Figure 6C). As expected, soluble DCG-0N preferentially decorated active CatS at 
37°C but did not label cathepsins at 4°C in live DC (Figure 6C, Lanes 2 and 3). By contrast, 
PS457 visualized the entire set of active cathepsins already at 4°C (Figure 6C, Lane 5), 
demonstrating that it reaches cathepsin-containing compartments efficiently, independent 
from endocytosis activity. In fact, PS457 labelled active cathepsins in intact DC at 4°C with 
efficiency comparable with DCG-0N at 37°C. Given the poor labelling characteristics of PS457 
compared with DCG-0N in cell lysates, passive transition of the plasma membrane facilitated 
by the nonaarginine CPP is at least in the same order of magnitude as the rate of fluid-phase 
endocytosis of MO-DC, which is known to be particularly high. Thus, CPP represent a powerful 
tool to deliver peptide-sized material to endocytic compartments, independently from active 
endocytic transport. Uptake of PS457 at 37°C significantly increased the amounts of proteases 
targeted by the probe, and LPS-induced down-modulation of endocytic internalization 
down-regulated this delivery. PS457 is thus internalized by a combination of endocytosis 
and passive, transport-independent transition of the cell membranes. In stark contrast to 
endocytosis-mediated uptake of DCG-0N, however, passive internalization of PS457 did not 
target CatS-containing compartments selectively but resulted in equally efficient delivery of 
the probe to active CatB and CatX. 
When intact DC were exposed to both compounds (DCG-0N vs. PS457) in a pulse-
chase format (Figure 6D), these differences became even more obvious: although at low 
concentrations of label (10 µM), the signal derived from exposure of the cells to DCG-0N 
remained at or below the threshold of detection, robust labelling of active cathepsins could 
be observed after incubation of DC with 10 µM PS457, where maximum signal intensity was 
reached already after 15 min. of chase. Note that CatB was visualized much stronger than CatS, 
similar to the pattern in the DC lysate and in contrast to the pattern observed after internalization 
of DCG-0N (compare also Figure 3B). We conclude that the delivery of exogenous, peptide-
like material to active endocytic proteases is increased significantly when this material is 
conjugated to the polycationic shuttle device. Under these conditions, exogenous material 
can enter endocytic compartments of DC independently from active transport and is routed 
to endocytic proteases in a nonselective manner in contrast to endocytosis-mediated delivery.
DISCUSSION
MO-DC loaded with antigenic peptide or complex protein represent the basis for 
several protocols, which aim at therapeutic vaccination in clinical trials. Different strategies 
are being applied to tailor antigenic material in a way that best exploits the nature of the 
internalization and processing machinery of MO-DC so that maximum amounts of the 
antigenic epitope are loaded ultimately on MHC II. Growing evidence indicates that the 
nature and specificity of the dominant protease(s) that mediate(s) the initial proteolytic attack 
on antigen after internalization by APC are of critical importance for the generation of a given 
antigenic epitope.19,20 Murine BM-derived macrophages selectively recruit active CatS to 
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internalized material during phagosome maturation, in contrast to murine BM-derived DC.24 
Protease contents and the architecture of endocytic compartments likely differ among various 
types of APC, DC preparations, and species, so that these results cannot a priori be transferred 
to human MO-DC. We therefore here aimed at resolving the interaction between endocytic 
proteases and internalized material in viable human MO-DC. In addition, we evaluated 
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Figure 6. Cell-penetrating peptides increase delivery to protease-containing compartments in DC.
(A) Structure of the cell-penetrating peptide analogue PS457, consisting of a DCG-0N-core attached to a nonaarginine 
cell-penetrating transport device. (B) Labelling of active cysteine proteases by PS457. Cytosolic extracts of human 
monocytes were incubated with 10 µM DCG-0N or PS457, respectively, for 30 min. at RT. Where indicated, 
cells were pretreated with different inhibitors for 60 min. (25 nM LHVS, 1 µM CA-074 or 25 µM E-64). Proteins 
were separated by SDS-PAGE on a reducing 12.5% SDS gel and reactive proteins were visualized by streptavidin 
blotting (n=3). (C) Live human DC were incubated with either DCG-0N or PS457 at 25 µM, either at 4°C or 37°C. 
Where indicated, DC were matured by addition of LPS 24 h. before labelling. Labelling of DC- and monocyte-
derived cell lysates at 37°C served as controls. The labelled polypeptides were visualized by anti-biotin blot after cell 
lysis and SDS-PAGE (n=4). (D) Intracellular delivery of PS457 in live DC. DC were incubated with either DCG-0N 
or PS457 (10 µM each) at 37°C for 10 min. (pulse), followed by extensive washing, and a 30 min. chase at 37°C. 
At each time point, cells were lysed and the targeted protease polypeptides visualized by streptavidin blot (n=3). 
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strategies that increase or modulate such delivery of exogenous material to protease-containing 
compartment(s). 
Our results show that human MO-DC efficiently internalize the peptide-like ABP when 
exposed to the soluble tracer in culture medium, in contrast to internalization via phagocytosis. 
Exogenous material, as such incorporated, is routed selectively to active CatS, and CatB, 
CatL, and CatX are only poorly targeted, if at all, by a mechanism that requires activity of 
the vacuolar H+-ATPase. This CatS-targeted delivery of exogenous, soluble matter in human 
DC could be observed as early as 3 min. after exposure of DC to the tracer and increased over 
20-30 min. after internalization. In addition, endosomes of human MO-DC containing the 
internalized tracer selectively acquired active CatS during maturation. This is not a specific 
trait for MO-DC but was similarly observed in primary human monocytes. Our data therefore 
suggest that CatS is a functionally dominant active protease in early endocytic compartments 
of both human monocytes and MO-DC. Fractionation experiments with resolution of 
endocytic subcompartments revealed a differential distribution of active proteases in human 
DC, where CatS and CatB polypeptides were present in early endosomes in roughly equal 
amounts, in contrast to CatX and CatL22, consistent with our results. The attribute the poor 
interaction between internalized DCG-0N and active CatB observed here to the only mildly 
acidic to near- neutral pH present in early endosomes, where CatB is expected to be inactive, 
in contrast to CatS, which shows a unique stability and activity from acidic up to neutral 
pH.37 Thus, the preferential interaction of internalized material with CatS likely represents the 
combined result of differential distribution of cathepsins in conjunction with the pH gradient 
along the endocytic route. These results strongly suggest CatS as a functionally dominant 
endocytic protease likely to initiate antigen breakdown in human MO-DC. However, it can 
not be excluded formally that nonpapain proteases, such as active AEP, CatD, or CatE, which 
cannot be monitored with the probe used here, are reached by an exogenous tracer within a 
similar time window. However, unlike CatS, none of these proteases have been shown to be 
active or present in early endosomal compartments, consistent with their low pH optima.
The direct comparison between human MO-DC and murine BM-derived DC resulted 
in a 1-log lower efficiency of internalization (number of positive cells x mean fluorescence 
intensity) of identical fluorochrome-coupled latex beads by human MO-DC, and a similar 
difference was not observed for fluid phase-mediated endocytosis of a soluble protein. 
Thus, fluid phase-endocytosis appears to be a preferred mode of uptake of exogenous 
material by MO-DC in vitro. Although it is not entirely clear which route of antigen uptake 
(endocytosis vs. phagocytosis) is the preferred one for human DC in vivo1, fluid-phase, 
mediated endocytosis has been shown to deliver antigen efficiently for T cell activation after 
vaccination in vivo.38,39
Proteolysis in the endocytic compartment of DC is regulated largely via the maturation 
state and the activity of the vacuolar ATPase. Although low ATPase activity is found in resting/
immature DC with a generally, slightly higher endosomal pH, LPS-mediated stimulation of 
DC leads to a drop in endocytic pH and more efficient proteolysis.40 We here demonstrate that 
changes in the ATPase activity induced by the inhibitor Concanamycin B or by LPS-mediated 
activation indeed modulate the interaction of internalized tracer with active cathepsins. 
Inhibition of the ATPase abolished the delivery of the probe to active CatS. This was not a 
result of inactivation of the protease per se, as demonstrated by labelling of active CatS in cell 
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lysates treated with ConB. Treatment with LPS resulted in an increased labelling of active 
CatS by the internalized probe at early chase-times, in comparison to non stimulated controls. 
This is consistent with the model of a LPS-induced decrease in endocytic pH, which is likely to 
induce (auto)-catalytic activation of CatS, already in early endocytic compartments, as well as 
with the redistribution of active CatS to earlier endocytic compartments, as demonstrated for 
human DC upon LPS stimulation.22 The intracellular maturation, activation, and degradation 
of newly synthesized CatS have not yet been addressed. As we here demonstrate by pulse-
chase analysis and immunoprecipitation of radiolabelled, newly synthesized protein, CatS 
is degraded in the endocytic compartment of LPS-stimulated DC within approximately 
60 min. of entry into the endocytic tract, in contrast to nonstimulated DC, and CatS biosynthesis 
and the rate of conversion of proCatS into its active, mature form are not influenced by DC 
maturation. Thus LPS-stimulated MO-DC limit the amounts of active CatS by degradation 
of the newly synthesized enzyme, in contrast to resting DC. This may control the (self-) 
destructive potential of CatS. However, the overall proteolytic environment of endocytosed 
antigens does not differ substantially between unstimulated and activated MO-DC. 
As active CatS controls Ii maturation and thereby MHC II peptide-loading, a facilitated 
delivery of exogenous material to CatS-containing compartments might allow improvement 
of vaccination protocols. Our results demonstrate that targeting of peptide-like, synthetic 
compounds to active cathepsins in live human DC can be increased substantially by attaching 
peptide to a protein-size carrier or to CPP. As internalization of typical, fluid-phase markers 
such as Dextran or HRP in DC is also mediated, at least in part, by receptor-mediated 
endocytosis via mannose receptor-binding35,36, we suggest that the improved internalization 
of the DCG-0N-streptavidin complex may also rely on this additional mode of uptake.
CPP-enhanced endocytic uptake was clearly the most efficient way of internalization into 
MO-DC. Despite their broad acceptance as molecular carriers, the mechanism of internalization 
of polycationic peptides is not well understood, and active, endocytosis-mediated as well 
as passive transition of the membrane are still under debate.28 As PS457 labelled active 
cathepsins in intact cells also at 4°C, we strongly argue that CPP can enter the DC efficiently, 
independently from energy-dependent mechanisms such as endocytosis. However, endocytosis 
clearly improves the uptake of PS457 into cathepsin-containing compartments, as shown by 
appropriate changes at 37°C and after LPS-induced down-regulation of macropinocytosis, 
respectively. Although the selective transport to CatS is preserved when macropinocytosis is 
facilitated by conjugation of the probe to a protein carrier, this type of selectivity is lost when 
internalization is achieved by CPP. We suggest that soluble peptide or peptide attached to a 
protein carrier only reaches a sub-population of endocytic compartments enriched in CatS 
activity and separated from conventional late endosomes/lysosomes by membrane barriers. 
We envision that CPP may transit these separating membranes after internalization by MO-
DC, and hence gain access to the entire spectrum of endocytic protease activity. 
Conjugation of the immunogenic peptide to a CPP carrier prior to vaccination resulted in 
a vaccination success and a CD4-T cell-dependent tumor regression as a result of sustained 
antigen presentation in a murine model for peptide-based cancer immunotherapy, and the same 
peptide without a CPP carrier proved ineffective.29 As demonstrated here, such conjugation of 
peptide to CPP greatly increases transport to CatS-containing endocytic compartments as well 
as to endocytic proteases in general. Both aspects might lead to improved antigen processing 
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and MHC II-peptide loading and hence, explain the sustained antigen presentation observed 
when antigen was delivered via CPP in vivo. In this sense, conjugation of antigen to CPP 
might serve as a universal strategy to shuttle antigenic peptide to the MHC II processing 
machinery. It should be noted, however, that facilitated delivery of antigenic protein to 
endocytic proteases (or to a broader selection of proteases) might also bear the potential to 
impair antigen presentation due to destructive processing. This likely depends of the nature 
and the processing pathway of the antigen used.18-20 
Because we here identify CatS as a major protease reached by such constructs, conjugation 
of antigen to CPP via a CatS-sensitive peptide bond might be a worthwhile strategy to 
selectively release antigenic material in the appropriate compartment. In addition, conjugation 
of antigenic peptide to CPP may allow achievement of sufficient internalization of antigen 
and its delivery to proteases, even in LPS-activated DC, which are highly immunogenic but 
poorly endocytotic. Clearly, these possible applications of CPP warrant further systematic 
investigation with respect to the T cell response elicited in vitro and in vivo.
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6.1. CONCLUSIONS
The following conclusions can be drawn from our studies:
1. DC cultured from bone-marrow precursors show several defects in the BB-DP rat
 model of endocrine autoimmunity:
a. Bone-marrow precursors of DC show a higher apoptosis during culture to DC, leading 
 to a lower yield of DC after 7 days of culture in GM-CSF/IL-4. This defect is present 
 in BB-DP rats, but absent in BB-DR rats.
b. Immature DC showed a reduced MHC class II cell surface expression in 3 BB-DP 
 sub-lines studied as compared to control rats. This defect was present in BB-DP rats, 
 but absent in BB-DR rats.
c. Immature DC of both BB-DP and BB-DR rats show a normal T cell stimulatory
  capacity as compared to DC of control rats.
d. Immature DC of BB-DP rats showed a poor capability to differentiate into fully mature
 DC, i.e. DC with a clearly raised MHC class II and a superb T cell stimulatory capacity.
  This defect was also found to a certain extent in BB-DR rats, which only showed a
  poor T cell stimulatory capacity of mature DC.
e. Immature DC of both BB-DP and BB-DR rats showed a reduced production of IL-10 
 as compared to control rats. 
2. To study the gene linkage of the DC defects of the BB rat we used in addition F344
rats congenic for the region of the BB-DP rat chromosome 4, on which the lyp gene is
located, designated F344.lyp rats.
Here it must be noted that BB-DP/Seattle (S) and BB-DR/S rats differ in
chromosome 4 with a relatively small region (1.4 Mb), which included the lyp gene
(iddm2, the mutated Ian5 gene), while F344.lyp rats differ from F344.+/+ rats in
chromosome 4 with a much larger region (51.1 Mb), not only including the lyp gene
(iddm2, the mutated Ian5 gene), but also other potential diabetogenic genes, in
particular iddm4.
We found that
a. DC precursors of F344.lyp animals show a higher apoptosis during culture to DC as
 compared to precursors of control F344.+/+, leading to a lower yield of DC after 
 7 days of culture in GM-CSF/IL-4. 
b. Immature DC of F344.lyp animals have a low MHC class II expression as compared 
 to DC of control F344.+/+. 
c. Immature DC of F344.lyp animals have a reduced capability to stimulate T cells in
  allogeneic MLR as compared to DC of control F344.+/+. 
d. Immature DC of F344.lyp animals have a normal capability to differentiate into fully 
 mature DC, a low MHC class II expression as compared to DC of control F344.+/+,
  i.e. DC with a clearly raised MHC class II and a superb T cell stimulatory capacity. 
e. Immature DC of F344.lyp animals have a reduced production of IL-10 (but only when
 lyp/lyp) as compared to control rats. 
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3. In a comparison of the abnormalities in the BB-DP/S versus BB-DR/S and those in F344.
 lyp/lyp rats versus the F344.+/+ rat we were able to construct a relatively detailed linkage of 
  lyp and other BB genes to the aberrancies typical of the BB rat model of diabetes 
 (see Table below).
Linkage of DC phenotype with the genetic background of the various sub-lines of the F344 and BB rats.
Genes involved F344.+/+ F344.lyp/lyp BB.+/+ BB.lyp/lyp
normal 
genes
normal genes 
plus BB genes on 
chromosome 4 
(42.5-93.6 Mb)
BB genes 
minus 
iddm2
BB genes plus iddm2
Iddm2 (lyp) Apoptosis precursors normal increased normal increased
MHC class II normal decreased normal decreased
expression
BB genes not on
the 42.5 Mb-93.6
Mb region of
chromosome 4
Yield of DC normal normal increased increased
In vitro maturation normal normal decreased decreased
capacity after LPS
Iddm4 (candidate) T cell stimulation normal decreased normal normal
Complex linkage IL-10 production normal decreased decreased decreased
(but equal to BB.+/+)
4. Bone-marrow precursor derived DC of BB rats and control rats did not express mRNA for
 Ian5 or other Ian genes.
5.  In an attempt to study thymus DC in the BB rat we used a protocol to isolate non-adherent
  low-density cells (LDC), a protocol that has been successfully used to isolate spleen DC
and a population of APC from the thyroid. However after careful phenotyping of the 
cells these thymus LDC (unlike spleen DC) turned out to be ED2+ branched cortical 
macrophages, and not OX62+ thymus cortico-medullary and medullary dendritic cells. 
These ED2+ branched cortical macrophages were excellent T cell stimulators, but more 
importantly rescued double-positive thymocytes from apoptosis. The ED2+ branched 
cortical macrophages of lymphopenic F344.lyp/lyp and BB-DP rats showed a reduced 
T cell stimulatory capacity as compared to non-lymphopenic F344.+/+ and BB-DR/S rats. 
LDC of lymphopenic rats were poor inducers of ART2+ regulatory T cells as compared to 
LDC of non-lymphopenic rats.
ED2+ branched cortical macrophages did express mRNA for Ian5 and showed a reduced 
expression of Ian5 in lyp/lyp animals (comparable to what was found in lyp/lyp thymocytes). 
Our study suggests that branched cortical macrophages play a role in positive selection 
and particular of naturally occurring Treg cells and that these cells are defective in BB-DP 
rats perhaps due to the lyp mutation (Chapter 4).
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6.  We simulated the rendezvous between antigen and endocytic proteases in human MO-DC. 
The most important endocytic proteases are the cysteine cathepsins, which we can identify 
with one tool showing all the active cysteine proteases.
After internalization of the peptide-size tracer by macropinocytosis only cathepsin S was 
targeted. Blocking of the vacuolar ATPase abolished this CatS-selective targeting, while 
LPS-induced maturation of DC resulted in degradation of active CatS, in keeping with the 
concept that immature DC change from antigen-uptake cells to antigen-presenting cells 
during maturation. Conjugation of the ABP to a protein facilitated the delivery to endocytic 
proteases and resulted in labelling of sizable amounts of CatB and CatX, although CatS 
still remained the major protease reached by this construct. Conjugation of the probe 
to a cell-penetrating peptide (CPP) routed the tracer to the entire panel of intracellular 
cathepsins, independently from endocytosis or LPS-stimulation. Thus, different means 
of internalization result in differential targeting of active cathepsins in live MO-DC. 
CPP may serve as vehicles to target antigen more efficiently to protease-containing 
endocytic compartments (Chapter 5). 
6.2. DEFECTS IN APC FUNCTION IN ANOTHER MODEL OF 
AUTOIMMUNE THYROIDITIS/DIABETES (THE NOD MOUSE) AND 
IN TYPE-1 DIABETES/ AUTOIMMUNE THYROIDITIS PATIENTS
The here found defects in the differentiation and function of DC are not only found in 
the BB rat model of autoimmune thyroiditis/diabetes. Similar defects have been found in 
the other important rodent model of autoimmune diabetes, the NOD mouse, and in type-1 
diabetes patients. But apart from similarities there are also many dissimilarities.
6.2.1. Similarities and dissimilarities of DC between the BB-DP rat model and the NOD 
mouse model
In the NOD mouse model many studies have focused on growth factor induced development 
of DC from bone-marrow precursors. In studies in our own lab we used GM-CSF without 
IL-4 to culture DC from NOD bone-marrow precursors. These experiments showed a poor 
generation of immature and mature DC from precursors and these DC had a reduced capability 
to stimulate T cells and showed a more macrophage-like phenotype being strongly positive 
for acid phosphatase.1 In not published experiments I also found the bone-marrow derived 
DC of the BB-DP rat to have a higher expression of the typical macrophage marker ED3 (see 
Figure 1).
Thus, NOD mouse bone-marrow derived DC show very similar defects as BB-DP rat 
bone-marrow derived DC being poor APC with a macrophage-like character.
It must be noted however, that, when bone-marrow precursors of the NOD mouse are 
cultured in GM-CSF plus IL-4, the defective and macrophage-skewed differentiation is 
restored resulting in DC with a superb T cell stimulatory capacity. This is thus different from 
BB-DP rat bone-marrow derived DC which show defects in differentiation also in the presence 
of additional IL-4 in the culture fluid.
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A similarity between NOD and BB-DP rat DC is that both are in a pro-inflammatory state, 
yet a difference is that NOD mouse bone-marrow derived DC reach this pro-inflammatory 
state in a different way as the BB-DP rat DC. While NOD DC show an increased IL-12p70 
production (due to increased levels of NF-κB)2,3,4, bone-marrow derived DC of the BB-DP rat 
show a decreased IL-10 production.
Also the genes involved in the aberrancies of DC in the NOD and BB-DP rat are different. 
We here show in this thesis that iddm2, another gene on chromosome 4 (perhaps iddm4) 
and genes on other locations are involved in the various abnormalities of the BB-DP DC. 
These gene abnormalities are not present in the NOD mouse and studies suggest that idd10, 
idd17 and idd18 are involved in the DC abnormalities of the NOD mouse.5
6.2.2. Similarities and dissimilarities of DC between the BB-DP rat model and human 
type-1 diabetes
As elaborated before, in the rodent animal model spleen DC, thyroid DC and in particular 
bone-marrow derived DC populations have been studied. This has not been possible in human 
type-1 diabetes: in patients it is only possible to study monocyte-derived DC and circulating 
myeloid and plasmacytoid DC.
In studies on such DC an inconsistent picture has arisen. While in initial studies there was 
a poor differentiation of DC from monocytes in type-1 diabetes patients and individuals at risk 
to develop diabetes (i.e. those with multiple islet-reactive antibodies present)6,7, later studies 
were unable to confirm these defects8 (this is also our experience), or even found an enhanced 
differentiation of DC from precursors. Also with regard to numbers and function of circulating 
mDC and pDC there is confusion: a first report showed increased levels of mDC and pDC9, 
while another report showed reduced numbers and function in mDC and pDC.10 Explanations 
for these discrepant results have been suggested to reside in the fact that in the different 
studies different isolation and culture methods have been used to obtain monocyte-derived 
DC. There is, however, also the issue of patient heterogeneity. It is very well possible that 
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Figure 1. Increased expression of the macrophage marker ED3 by bone-marrow derived DC of the BB-DP 
and BB-DR rat. 
The expression of the macrophage marker ED3 (CD169) on bone-marrow derived DC of BB-DP, BB-DR and Wistar 
rats was analyzed by flowcytometry. Bone-marrow derived DC of the BB rat, both BB-DP and BB-DR, showed a 
trend towards higher expression of the macrophage marker ED3 as compared to bone-marrow derived DC of the 
control Wistar rat (n=3-5).
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type-1 diabetes starting in childhood is different from type-1 diabetes starting in adulthood. 
In one of the reports it was found that the reduced numbers of mDC and pDC in the circulation 
were in particular present in childhood onset diabetes, while age was a confounding factor for 
these numbers.7
Interestingly, our group has detected more consistent defects regarding other myeloid 
circulating APC populations in type-1 diabetes and autoimmune thyroiditis patients: 
The generation of an APC population very similar to the monocyte-derived DC, i.e. of 
monocyte-derived veiled macrophage-like cells, was found hampered in type-1 diabetes and 
autoimmune thyroiditis patients, particularly after fibronectin adhesion of the monocytes, 
which normally up-regulates the generation of such veiled APC from monocytes. 
This hampered differentiation resulted in a low T cell stimulatory capacity of the APC.11,12
With regard to IL-10 and IL-12 production abnormalities of human APC, recent reports 
show a decreased in vitro IL-10 (and IL-4) production by peripheral blood cells of first-degree 
relatives at a high risk of type-1 diabetes.13 Additional evidence for an IL-10 production 
aberrancy comes from twin studies: type-1 diabetes-discordant twins with a raised risk (i.e. 
islet cell antibody-positive) show a reduced IL-10 response to hsp60 as compared to twins at 
low risk.14 In addition there appears to be a defect in the production of IL-10 (and IL-4) in the 
pancreas of recently diagnosed type-1 diabetes mellitus patients.15
6.2.3. A general blueprint of APC defects in rodent models and type-1 diabetes patients
Collectively our rat data and those of others in mice and humans thus show a general 
blueprint regarding the aberrant function of professional myeloid derived APC, i.e. of DC and 
veiled macrophages: The differentiation of such APC from precursors is defective, resulting 
in a pro-inflammatory state of these cells and a defective capability of the cells to induce Treg 
cells and/or to induce tolerance via AITCD (Figure 2). However the genes governing these 
defects, the pathways via which these defects are reached and the actual APC forms affected 
differ between the rodent models and patients. This suggests heterogeneity of the immune 
pathogenesis of autoimmune diabetes between the two rodent models and between the 
rodent models and the human disease, at least at the level of the initiation of the autoimmune 
response.
6.3. DO DEFECTIVE MYELOID APC PLAY AN ESSENTIAL ROLE 
IN DIABETES DEVELOPMENT?
Presently it is known that semi-mature and mature DCs are required for optimal tolerance 
induction. As discussed in the introduction section various mechanisms play a role in such 
tolerance induction; I here want to highlight the induction and maintenance of Treg cells in 
the thymus and periphery respectively.
6.3.1. The induction of ART2+ regulatory T cells in the thymus
We here report that thymus branched cortical macrophages of BB-DP rats were poor 
rescuers of regulatory ART2+ T cells as compared to those of BB-DR rats.
Previous work has shown that transfers of thymus APC of BB-DR rats to BB-DP rats are 
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partially able to restore the defects of ART2+ T in BB-DP rats and to prevent insulitis and 
diabetes.16,17,18 Similar results were found when thymus macrophages from control CBA mice 
were adoptively transferred into neonatal NOD mice, preventing autoimmunity.19,20
Thus, it is very likely that the here described ART2+ regulatory T cell induction defects of 
APC at the level of the thymus play a role in the faulty tolerance induction of the BB-DP rat 
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Figure 2. General blueprint for the animal models of type-1 diabetes.
Our rat data and those of others in mice and humans show a general blueprint regarding the aberrant function of 
professional myeloid derived APC, i.e. of DC, thymic branched cortical macrophages and veiled macrophages. 
The differentiation of such APC from precursors is defective, resulting in a pro-inflammatory state of these cells and a 
defective capability of the cells to induce regulatory T cells and/or to induce tolerance via AITCD. This loss of tolerance 
contributes to the destruction of the β cell. Ab, Antibody; B, B cell; β, beta cell; APC, antigen-presenting cell; ECM, 
extracellular matrix; Mo, monocyte; Mφ, macrophage; NK, natural killer cell; P, progenitor; Pre, precursor; Th1, 
T helper 1 cell; Th2, T helper 2 cell; Tc, cytotoxic T cell; Tn, naïve T cell; Tr, regulatory T cell.
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towards various endocrine autoantigens, though this needs now to be studied further.
Intrathymic tolerance induction is dependent on the local expression of autoantigens in 
the thymus. With regard to diabetes, different thymic cells express the insulin peptide family. 
All members of the insulin family are expressed in the thymus stroma according to a specific 
hierarchy and cellular topography. IGF-2 expression by TEC is the highest followed by IGF-1
by macrophages and insulin (INS) by thymic medullary epithelial cells and/or dendritic 
cells. This specific hierarchy in gene expression pattern is in accord with the observation that 
IGF-2 is better tolerated than INS. In the BB-DP rat model, IGF-2 expression was defective in 
11 of 15 thymuses in close concordance with the diabetes incidence in their rat strain (while 
IGF-1 and insulin expression were intact).21 Thus apart from the branched cortical macrophage 
defect autoantigen expression defects may contribute to the build up of the autoantigenic 
effector T cell repertoire of the BB-DP rat. However it needs further exploration how the 
defect in the branched cortical macrophages in the BB-DP rat relates to the putative defect of 
these cells to express members of the insulin antigen family.
A study in humans showed that IGF-2 peptide 11-25, which binds with the same affinity 
to DQ8 as insulin B chain peptide 9-23, induced an anti-inflammatory T cell response.22 
These studies provide an interesting view that not insulin, but IGF-2 should be the target 
autoantigen to establish a tolerogenic state in diabetes-prone individuals. 
6.3.2. The maintenance and induction of regulatory T cells in the periphery
At an earlier occasion our group reported on a poor capability of the spleen DC of the 
BB-DP rat to support the expansion of ART2+ T cells. Tolerance is partly dependent on survival 
and proliferation of regulatory T cells. At present a general consensus exists that IL-2 is a key 
stimulatory factor in this process. An additional factor, which seems to be important for the 
peripheral maintenance of regulatory T cells is CD28. At particularly this point peripheral DC 
of BB-DP rats seem to provide an insufficient stimulatory signal for proper peripheral Treg 
maintenance. The defect as described in this thesis of immature DC of the BB-DP rat to fully 
mature into MHC class II, CD80 and CD86 expressing mature DC results in a low capacity 
of these defectively maturated APC to stimulate T cells via the MHC class II-TCR and 
CD80-CD28 route.23-29 Precisely such triggering via the latter route is essential to prevent the 
development of diabetes in the BB-DP rat and NOD mouse model. In vivo treatment of BB-
DP rats with stimulatory anti-CD28 monoclonal Abs completely prevents the development of 
both insulitis and diabetes. Recent experiments show that this treatment expands in particular 
CD4+CD25+ Treg cells in the BB-DP rat (Visser, personal communication). 
Apart from the defective APC signaling required for natural Treg cell maintenance, the 
pro-inflammatory state of the aberrant bone-marrow derived DC of the BB-DP rat, i.e. their 
reduced IL-10 production, must lead to a defective induction of at least the inducible forms of 
Treg cells, since IL-10 has been described as an important stimulator for Tr1 cell induction. 
However this needs further study.
In sum, the defective development of APC in BB-DP rats resulting in poor APC with a 
pro-inflammatory set point most likely contributes to the poor tolerogenic capability of the 
animals and the heightened aggressiveness to endocrine glandular cells.
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6.4. FUTURE DIRECTIONS
6.4.1. In vivo effects of functionally restored DC and cortical branched macrophages
Future work in the BB-DP rat regarding DC defects should study their functional 
consequences in vivo. We expect that transfer of fully mature bone-marrow derived DC (of 
e.g. Wistar rats) to BB-DP rats would reduce/prevent diabetes. Such transfers have been 
shown to be effective in the NOD mouse model.30,31
Another approach would be to study the in vitro and in vivo suppressive function of 
regulatory ART2+ T cells, after their in vitro generation in APC driven systems, e.g. via Wistar 
bone-marrow derived DC or thymus LDC. The generated ART2+ regulatory T cells should 
suppress the proliferation of ART2- T cells in vitro. Final proof that the thymus LDC and fully 
mature bone-marrow derived DC are important in the prevention of diabetes could be best 
shown by purification of the induced ART2+ T cells followed by adoptive transfer into pre-
diabetic BB-DP rats to show that insulitis/diabetes can be prevented. Alternatively selective 
depletion of BB-DP LDC and the adoptive transfer of BB-DR LDC would give direct evidence 
that these cells are involved in the prevention of diabetes; a similar approach using thymus 
APC has been performed previously16, although investigators were unable to phenotype the 
APC as branched cortical macrophages at that time. 
6.4.2. Plasmacytoid DC
Future work should also focus on the other major DC population, the plasmacytoid DC. 
Plasmacytoid DC (pDC) are derived from plasmacytoid pre-DC, formerly called plasmacytoid 
cells or interferon-producing cells (IPC). Indeed these cells are specialized in a high 
production of type I IFN (IFN-α and β) upon viral/bacterial stimulation. First discovered in 
1958 by Lennert en Remmele, they were mistakingly designated plasmacytoid T cells based 
on their plasma cell-like morphology (eccentric nucleus) and their presence in T cell areas 
of lymphoid organs.32 At that time they were thought to be the T cell counterpart of plasma 
cells. In fact, their plasma cell-like appearance is an indication for their high production of 
proteins, which turned out to be the production of type I IFN. In comparison to other cells they 
are the cells producing the largest amount of type I IFN.33 The human pDC lineage expresses 
CD45RA, BDCA-2, BDCA-4, CD123 (IL-3Rα) and survival is mainly dependent on IL-3. 
The mouse pDC lineage, in contrast to the human pDC lineage, does not express CD123. 
The phenotype of mouse pDC is CD11b-CD11clowB220+Gr-1+. The complete phenotype of rat 
pDC is CD3-CD4+CD5+CD90+ CD45R+CD45RC+ CD11b-CD11c-CD161a+CD200+CD172+
CD32+CD86+OX62-.34 They appear homologous to human pDC as they produced type I IFN 
upon viral/bacterial stimulation via restricted expression of TLRs, namely TLR7 and TLR9. 
TLR9 confers responsiveness to bacterial DNA35, while TLR7 responds to single stranded 
RNA from viruses (ssRNA). Other cytokines produced by rat pDC include IL-12 and IL-6.34  
Interestingly Summers et al found that pDCs in human type-1 diabetes produced less 
IFN-α.36 Could it be that a defective anti-viral response by pDC is the trigger for diabetes 
development? These studies could be performed in the BB rat model using both BB-DP 
and BB-DR rats, the latter with or without infection with Kilham virus or after poly I:C 
treatment.
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6.4.3. Further studies on autoantigen effects and processing
A drawback of the studies described in this thesis is that none of the experiments has 
been done in the presence of diabetes relevant antigens. Particularly the T cell stimulation 
assays by faulty APC of the BB-DP rat should be carried out with relevant autoantigen(s). 
These include for the BB-DP rat IGF-2. 
Also further work on the processing and presentation of diabetic autoantigens must consist 
of studies using such antigens, which are in vitro digested by isolated endolysosomal endocytic 
proteases of primary human and rat APC. This will provide information about the endocytic 
proteases involved and the actual peptide fragments generated from the autoantigens. 
Functional studies must then address the actual effect of the generated peptide fragment on 
the stimulation of autoantigen-specific T cells. 
In our study in Chapter 5 we used ABP to address the delivery of exogenous material to 
active, papain-like cathepsins in human MO-DC. Cell-penetrating peptides (CPP) modulated 
the patterns and efficiency of the delivery of exogenous antigenic material to endocytic proteases 
in intact viable DC. Especially the use of such CPPs to deliver antigen efficiently inside the 
cells is an interesting approach, since this does not require an active uptake and antigen can 
reach MHC class I and MHC class II pathways in high amounts in both non-professional 
and professional APC. The use of cell-penetrating peptides coupled to autoantigens could be 
a promising approach to activate both CD4+ regulatory T cells and CD8+ regulatory T cells, 
since both MHC class II and MHC class I pathway are targeted by CPP coupled antigens. Such 
a strategy could be used to design a vaccine-like method to deliver autoantigens efficiently 
into (tolerogenic) DC to induce regulatory T cells, which are able to prevent the development 
of autoimmunity. The BB-DP rat could be a model to test such approaches.
6.5. SO IN THE END: WHAT DO WE LEARN FROM THE BB RAT 
MODEL FOR ENDOCRINE ORGAN-SPECIFIC AUTOIMMUNE 
DISEASES IN THE CLINIC?
It must be emphasized again that studying the BB rat cannot answer all the problems 
presented by endocrine organ-specific autoimmune diseases when seen in the clinic. It must be 
expected, considering the various etiologies, immunopathogenic pathways and genes involved 
seen in the BB-DP rat and the NOD mouse, that the causes of the diseases in the human and 
the involvement of various genes and environmental factors may differ from patient sub-set 
to patient sub-set. Yet in the study of particularly the pre-autoimmune phases of the diseases 
there is hardly an alternative than to study the animal models, the BB-DP rat and the NOD 
mouse. Only limited series of experiments can be carried out in individuals who are at risk to 
develop endocrine autoimmune diseases. Moreover the etio-pathogenesis found in the animal 
models may provide novel information of mechanisms that are relevant to human studies. 
Defects present in both the BB-DP rat, the NOD mouse and diabetes-prone individuals should 
in particular be considered for designing prophylactic and therapeutic therapies. 
From this thesis it is clear that such target defects are the shared aberrancies of APC (poor 
generation, poor T cell stimulatory function, pro-inflammatory state), since they appear as 
cornerstones in the development of endocrine autoimmunity. 
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In summary, we believe that the BB rat model of endocrine organ-specific autoimmune 
disease still holds immense promise for the discovery of pathways, genes and environmental 
factors that determine the development of overt endocrine organ-specific autoimmune 
diseases. The BB rat is a good example of the success of this approach. 
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ABBREVIATIONS
ABP   Activity-based probe
Ag   Antigen
AITCD   Activation Induced T Cell Death
Aire   Autoimmune regulator
APC     Antigen-presenting cell
APS   Autoimmune polyglandular syndrome
ART2   ADP-ribosyltransferase-2
BB-DP   Biobreeding-Diabetes Prone
BB-DR   Biobreeding-Diabetes Resistant
BM   Bone-marrow
CPP   Cell-penetrating peptide
CTLA-4   Cytotoxic T-lymphocyte-associated protein 4  
DC   Dendritic cell
DN   Double-negative
EAE   Experimental Autoimmune Encephalomyelitis
ECM   Extracellular matrix
EGFP   Enhanced green fluorescence protein
ER   Endoplasmatic reticulum
Foxp3   Forkhead box p3
GITR   Glucocorticoid-induced TNF receptor
HSA   Heat stable antigen 
Ian   Immune associated nucleotide
Iddm   Insulin-dependent diabetes mellitus gene (rat)
IFN   Interferon
IGF   Insulin-like growth factor
IL   Interleukin
INS   Insulin gene
LDC   Low-density cell
LPS   Lipopolysaccharide
MBT   Mycobacterium tuberculosis
MHC   Major histocompatibility complex
MO-DC   Monocyte-derived DC
NKT   Natural Killer T cell
NO   Nitric oxide
NOD   Non-obese diabetic
nTreg   Naturally occurring regulatory T cell
OS   Obese strain
Poly I:C   Polyinosinic-polycytidylic acid
PTPN22   Protein tyrosine phosphatase non-receptor type 22
PVS   Peri-vascular spaces
RAG   Recombination activating gene
RIP-LCMV  Rat insulin promoter-lymphocytic choriomeningitis virus
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RTE   Recent thymic emigrant
SAC   Staphylococcus aureus Cowan
Scid   Severe combined immunodeficiency
SP   Single-positive
T1D   Type-1 diabetes
TCR   T cell receptor
Tg   Transgenic
TLR   Toll-like receptor
TNF   Tumor necrosis factor
Treg   Regulatory T cells
TSLP   Thymic stromal lymphopoietin 
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Type-1 diabetes is the result of a T cell mediated immune response against the insulin-
producing β cells in the islet of Langerhans. In humans, until now, the disease is only clearly 
detectable at the onset of the disease. Therefore studies to identify initial factors involved in 
the etio-pathogenesis are impossible in humans prone to develop diabetes. In order to study 
the early, prodromal phases of type-1 diabetes we used a spontaneous rodent animal model of 
the disease, the Biobreeding-Diabetes Prone (BB-DP) rat. This rat develops diabetes, because 
it is in particular defective for a population of regulatory T cells, the ART2+ regulatory T cells 
and because it possesses the disease-prone MHC haplotype RT1u (iddm1).
We investigated (Chapter 2) the myeloid dendritic cells (DC) in this animal model, 
since DC, the antigen-presenting cells par excellence, are able to elicit immune responses 
from naïve T cells and are known to be involved in autoimmune responses because they 
are capable of modulating immunity versus tolerance. We studied bone-marrow precursor 
derived myeloid DC of three BB-DP rat sub-lines (Worcester, Groningen, Seattle) to identify 
defects in these DC, which could be responsible for the defective tolerance induction towards 
diabetes-associated islet autoantigens in this rat model. We found that the myeloid DC 
generated from bone-marrow precursors were defective in these three BB-DP rat sub-lines, 
showing an immature, more macrophage-like phenotype, a low MHC class II expression 
on their surface, a reduced T cell stimulatory capacity, a reduced capability to differentiate 
into fully mature DC and a reduced production of the immunosuppressive cytokine IL-10 as 
compared to two control rat strains (Wistar, F344). We assume that such DC defects contribute 
to the decreased tolerance towards islet autoantigens in the autoimmune diabetes of the 
BB-DP rat, since such defective DC are in particular defective to stimulate ART2+ regulatory 
T cells sufficiently. 
We went on to study the gene linkage of the DC defects in the BB rat model (Chapter 2
and Chapter 3) and firstly we studied the DC development from bone marrow precursors 
in BB-diabetes resistant (DR) rats of the Seattle (S) sub-line. The BB-DP/S rat develops 
diabetes, the BB-DR/S rat not. The BB-DP/S rat is lymphopenic (particularly for the ART2+ 
regulatory T cells), the BB-DR/S rat is not. Genetically the BB-DP/S and DR/S rat differ 
for the Ian5 gene at the lyp gene locus (iddm2). This gene regulates the apoptosis of recent 
thymic emigrants and particularly induces the lymphopenia of the ART2+ Treg cells in the rat. 
In this model we found almost similar defects as in the generation of DC from bone-marrow 
precursors, but there was a difference with the BB-DP rat in that the DC had a normal MHC 
class II expression.
Secondly we used F344.lyp rats congenic for a large stretch of chromosome 4 of the BB-
DP/S rat which harbours the lyp gene (iddm2), but also other diabetes-linked genes such as 
iddm4. This F344.lyp rat resembles the BB-DP rat in that it has a strong lymphopenia, but in 
contrast to the BB-DP rat does not develop diabetes, due to the lack of other important diabetes 
susceptibility genes (such as iddm1). The DC of these rats showed almost similar defects as 
found in the BB-DP rat model, but in contrast had a normal capability to differentiate into 
fully mature DC. 
From these observations in the various BB-related models we were able to construct a 
relatively detailed linkage of lyp and other BB genes with the DC differentiation defects 
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present in the BB-DP rat: 
1. the low MHC class II expression is linked to lyp (iddm2), 
2. the reduced T cell stimulatory capacity is linked to other genes on chromosome 4 
 (candidate gene: iddm4) and 
3. the reduced IL-10 production has a complex linkage pattern, including iddm2.
In Chapter 4 we set out to isolate the thymus DC of the BB-DP rats and isolated the low-
density non-adherent cells from rat thymuses. For other tissues (lymph nodes, spleen, thyroid) 
this procedure results in a (relatively) pure population of DC. To our surprise the thymus 
isolated low-density cells were not DC, but appeared to be a relatively unknown population of 
accessory cells in the thymus, the branched cortical macrophages. These cortical macrophages 
are involved in positive selection in the thymus cortex. The branched cortical macrophages 
of the BB-DP and the F344.lyp rat appeared to be defective in function and less capable of 
rescuing double-positive thymocytes from apoptosis as compared to BB-DR and F344.+/+ 
rats. This defect was thus linked at least in part to the lyp gene. Interestingly the defective 
branched cortical macrophages of the BB-DP and F344.lyp rat were also poor rescuers of the 
thymus generated ART2+ Treg cells. Hence defects in the branched cortical macrophages, as 
described here in the BB-DP rat model, most likely contribute both to the T cell lymphopenia 
of the rat and its deficient tolerogenic state.
In experiments described in Chapter 5 we simulated the rendezvous between antigen 
and endocytic proteases in human monocyte-derived DC. The most important endocytic 
proteases are the cysteine cathepsins, which we can identify with a chemical tool, called 
activity-based probe (ABP), which identifies all the active cysteine cathepsins. By the action 
of these cysteine cathepsins exogenous proteins/peptides are digested into small peptides, 
which are eligible for loading onto MHC class II molecules followed by presentation to 
T cells. After internalization of ABP by macropinocytosis only cathepsin S is targeted. Blocking 
of the vacuolar ATPase abolishes this CatS-selective targeting, while LPS-induced maturation 
of DC results in degradation of active CatS, in keeping with the concept that immature DC 
change from antigen-uptake cells to antigen-presenting cells during maturation. Conjugation 
of the ABP to a protein facilitated the delivery to endocytic proteases and resulted in labelling 
of sizable amounts of CatB and CatX, although CatS still remained the major protease reached 
by this construct. Conjugation of the probe to a cell-penetrating peptide (CPP) routed the 
tracer to the entire panel of intracellular cathepsins, independently from endocytosis or LPS-
stimulation. Thus, different means of internalization result in differential targeting of active 
cathepsins in live monocyte-derived DC. We also concluded that CPP may serve as vehicles 
to target antigen more efficiently into cells.
Taken together, when our DC data obtained in the BB rat model of type-1 diabetes are 
compared to DC data previously obtained in a mouse model of type-1 diabetes (the NOD 
mouse) and to those in type-1 diabetic patients, a blueprint regarding the aberrant function 
of professional myeloid APC (DC and accessory macrophages) becomes evident: The T cell 
stimulatory function of such cells is defective, while the cells are more macrophage-like and in 
a pro-inflammatory state. The pro-inflammatory state of the APC skews naïve T effector cells 
into predominantly “dangerous” Th1 cells. Due to their defective T cell stimulatory capability 
the APC support/induce Treg cells insufficiently and are less capable of inducing tolerance via 
activation induced T cell death (AITCD). We therefore consider the here described defects in 
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myeloid DC as cornerstones in the etio-pathogenesis of T1D contributing to the breakdown of 
tolerance towards islet autoantigens finally leading to the destruction of the insulin-producing 
β cells.
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Type-1 diabetes is het gevolg van een T cel gemedieerde autoimmuun reactie tegen de 
insuline-producerende β cellen in de eilandjes van Langerhans. In de mens is, op dit moment, 
de ziekte alleen bij aanvang duidelijk detecteerbaar en kan de vaak lange (enkele jaren 
durende) prodromale fase niet worden geïdentificeerd. Daarom zijn studies die factoren willen 
onderzoeken, die betrokken zijn bij het vroege ontstaan van de ziekte, vrijwel onmogelijk bij 
patiënten of individuen die de aandoening onder de leden hebben. Om in staat te zijn deze 
vroege, prodromale fase van type-1 diabetes te bestuderen, hebben wij gebruik gemaakt van 
een spontaan knaagdier model van de ziekte, de Biobreeding-Diabetes Prone (BB-DP) rat. 
Deze rat ontwikkelt een autoimmuun vorm van diabetes, omdat de rat 
1. Een tekort heeft aan een populatie van regulatoire T cellen, de ART2+ regulatoire  
 (reg) T cellen, die bij normale ratten in staat is de autoimmuun reactie te onderdrukken,
  en
2. Positief is voor een bepaald MHC haplotype, nl. RT1u, een specifiek molekuul op
 zogenaamde antigeen-presenterende cellen (APC) dat bepaalde stukken van eiwitten
 (antigeen peptiden, vermoedelijk diabetes gerelateerde lichaamseigen antigeen
  peptiden) beter aan het afweer systeem (de T cellen) aanbiedt.
We onderzochten in eerste instantie (Hoofdstuk 2) de dendritische cellen (DC) in dit 
diermodel, aangezien 
1. De DC, antigeen-presenterende cellen par excellence, in staat zijn een afweer reactie
 op te starten vanuit naïve T cellen, en 
2. De DC bekend staan om hun invloed op autoimmuun reacties: Ze zijn in staat
   afweer versus tolerantie (het vermijden van afweer tegen lichaamseigen antigene
   peptiden) te moduleren. 
We bestudeerden DC ontstaan uit voorlopercellen in het beenmerg van drie BB-DP rat 
lijnen (Worcester, Groningen, Seattle) met het doel defecten in deze DC te identificeren, die 
verantwoordelijk zouden kunnen zijn voor de defecte tolerantie jegens diabetes geassocieerde 
eiland autoantigenen in dit rat model. We vonden dat DC gegenereerd uit beenmerg 
voorlopercellen defecten vertoonden in deze drie BB-DP rat stammen in vergelijking met 
twee gezonde controle rattenstammen (Wistar, F344): De DC vertoonden een onrijp, meer 
macrofaag-achtig fenotype, een lage MHC klasse II expressie op hun oppervlak, een verlaagde 
T cel stimulatie capaciteit, een verlaagde mogelijkheid te differentiëren naar volledig rijpe 
DC en een verminderde produktie van het immunosuppressieve cytokine IL-10. We hebben 
aanwijzingen dat zulke defecten van de DC bijdragen aan de verlaagde tolerantie ten opzichte 
van eiland autoantigenen in de autoimmuun diabetes van de BB-DP rat, aangezien zulke 
defecte DC in het bijzonder defect zijn in het voldoende stimuleren van de ART2+ regulatoire 
T cellen. 
We bestudeerden verder de genetische associatie van de bovengenoemde DC defecten in 
het BB rat model van type-1 diabetes (Hoofdstuk 2 en Hoofdstuk 3). Ten eerste bestudeerden 
we de DC onwikkeling vanuit beenmerg voorlopercellen in een andere BB rat stam, de BB-
diabetes resistente (DR) ratten van de Seattle (S) sub-lijn. Terwijl de BB-DP/S rat diabetes 
ontwikkelt, doet de BB-DR/S rat dat niet. De BB-DP/S rat heeft een sterk gebrek aan T 
cellen (in het bijzonder aan de ART2+ regulatoire T cellen), de BB-DR/S rat heeft dat niet. 
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Genetisch onderscheiden de BB-DP/S en de DR/S rat zich van elkaar wat betreft een “fout” 
Ian5 gen. Dit foute gen veroorzaakt een “fout” versneld afsterven (apoptose) van T cellen die 
uit de thymus (de ontstaansplaats van T cellen) naar het bloed migreren en in het bijzonder 
het versneld afsterven van de ART2+ Treg cellen. In het BB-DR/S model vonden we bijna 
vergelijkbare defecten in het ontstaan van DC vanuit beenmerg voorlopercellen, maar er was 
één verschil met de BB-DP/S rat: de DC van de BB-DR/S ratten hadden een normale MHC 
klasse II expressie op hun DC. Dit betekent dat dit defect in de DC gerelateerd is aan het foute 
Ian5 gen.
Ten tweede maakten we gebruik van F344.lyp ratten, dit zijn gezonde F344 ratten die 
een stuk gen hebben gekregen van de BB-DP/S rat. Dit stuk is een tamelijk groot stuk van 
chromosoom 4 van de BB-DP/S rat en dit stuk bevat zowel het foute Ian5 gen (ook wel het 
lyp gen of iddm2 genoemd) alsook andere diabetes vatbaarheidgenen, zoals het iddm4. Deze 
F344.lyp rat lijkt op de BB-DP/S rat in dat de rat een sterk gebrek aan T cellen (en vooral 
de ART2+ Treg cellen) bezit; maar in tegenstelling tot de BB-DP/S rat ontwikkelt de F344.
lyp rat geen diabetes door de afwezigheid van andere belangrijke diabetes vatbaarheidgenen 
genen die de BB-DP/S rat wel bezit, zoals het RT1u (ook wel iddm1 genoemd). De DC van 
deze F344.lyp ratten vertoonden ook weer bijna dezelfde defecten als die in het BB-DP/S rat 
model, maar er was nu geen gestoorde differentiatiemogelijkheid naar volledig rijpe DC. 
Uit deze observaties in de diverse BB rat-gerelateerde modellen van type-1 diabetes waren 
we in staat een relatief gedetailleerde associatie te construeren van de invloed van het foute 
Ian5 gen en andere BB rat vatbaarheidgenen op de DC differentiatie defecten aanwezig in de 
BB-DP rat: 
1. de lage MHC klasse II expressie op BB-DP rat DC is geassocieerd met het lyp 
  (iddm2) gen, 
2. de verlaagde T cel stimulatoire capaciteit van de BB-DP rat DC is geassocieerd met
  andere genen op chromosoom 4 (kandidaat gen: iddm4) en 
3. de verminderde productie van het immuun suppressieve IL-10 door de DC heeft een
 complex associatie patroon, waarbij het lyp (iddm2) gen ook een rol speelt.
In Hoofdstuk 4 beschrijven we experimenten waarin wij van plan waren om DC van 
de thymus van BB-DP/S ratten te isoleren. Wij isoleerden de lage-dichtheid niet-adherente 
cellen uit ratten thymussen. Voor andere weefsels (lymfeklier, milt, schildklier) genereert deze 
procedure een (relatief) zuivere populatie van DC vanuit die weefsels. Tot onze verbazing 
waren de uit de thymus geïsoleerde lage-dichtheidscellen geen DC, maar waren het een relatief 
onbekende populatie van andere antigeen-presenterende cellen uit de thymus, de zogenaamde 
dendritische corticale thymus macrofagen. Deze vertakte corticale macrofagen zijn betrokken 
bij het “redden” van geschikte (bruikbare) T cellen die ontstaan in de cortex (schors) van de 
thymus en die anders zouden afsterven. De vertakte corticale macrofagen van de BB-DP en 
de F344.lyp rat bleken afwijkend in functie en slechter in staat deze geschikte T cellen van de 
dood te redden. Ook waren de defecte vertakte corticale macrofagen van de BB-DP en F344.
lyp rat slechte redders van de in de thymus gegenereerde ART2+ Treg cellen. Defecten in de 
vertakte corticale macrofagen, als beschreven in het BB-DP rat model, dragen dus hoogst 
waarschijnlijk bij aan de deficiënte tolerogene staat van de rat.
In experimenten beschreven in Hoofdstuk 5 simuleerden we de rendezvous tussen antigeen 
en endocytische proteasen in DC die we uit menselijke monocyten hadden opgekweekt. 
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Endocytische proteasen zijn enzymen die betrokken zijn bij het zodanig knippen van antigenen 
dat zij goed aangeboden kunnen worden door DC aan T cellen in het immuniseringproces. 
Door de werking van deze enzymen worden de antigene eiwitten verteerd tot kleine peptiden, 
die geschikt zijn voor belading van MHC klasse II molekulen gevolgd door presentatie aan 
T cellen. De meest belangrijke endocytische proteasen zijn de cysteïne cathepsinen, die we 
kunnen identificeren met behulp van een chemisch instrument, een soort model antigeen, 
het “activity-based probe” (ABP) genoemd. Dit ABP bindt zich aan alle actieve cysteïne 
cathepsinen na opname door een APC. Na opname van ABP door de monocyt-afkomstige DC 
via macropinocytose bleek alleen het cathepsine S door dit ABP bereikt te worden. Blokkade 
van de vacuolaire ATPase bleek deze CatS-selectieve “targeting”, te voorkomen, terwijl 
LPS-geïnduceerde rijping van DC in degradatie van het actieve CatS resulteerde. Dit is in 
overeenstemming met het concept dat onrijpe DC veranderen van antigeen-opnemende cellen 
naar antigeen-presenterende cellen tijdens de rijping. Conjugatie van de ABP aan een eiwit 
vergemakkelijkte het transport naar de endocytische proteasen en resulteerde in het binden van 
ABP aan ook behoorlijke hoeveelheden van andere cysteïne cathepsinen, het CatB en CatX, 
alhoewel CatS toch de belangrijkste protease bleef die bereikt werd door ABP. Conjugatie 
van ABP aan “Cel-Penetrerend Peptide” (CPP) bracht de probe naar het gehele scala aan 
intracellulaire cathepsinen, onafhankelijk van endocytose of LPS-stimulatie. In conclusie: 
Verschillende manieren van antigeen opname resulteren in het verschillend “targeten” van 
actieve cathepsinen in monocyt-afkomstige DC. We concludeerden verder dat CPP kan dienen 
als een vehikel dat antigenen efficiënter in APC kan brengen.
Wanneer wij al de experimenten in het BB rat model samenvatten en vergelijken met 
de gegevens voorheen verkregen met DC in het muis model van type-1 diabetes (de NOD 
muis) en de gegevens gevonden in type-1 diabetes patiënten, wordt een blauwdruk (sjabloon) 
duidelijk wat betreft een gestoorde functie van APC in autoimmuun vormen van diabetes: 
de T cel stimulerende functie van APC is defectieus, de cellen zijn meer macrofaag-achtig 
en zij staan in een ontstekingsbevorderende (pro-inflammatoire) staat afgesteld. De pro-
inflammatoire staat van de APC drijft naïve T cellen voornamelijk in de richting naar de-voor-
de- ontwikkeling-van-diabetes “gevaarlijke” Th1 cellen. Door hun defecte T cel stimulerende 
capaciteit ondersteunen/induceren de defecte APC regulatoire T cellen onvoldoende en zijn 
zij ook minder in staat tot inductie van tolerantie door middel van andere processen, zoals de 
“Activation Induced T Cell Death” (AITCD). De in mijn proefschrift beschreven defecten 
van de DC kunnen daarom als een hoeksteen in de ontstaanswijze van type-1 diabetes worden 
beschouwd.
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De schrijver van dit proefschrift werd geboren te Paramaribo, Suriname. Hij volgde 
zijn voortgezet onderwijs (atheneum) aan het Christelijk Lyceum te Alphen aan den Rijn. 
Na zijn atheneum besloot hij de studie Biologie aan de Rijksuniversiteit Leiden te volgen. 
Als specialisatie werd de richting Medische Biologie gekozen. Het doctoraal examen in de 
Medische Biologie werd behaald met als hoofdvakken dierfysiologie en immunopathologie.
Na de studie Medische Biologie werd begonnen aan het promotieonderzoek op de 
afdeling Immunologie van het Erasmus MC onder leiding van prof. dr. H.A. Drexhage. 
Tijdens het promotieonderzoek werden defecten in de antigeen-presenterende cellen in het 
BB rat model voor type-1 diabetes onderzocht. Tijdens deze periode werden verschillende 
cursussen gevolgd: Medische Immunologie, stralingshygiëne 5B, proefdierkunde, cursus 
Moleculaire Biologie en Oxford English Exam. Na een korte periode docent Biologie te zijn 
geweest, werd in oktober 2005 aangevangen als Postdoc/Research Scientist aan de Eberhard 
Karls Universiteit te Tübingen onder leiding van dr. C. Driessen. Het onderzoeksproject werd 
gefinancieerd door het Marie Curie Research Training Network Project ‘Drugs for therapy’. 
Het doel van dit onderzoeksproject is de rol van endolysosomale proteasen (cathepsinen) in 
antigeen-processering en antigeen-presentatie te elucideren.
The writer of this thesis was born in Paramaribo, Suriname. He followed his High School 
education (atheneum) at the Christian Lyceum in Alphen aan den Rijn. After his high school 
education, he decided to study Biology at the University of Leiden. As a specialization 
Medical Biology was chosen. His doctoral degree in Medical Biology was achieved with 
majors in animal physiology and immunopathology.
After studying Medical Biology he started his PhD research at the department of 
Immunology at the Erasmus MC under supervision of Prof.Dr. H.A. Drexhage. During his 
PhD research he investigated the defects in the antigen-presenting cells in the BB rat model 
of type-1 diabetes. During this period several courses were followed: Medical Immunology, 
radiation course, experimental animal course, Molecular Biology and Oxford English Exam. 
After a short period working as a Biology teacher, he started his current Postdoc/Research 
Scientist position in October 2005 at the Eberhard Karls University in Tübingen under 
supervision of Dr. C. Driessen. The research project was financed by the Marie Curie Research 
Training Network ‘Drugs for therapy’. The aim of this research project is to elucidate the role 
of endolysosomal proteases (cathepsins) in antigen-processing and antigen-presentation.
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Chapter II Figure 1. Characteristics of rat bone-marrow derived DC. 
When bone-marrow precursors are cultured in GM-CSF/IL-4 two OX62+CD11c+ populations are obtained: 
(A) a population of adherent (colony-forming) cells and (B) a non-adherent population of floating single cells. 
Although the non-adherent cells show a definite, but lower expression of MHC class II (C) as compared to adherent 
cells, the cells have a much higher capability to stimulate T cells to proliferate (D, mean ± standard deviations are 
shown; n=10). The T cell stimulatory capacity was measured in syngeneic MLR and expressed as the incorporation 
of 3H-thymidine (c.p.m.) in the stimulated T cells. The adherent cells also have various macrophage characteristics 
like a higher ED1 (E), ED2 (F) and ED3 (G) expression and a stronger and ‘‘spotty’’ acid phosphatase activity (A). 
We therefore consider the non-adherent cells as the typical DC. The grey tone in (C, E, F and G) represents the non-
adherent cells. The black line in (C, E, F and G) represents the adherent cells. The isotype control is depicted as a grey 
line. Representative figures are shown in (C, E, F and G) (n=18). Wistar rat DC are shown (similar results are found 
for BB and Fischer rats; data not shown).
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Appendix
Chapter III Figure 1. Characteristics of rat bone-marrow derived DC. When bone-marrow precursors are 
cultured in GM-CSF/IL-4 two OX62+CD11c+ populations are obtained: a population of adherent (colony-
forming) cells and a non-adherent population of floating single cells.
Although the non-adherent cells show a definite, but lower expression of MHC class II (C) as compared to adherent 
cells, the cells have a much higher capability to stimulate T cells to proliferate (D; n=10). The adherent cells also 
have more macrophage characteristics like a higher ED1 (E), ED2 (F) and ED3 (G) expression and a stronger and 
‘‘spotty’’ acid phosphatase activity (A). We therefore consider the non-adherent cells as the typical DC. Interestingly, 
Ian5 mRNA is not expressed in myeloid DC (H). The grey tone in (C), (E)-(G) represents the non-adherent cells. 
The dotted line represents isotype control. Representative figures are shown in (C), (E)-(G) (n=18). Experiments 
shown were performed in Wistar rats. The magnification for (A) and (B) is 64x and 96x, respectively. 
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Chapter IV Figure 1. 
(A) Dot plot of thymus low-density cells (LDC) with ED2 expression on the x-axis and MHC class II on the y-axis. 
Negative cells are in the boxed area. Note that the majority of the LDC are ED2+ and approximately half are MHC 
class II+. The latter population is also the strongest positive for ED2 (for quantitative data, see Figure 1F). (B) Dot 
plot of thymus LDC with OX62 expression on the x-axis and MHC class II on the y-axis. Note that only a minority 
of LDC is intermediately positive for OX62 (for quantitative data see Figure 1F). (C) Immune cytology of thymus 
LDC with ED2 (red) and MHC class II (blue). Magnification X 1000; no counterstaining. It can clearly be seen that 
the majority of cells is ED2+, and that about half of them stain double for MHC class II (particularly the large cells).
(D) Immune cytology of thymus LDC with ED2 (red) and OX62 (blue). Magnification X 1000. A weaker staining was 
used for ED2 as compared with Figure 1C by shorter development of the staining step, since OX62 staining appeared 
rather faint; no counterstaining. It shows that part of the ED2+ cells are also faintly OX62+. (E) Immune cytology 
of thymus LDC with MHC class II (blue). Magnification X 1000. Overstaining was used by longer development 
of the staining step to clearly visualize the long, cellular protrusions (branches/dendrites). No counterstaining. 
(F) Quantification of marker positive LDC in flowcytometric analysis.
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Chapter IV Figure 2.
(A) Immunohistochemistry of a F344.+/+ rat thymus stained for ED2 (magnification X 150). The ED2+ cells in the 
cortex (i.e. the branched cortical macrophages) are clearly visible. (B) Immunohistochemistry of a F344.+/+ rat 
thymus stained for OX62 (magnification X 150). The positivity for OX62 of the cortico-medullary and medullary 
dendritic cells can clearly be seen.

